RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy17162
         (182 letters)



>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity
           Protein Kinases, MAP kinase kinases 3 and 6.  Protein
           kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6
           subfamily, catalytic (c) domain. PKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MKK3 and MKK6 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MKK3 and MKK6 are dual-specificity PKs that
           phosphorylate and activate their downstream target, p38
           MAPK, on specific threonine and tyrosine residues.
           MKK3/6 plays roles in the regulation of cell cycle
           progression, cytokine- and stress-induced apoptosis,
           oncogenic transformation, and adult tissue regeneration.
           In addition, MKK6 plays a critical role in osteoclast
           survival in inflammatory disease while MKK3 is
           associated with tumor invasion, progression, and poor
           patient survival in glioma.
          Length = 283

 Score =  139 bits (353), Expect = 3e-41
 Identities = 47/82 (57%), Positives = 64/82 (78%), Gaps = 1/82 (1%)

Query: 101 ADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQ 160
           A C P ++ PERI+P  N   YD++SDVWSLGI++IELATGRFPYD+W +PF+QLKQVV+
Sbjct: 164 AGCKP-YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Query: 161 DDPPRLPPGEFSSDFKDFITLW 182
           +  P+LP  +FS +F+DF+   
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKC 244


>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein
           Kinase, MAP kinase kinase 4.  Protein kinases (PKs), MAP
           kinase kinase 4 (MKK4) subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MKK4 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising of the MAP
           kinase (MAPK), which is phosphorylated and activated by
           a MAPK kinase (MAPKK or MKK), which itself is
           phosphorylated and activated by a MAPK kinase kinase
           (MAPKKK or MKKK). MKK4 is a dual-specificity PK that
           phosphorylates and activates the downstream targets,
           c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific
           threonine and tyrosine residues. JNK and p38 are
           collectively known as stress-activated MAPKs, as they
           are activated in response to a variety of environmental
           stresses and pro-inflammatory cytokines. Their
           activation is associated with the induction of cell
           death. Mice deficient in MKK4 die during embryogenesis
           and display anemia, severe liver hemorrhage, and
           abnormal hepatogenesis. MKK4 may also play roles in the
           immune system and in cardiac hypertrophy. It plays a
           major role in cancer as a tumor and metastasis
           suppressor. Under certain conditions, MKK4 is
           pro-oncogenic.
          Length = 288

 Score =  122 bits (308), Expect = 2e-34
 Identities = 48/84 (57%), Positives = 57/84 (67%), Gaps = 5/84 (5%)

Query: 101 ADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQ 160
           A C P ++ PERIDPS     YD+RSDVWSLGI+L E+ATG+FPY  W S F+QL QVV+
Sbjct: 168 AGCRP-YMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK 225

Query: 161 DDPPRLPPG---EFSSDFKDFITL 181
            DPP L      EFS  F +FI L
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINL 249


>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity
           Protein Kinase, Mitogen-Activated Protein Kinase Kinase.
            Protein kinases (PKs), MAP kinase kinase (MAPKK)
           subfamily, catalytic (c) domain. PKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK or MAP2K), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK or
           MAP3K). MAPKKs are dual-specificity PKs that
           phosphorylate their downstream targets, MAPKs, at
           specific threonine and tyrosine residues. There are
           three MAPK subfamilies: extracellular signal-regulated
           kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In
           mammalian cells, there are seven MAPKKs (named MKK1-7)
           and 20 MAPKKKs. Each MAPK subfamily can be activated by
           at least two cognate MAPKKs and by multiple MAPKKKs.
          Length = 265

 Score =  114 bits (288), Expect = 9e-32
 Identities = 41/80 (51%), Positives = 55/80 (68%), Gaps = 8/80 (10%)

Query: 106 NFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY----DTWGSPFEQLKQVVQD 161
           +++ PERI  +     Y ++SD+WSLG+SLIELATGRFPY    D     FE L+ +V +
Sbjct: 164 SYMAPERIQGND----YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219

Query: 162 DPPRLPPGEFSSDFKDFITL 181
            PPRLP G+FS DF+DF+ L
Sbjct: 220 PPPRLPSGKFSPDFQDFVNL 239


>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein
           Kinase, MAP kinase kinase 7.  Protein kinases (PKs), MAP
           kinase kinase 7 (MKK7) subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MKK7 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MKK7 is a dual-specificity PK that phosphorylates and
           activates its downstream target, c-Jun N-terminal kinase
           (JNK), on specific threonine and tyrosine residues.
           Although MKK7 is capable of dual phosphorylation, it
           prefers to phosphorylate the threonine residue of JNK.
           Thus, optimal activation of JNK requires both MKK4 (not
           included in this subfamily) and MKK7. MKK7 is primarily
           activated by cytokines. MKK7 is essential for liver
           formation during embryogenesis. It plays roles in G2/M
           cell cycle arrest and cell growth. In addition, it is
           involved in the control of programmed cell death, which
           is crucial in oncogenesis, cancer chemoresistance, and
           antagonism to TNFalpha-induced killing, through its
           inhibition by Gadd45beta and the subsequent suppression
           of the JNK cascade.
          Length = 296

 Score =  112 bits (282), Expect = 1e-30
 Identities = 45/83 (54%), Positives = 57/83 (68%), Gaps = 2/83 (2%)

Query: 100 GADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVV 159
            A C   ++ PERIDP      YDIR+DVWSLGISL+ELATG+FPY    + FE L +++
Sbjct: 174 SAGC-AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 160 QDDPPRLPPGE-FSSDFKDFITL 181
           Q++PP LPP E FS DF  F+ L
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDL 255


>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant
           dual-specificity MAP kinase kinases and similar
           proteins.  Protein kinases (PKs), MAP kinase kinase
           (MAPKK) subfamily, Plant MAPKKs and similar proteins,
           catalytic (c) domain. PKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine or
           tyrosine residues on protein substrates. The MAPKK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein serine/threonine
           kinases, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. The mitogen-activated protein
           (MAP) kinase signaling pathways are important mediators
           of cellular responses to extracellular signals. The
           pathways involve a triple kinase core cascade comprising
           of the MAP kinase (MAPK), which is phosphorylated and
           activated by a MAPK kinase (MAPKK or MKK), which itself
           is phosphorylated and activated by a MAPK kinase kinase
           (MAPKKK or MKKK). Members of this group include MAPKKs
           from plants, kinetoplastids, alveolates, and mycetozoa.
           The MAPKK, LmxPK4, from Leishmania mexicana, is
           important in differentiation and virulence.
           Dictyostelium discoideum MEK1 is required for proper
           chemotaxis. MEK1 null mutants display severe defects in
           cell polarization and directional movement. Plants
           contain multiple MAPKKs like other eukaryotes. The
           Arabidopsis genome encodes for 10 MAPKKs while poplar
           and rice contain 13 MAPKKs each. The functions of these
           proteins have not been fully elucidated. There is
           evidence to suggest that MAPK cascades are involved in
           plant stress responses. In Arabidopsis, MKK3 plays a
           role in pathogen signaling, MKK2 is involved in cold and
           salt stress signaling, MKK4/MKK5 participates in innate
           immunity, and MKK7 regulates basal and systemic acquired
           resistance.
          Length = 264

 Score = 86.9 bits (216), Expect = 4e-21
 Identities = 31/74 (41%), Positives = 45/74 (60%), Gaps = 6/74 (8%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY--DTWGSPFEQLKQVVQDDPPRLP 167
           PERI   G   +Y   +D+WSLG++L+E A G+FP+      S FE ++ +    PP LP
Sbjct: 169 PERIQ--GESYSYA--ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP 224

Query: 168 PGEFSSDFKDFITL 181
             EFS +F+DFI+ 
Sbjct: 225 AEEFSPEFRDFISA 238


>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like
           dual-specificity MAP kinase kinases.  Protein kinases
           (PKs), MAP kinase kinase (MAPKK) subfamily, fungal
           PBS2-like proteins, catalytic (c) domain. PKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK).
           Members of this group include the MAPKKs Polymyxin B
           resistance protein 2 (PBS2) from Saccharomyces
           cerevisiae, Wis1 from Schizosaccharomyces pombe, and
           related proteins. PBS2 and Wis1 are components of
           stress-activated MAPK cascades in budding and fission
           yeast, respectively. PBS2 is the specific activator of
           the MAPK Hog1, which plays a central role in the
           response of budding yeast to stress including exposure
           to arsenite and hyperosmotic environments. Wis1
           phosphorylates and activates the MAPK Sty1 (also called
           Spc1 or Phh1), which stimulates a transcriptional
           response to a wide range of cellular insults through the
           bZip transcription factors Atf1, Pcr1, and Pap1.
          Length = 286

 Score = 83.4 bits (206), Expect = 9e-20
 Identities = 37/81 (45%), Positives = 56/81 (69%), Gaps = 7/81 (8%)

Query: 106 NFIRPERI---DPSGNPSNYDIRSDVWSLGISLIELATGRFPY--DTWGSPFEQLKQVVQ 160
           +++ PERI    P+ NP+ Y ++SDVWSLG+S++E+A GR+PY  +T+ + F QL  +V 
Sbjct: 166 SYMAPERIKSGGPNQNPT-YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224

Query: 161 DDPPRLPPGEFSSDFKDFITL 181
            DPP LP G +S D +DF+  
Sbjct: 225 GDPPTLPSG-YSDDAQDFVAK 244


>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein
           Kinase, MAP kinase kinase 5.  Protein kinases (PKs), MAP
           kinase kinase 5 (MKK5) subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MKK5 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising of the MAP
           kinase (MAPK), which is phosphorylated and activated by
           a MAPK kinase (MAPKK or MKK), which itself is
           phosphorylated and activated by a MAPK kinase kinase
           (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a
           dual-specificity PK that phosphorylates its downstream
           target, extracellular signal-regulated kinase 5 (ERK5),
           on specific threonine and tyrosine residues. MKK5 is
           activated by MEKK2 and MEKK3 in response to mitogenic
           and stress stimuli. The ERK5 cascade promotes cell
           proliferation, differentiation, neuronal survival, and
           neuroprotection. This cascade plays an essential role in
           heart development. Mice deficient in either ERK5 or MKK5
           die around embryonic day 10 due to cardiovascular
           defects including underdevelopment of the myocardium. In
           addition, MKK5 is associated with metastasis and
           unfavorable prognosis in prostate cancer.
          Length = 279

 Score = 80.3 bits (198), Expect = 2e-18
 Identities = 42/80 (52%), Positives = 50/80 (62%), Gaps = 10/80 (12%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY----DTWGS--PFEQLKQVVQ 160
           ++ PERI  SG    Y I SDVWSLGIS +ELA GRFPY       GS  P + L+ +V 
Sbjct: 159 YMAPERI--SGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214

Query: 161 DDPPRLPPGEFSSDFKDFIT 180
           +DPP LP G+FS  F  FIT
Sbjct: 215 EDPPVLPVGQFSEKFVHFIT 234


>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like
           dual-specificity MAP kinase kinases.  Protein kinases
           (PKs), MAP kinase kinase (MAPKK) subfamily, fungal
           Byr1-like proteins, catalytic (c) domain. PKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK).
           Members of this group include the MAPKKs Byr1 from
           Schizosaccharomyces pombe, FUZ7 from Ustilago maydis,
           and related proteins. Byr1 phosphorylates its downstream
           target, the MAPK Spk1, and is regulated by the MAPKKK
           Byr2. The Spk1 cascade is pheromone-responsive and is
           essential for sporulation and sexual differentiation in
           fission yeast. FUZ7 phosphorylates and activates its
           target, the MAPK Crk1, which is required in mating and
           virulence in U. maydis.
          Length = 284

 Score = 77.5 bits (191), Expect = 2e-17
 Identities = 36/83 (43%), Positives = 50/83 (60%), Gaps = 14/83 (16%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY-------DTWGSP---FEQLK 156
           ++ PERI        Y ++SDVWSLGIS+IELA G+FP+       D    P    + L+
Sbjct: 168 YMSPERI----QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223

Query: 157 QVVQDDPPRLPPGEFSSDFKDFI 179
           Q+VQ+ PPRLP  +F  D +DF+
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFV 246


>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like
           dual-specificity MAP kinase kinases.  Protein kinases
           (PKs), MAP kinase kinase(MAPKK) subfamily, fungal
           Pek1-like proteins, catalytic (c) domain. PKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK).
           Members of this group include the MAPKKs Pek1/Skh1 from
           Schizosaccharomyces pombe and MKK2 from Saccharomyces
           cerevisiae, and related proteins. Both fission yeast
           Pek1 and baker's yeast MKK2 are components of the cell
           integrity MAPK pathway. In fission yeast, Pek1
           phosphorylates and activates the MAPK Pmk1/Spm1 and is
           regulated by the MAPKKK Mkh1. In baker's yeast, the
           pathway involves the MAPK Slt2, the MAPKKs MKK1 and
           MKK2, and the MAPKKK Bck1. The cell integrity MAPK
           cascade is activated by multiple stress conditions, and
           is essential  in cell wall construction, morphogenesis,
           cytokinesis, and ion homeostasis.
          Length = 287

 Score = 67.5 bits (165), Expect = 8e-14
 Identities = 36/79 (45%), Positives = 44/79 (55%), Gaps = 13/79 (16%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGS----PFEQLKQVVQDDPPR 165
           PERI   G P  Y I SDVWSLG++L+E+A  RFP+   G     P E L  +V    P 
Sbjct: 172 PERI--QGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227

Query: 166 LP--PGE---FSSDFKDFI 179
           L   PG    +S +FKDFI
Sbjct: 228 LKDEPGNGIKWSEEFKDFI 246


>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases.
           Protein Kinases (PKs), STE family, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The STE family is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases (STKs), protein
           tyrosine kinases (PTKs), RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase (PI3K). This family is composed of STKs, and
           some dual-specificity PKs that phosphorylate both
           threonine and tyrosine residues of target proteins. Most
           members are kinases involved in mitogen-activated
           protein kinase (MAPK) signaling cascades, acting as MAPK
           kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK
           kinase kinase kinases (MAP4Ks). The MAPK signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAPK, which is
           phosphorylated and activated by a MAPKK, which itself is
           phosphorylated and activated by a MAPKKK. Each MAPK
           cascade is activated either by a small GTP-binding
           protein or by an adaptor protein, which transmits the
           signal either directly to a MAPKKK to start the triple
           kinase core cascade or indirectly through a mediator
           kinase, a MAP4K. Other STE family members include
           p21-activated kinases (PAKs) and class III myosins,
           among others. PAKs are Rho family GTPase-regulated
           kinases that serve as important mediators in the
           function of Cdc42 (cell division cycle 42) and Rac.
           Class III myosins are motor proteins containing an
           N-terminal kinase catalytic domain and a C-terminal
           actin-binding domain, which can phosphorylate several
           cytoskeletal proteins, conventional myosin regulatory
           light chains, as well as autophosphorylate the
           C-terminal motor domain. They play an important role in
           maintaining the structural integrity of photoreceptor
           cell microvilli.
          Length = 253

 Score = 65.7 bits (161), Expect = 2e-13
 Identities = 33/78 (42%), Positives = 46/78 (58%), Gaps = 6/78 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  +G P  YD ++D+WSLGI+ IELA G+ PY     P + L ++  + PP
Sbjct: 161 PYWMAPEVI--NGKP--YDYKADIWSLGITAIELAEGKPPYSELP-PMKALFKIATNGPP 215

Query: 165 RLPPGEFSSD-FKDFITL 181
            L   E  SD FKDF+  
Sbjct: 216 GLRNPEKWSDEFKDFLKK 233


>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic
           domain.  Phosphotransferases. Serine or
           threonine-specific kinase subfamily.
          Length = 254

 Score = 64.9 bits (159), Expect = 5e-13
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 5/76 (6%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE +   G    Y    D+WSLG+ L EL TG+ P+       E  K++ +  PP
Sbjct: 160 PEYMAPEVLLGKG----YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 215

Query: 165 -RLPPGEFSSDFKDFI 179
              P  + S + KD I
Sbjct: 216 FPPPEWDISPEAKDLI 231


>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like
           protein kinase 3-like Protein Serine/Threonine Kinases. 
           Serine/threonine kinases (STKs), mammalian Ste20-like
           protein kinase 3 (MST3)-like subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MST3-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This subfamily is composed of MST3, MST4,
           STK25, Schizosaccharomyces pombe Nak1 and Sid1,
           Saccharomyces cerevisiae sporulation-specific protein 1
           (SPS1), and related proteins. Nak1 is required by
           fission yeast for polarizing the tips of actin
           cytoskeleton and is involved in cell growth, cell
           separation, cell morphology and cell-cycle progression.
           Sid1 is a component in the septation initiation network
           (SIN) signaling pathway, and plays a role in
           cytokinesis. SPS1 plays a role in regulating proteins
           required for spore wall formation. MST4 plays a role in
           mitogen-activated protein kinase (MAPK) signaling during
           cytoskeletal rearrangement, morphogenesis, and
           apoptosis. MST3 phosphorylates the STK NDR and may play
           a role in cell cycle progression and cell morphology.
           STK25 may play a role in the regulation of cell
           migration and polarization.
          Length = 274

 Score = 63.4 bits (155), Expect = 2e-12
 Identities = 26/60 (43%), Positives = 36/60 (60%), Gaps = 1/60 (1%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
           S YD ++D+WSLGI+ IELA G  P      P   L  + +++PP L   +FS  FKDF+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231


>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control
           protein 7-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs),  (Cdc7)-like subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Cdc7-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this subfamily include
           Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae
           Cdc15, Arabidopsis thaliana mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK) epsilon, and
           related proteins. MAPKKKs phosphorylate and activate
           MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals. Fission yeast Cdc7
           is essential for cell division by playing a key role in
           the initiation of septum formation and cytokinesis.
           Budding yeast Cdc15 functions to coordinate mitotic exit
           with cytokinesis. Arabidopsis MAPKKK epsilon is required
           for pollen development in the plasma membrane.
          Length = 254

 Score = 63.0 bits (154), Expect = 2e-12
 Identities = 33/76 (43%), Positives = 44/76 (57%), Gaps = 6/76 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I+ SG        SD+WSLG ++IEL TG  PY    +P   L ++VQDD P
Sbjct: 163 PYWMAPEVIEMSG----ASTASDIWSLGCTVIELLTGNPPYYD-LNPMAALFRIVQDDHP 217

Query: 165 RLPPGEFSSDFKDFIT 180
            LP G  S + KDF+ 
Sbjct: 218 PLPEG-ISPELKDFLM 232


>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein
           Kinase, MAP/ERK Kinase.  Protein kinases (PKs), MAP/ERK
           kinase (MEK) subfamily, catalytic (c) domain. PKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine or tyrosine residues on protein
           substrates. The MEK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1
           and MEK2 are dual-specificity PKs that phosphorylate and
           activate the downstream targets, ERK(extracellular
           signal-regulated kinase) 1 and ERK2, on specific
           threonine and tyrosine residues. The ERK cascade starts
           with extracellular signals including growth factors,
           hormones, and neurotransmitters, which act through
           receptors and ion channels to initiate intracellular
           signaling that leads to the activation at the MAPKKK
           (Raf-1 or MOS) level, which leads to the transmission of
           signals to MEK1/2, and finally to ERK1/2. The ERK
           cascade plays an important role in cell proliferation,
           differentiation, oncogenic transformation, and cell
           cycle control, as well as in apoptosis and cell survival
           under certain conditions. This cascade has also been
           implicated in synaptic plasticity, migration,
           morphological determination, and stress response
           immunological reactions. Gain-of-function mutations in
           genes encoding ERK cascade proteins, including MEK1/2,
           cause cardiofaciocutaneous (CFC) syndrome, a condition
           leading to multiple congenital anomalies and mental
           retardation in patients.
          Length = 308

 Score = 63.6 bits (155), Expect = 2e-12
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 39/108 (36%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP---------------------- 144
           ++ PER+      ++Y ++SD+WSLG+SL+E+A GR+P                      
Sbjct: 164 YMSPERL----QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219

Query: 145 ----YDTWGSP---------FEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
                   G P         FE L  +V + PP+LP G FS +F+DF+
Sbjct: 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFV 267


>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein
           Serine/Threonine Kinases, Oxidative stress response
           kinase and Ste20-related proline alanine-rich kinase.
           Serine/threonine kinases (STKs), oxidative stress
           response kinase (OSR1) and Ste20-related proline
           alanine-rich kinase (SPAK) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The OSR1 and SPAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. SPAK is also referred to as STK39 or PASK
           (proline-alanine-rich STE20-related kinase). OSR1 and
           SPAK regulate the activity of cation-chloride
           cotransporters through direct interaction and
           phosphorylation. They are also implicated in
           cytoskeletal rearrangement, cell differentiation,
           transformation and proliferation. OSR1 and SPAK contain
           a conserved C-terminal (CCT) domain, which recognizes a
           unique motif ([RK]FX[VI]) present in their activating
           kinases (WNK1/WNK4) and their substrates.
          Length = 267

 Score = 62.0 bits (151), Expect = 6e-12
 Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 5/64 (7%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGE----FSSDFKD 177
           YD ++D+WS GI+ IELATG  PY  +  P + L   +Q+DPP L  G     +S  F+ 
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQNDPPSLETGADYKKYSKSFRK 242

Query: 178 FITL 181
            I+L
Sbjct: 243 MISL 246


>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III
           myosin-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs), Class III myosin-like
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           class III myosin-like subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Class III myosins are motor
           proteins with an N-terminal kinase catalytic domain and
           a C-terminal actin-binding motor domain. Class III
           myosins are present in the photoreceptors of
           invertebrates and vertebrates and in the auditory hair
           cells of mammals. The kinase domain of myosin III can
           phosphorylate several cytoskeletal proteins,
           conventional myosin regulatory light chains, and can
           autophosphorylate the C-terminal motor domain. Myosin
           III may play an important role in maintaining the
           structural integrity of photoreceptor cell microvilli.
           It may also function as a cargo carrier during
           light-dependent translocation, in photoreceptor cells,
           of proteins such as transducin and arrestin. The
           Drosophila class III myosin, called NinaC (Neither
           inactivation nor afterpotential protein C), is critical
           in normal adaptation and termination of photoresponse.
           Vertebrates contain two isoforms of class III myosin,
           IIIA and IIIB. This subfamily also includes mammalian
           NIK-like embryo-specific kinase (NESK), Traf2- and
           Nck-interacting kinase (TNIK), mitogen-activated protein
           kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or
           MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in
           some MAPK signaling pathways by activating a MAPK kinase
           kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is
           activated either by a small GTP-binding protein or by an
           adaptor protein, which transmits the signal either
           directly to a MAP3K to start the triple kinase core
           cascade or indirectly through a mediator kinase, a
           MAP4K. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
          Length = 275

 Score = 61.5 bits (150), Expect = 8e-12
 Identities = 34/79 (43%), Positives = 46/79 (58%), Gaps = 5/79 (6%)

Query: 105 PNFIRPERIDPSGNP-SNYDIRSDVWSLGISLIELATGRFPY-DTWGSPFEQLKQVVQDD 162
           P ++ PE I     P ++YD RSDVWSLGI+ IELA G+ P  D    P   L ++ ++ 
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM--HPMRALFKIPRNP 234

Query: 163 PPRL-PPGEFSSDFKDFIT 180
           PP L  P  +S  F DFI+
Sbjct: 235 PPTLKSPENWSKKFNDFIS 253


>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like
           Protein Serine/Threonine Kinases.  Serine/threonine
           kinases (STKs), Ste20-like kinase (SLK)-like subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The SLK-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of the subfamily include SLK, STK10
           (also called LOK for lymphocyte-oriented kinase), SmSLK
           (Schistosoma mansoni SLK), and related proteins. SLK
           promotes apoptosis through apoptosis signal-regulating
           kinase 1 (ASK1) and the mitogen-activated protein kinase
           (MAPK) p38. It also plays a role in mediating actin
           reorganization. STK10 is responsible in regulating the
           CD28 responsive element in T cells, as well as leukocyte
           function associated antigen (LFA-1)-mediated lymphocyte
           adhesion. SmSLK is capable of activating the MAPK Jun
           N-terminal kinase (JNK) pathway in human embryonic
           kidney (HEK) cells as well as in Xenopus oocytes. It may
           participate in regulating MAPK cascades during
           host-parasite interactions.
          Length = 280

 Score = 59.0 bits (143), Expect = 7e-11
 Identities = 25/60 (41%), Positives = 39/60 (65%), Gaps = 2/60 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRL-PPGEFSSDFKDFIT 180
           YD ++D+WSLGI+LIELA    P+    +P   L ++++ +PP L  P ++SS F DF+ 
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243


>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein
           Serine/Threonine Kinases, Mammalian Ste20-like protein
           kinase 1 and 2.  Serine/threonine kinases (STKs),
           mammalian Ste20-like protein kinase 1 (MST1) and MST2
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MST1/2 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This subfamily is composed of MST1, MST2, and
           related proteins including Drosophila Hippo and
           Dictyostelium discoideum Krs1 (kinase responsive to
           stress 1). MST1/2 and Hippo are involved in a conserved
           pathway that governs cell contact inhibition, organ size
           control, and tumor development. MST1 activates the
           mitogen-activated protein kinases (MAPKs) p38 and c-Jun
           N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and
           MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase
           kinase kinase (MAPKKKK). Activation of JNK by MST1 leads
           to caspase activation and apoptosis. MST1 has also been
           implicated in cell proliferation and differentiation.
           Krs1 may regulate cell growth arrest and apoptosis in
           response to cellular stress.
          Length = 256

 Score = 58.0 bits (141), Expect = 1e-10
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 6/76 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I        Y+ ++D+WSLGI+ IE+A G+ PY     P   +  +    PP
Sbjct: 163 PFWMAPEVI----QEIGYNNKADIWSLGITAIEMAEGKPPYSDI-HPMRAIFMIPNKPPP 217

Query: 165 RLP-PGEFSSDFKDFI 179
            L  P ++S +F DF+
Sbjct: 218 TLSDPEKWSPEFNDFV 233


>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine
           Kinase, Thousand-and-one amino acids proteins.
           Serine/threonine kinases (STKs), thousand-and-one amino
           acids (TAO) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. They activate the MAPKs, p38 and c-Jun
           N-terminal kinase (JNK), by phosphorylating and
           activating the respective MAP/ERK kinases (MEKs, also
           known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK
           signaling cascades are important in mediating cellular
           responses to extracellular signals. Vertebrates contain
           three TAO subfamily members, named TAO1, TAO2, and TAO3.
          Length = 307

 Score = 57.9 bits (140), Expect = 2e-10
 Identities = 26/77 (33%), Positives = 41/77 (53%), Gaps = 2/77 (2%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  + +   YD + DVWSLGI+ IELA  + P     +    L  + Q+D P
Sbjct: 175 PYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNDSP 232

Query: 165 RLPPGEFSSDFKDFITL 181
            L   ++S  F++F+  
Sbjct: 233 TLSSNDWSDYFRNFVDS 249


>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like
           Protein Serine/Threonine Kinases.  Serine/threonine
           kinases (STKs), Nak1 subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The Nak1 subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. This subfamily is composed of
           Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae
           Kic1p (kinase that interacts with Cdc31p) and related
           proteins. Nak1 (also known as N-rich kinase 1), is
           required by fission yeast for polarizing the tips of
           actin cytoskeleton and is involved in cell growth, cell
           separation, cell morphology and cell-cycle progression.
           Kic1p is required by budding yeast for cell integrity
           and morphogenesis. Kic1p interacts with Cdc31p, the
           yeast homologue of centrin, and phosphorylates
           substrates in a Cdc31p-dependent manner.
          Length = 277

 Score = 57.1 bits (138), Expect = 3e-10
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 4/77 (5%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I        YD ++D+WSLGI++ E+ATG  PY      F  +  + +  PP
Sbjct: 165 PYWMAPEVITEG---KYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIPKSKPP 220

Query: 165 RLPPGEFSSDFKDFITL 181
           RL    +S   ++F+  
Sbjct: 221 RLEDNGYSKLLREFVAA 237


>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein
           Kinase, MAP/ERK Kinase 2.  Protein kinases (PKs),
           MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MEK subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MEK2 is a dual-specificity PK that phosphorylates and
           activates the downstream targets, extracellular
           signal-regulated kinase (ERK) 1 and ERK2, on specific
           threonine and tyrosine residues. The ERK cascade starts
           with extracellular signals including growth factors,
           hormones, and neurotransmitters, which act through
           receptors and ion channels to initiate intracellular
           signaling that leads to the activation at the MAPKKK
           (Raf-1 or MOS) level, which leads to the transmission of
           signals to MEK2, and finally to ERK1/2. The ERK cascade
           plays an important role in cell proliferation,
           differentiation, oncogenic transformation, and cell
           cycle control, as well as in apoptosis and cell survival
           under certain conditions. Gain-of-function mutations in
           genes encoding  ERK cascade proteins, including MEK2,
           cause cardiofaciocutaneous (CFC) syndrome, a condition
           leading to multiple congenital anomalies and mental
           retardation in patients.
          Length = 331

 Score = 56.6 bits (136), Expect = 6e-10
 Identities = 32/120 (26%), Positives = 53/120 (44%), Gaps = 49/120 (40%)

Query: 106 NFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYD---------TWGSP----- 151
           +++ PER+      ++Y ++SD+WS+G+SL+ELA GR+P            +G P     
Sbjct: 167 SYMSPERL----QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE 222

Query: 152 -------------------------------FEQLKQVVQDDPPRLPPGEFSSDFKDFIT 180
                                          FE L  +V + PP+LP G F+ DF++F+ 
Sbjct: 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVN 282


>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein
           Serine/Threonine Kinases, Mitogen-Activated Protein
           Kinase Kinase Kinase Kinase 4 and 6.  Serine/threonine
           kinases (STKs), mitogen-activated protein kinase (MAPK)
           kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6
           (or MAP4K6) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The MAP4K4/MAP4K6 subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Members of this subfamily
           contain an N-terminal catalytic domain and a C-terminal
           citron homology (CNH) regulatory domain. MAP4Ks (or
           MAPKKKKs) are involved in MAPK signaling pathways that
           are important in mediating cellular responses to
           extracellular signals by activating a MAPK kinase kinase
           (MAPKKK or MAP3K or MKKK). Each MAPK cascade is
           activated either by a small GTP-binding protein or by an
           adaptor protein, which transmits the signal either
           directly to a MAP3K to start the triple kinase core
           cascade or indirectly through a mediator kinase, a
           MAP4K. MAP4K4 is also called Nck Interacting kinase
           (NIK). It facilitates the activation of the MAPKs,
           extracellular signal-regulated kinase (ERK) 1, ERK2, and
           c-Jun N-terminal kinase (JNK), by phosphorylating and
           activating MEKK1. MAP4K4 plays a role in tumor necrosis
           factor (TNF) alpha-induced insulin resistance. MAP4K4
           silencing in skeletal muscle cells from type II diabetic
           patients restores insulin-mediated glucose uptake.
           MAP4K4, through JNK, also plays a broad role in cell
           motility, which impacts inflammation, homeostasis, as
           well as the invasion and spread of cancer. MAP4K4 is
           found to be highly expressed in most tumor cell lines
           relative to normal tissue. MAP4K6 (also called MINK for
           Misshapen/NIKs-related kinase) is activated after Ras
           induction and mediates activation of p38 MAPK. MAP4K6
           plays a role in cell cycle arrest, cytoskeleton
           organization, cell adhesion, and cell motility.
          Length = 282

 Score = 55.8 bits (134), Expect = 9e-10
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 2/76 (2%)

Query: 105 PNFIRPERIDPSGNP-SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDP 163
           P ++ PE I    NP + YD RSD+WSLGI+ IE+A G  P      P   L  + ++ P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPP 243

Query: 164 PRLPPGEFSSDFKDFI 179
           P+L   ++S  F DFI
Sbjct: 244 PKLKSKKWSKKFIDFI 259


>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein
           Kinase, MAP/ERK Kinase 1.  Protein kinases (PKs),
           MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MEK subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MEK1 is a dual-specificity PK that phosphorylates and
           activates the downstream targets, extracellular
           signal-regulated kinase (ERK) 1 and ERK2, on specific
           threonine and tyrosine residues. The ERK cascade starts
           with extracellular signals including growth factors,
           hormones, and neurotransmitters, which act through
           receptors and ion channels to initiate intracellular
           signaling that leads to the activation at the MAPKKK
           (Raf-1 or MOS) level, which leads to the transmission of
           signals to MEK1, and finally to ERK1/2. The ERK cascade
           plays an important role in cell proliferation,
           differentiation, oncogenic transformation, and cell
           cycle control, as well as in apoptosis and cell survival
           under certain conditions. Gain-of-function mutations in
           genes encoding ERK cascade proteins, including MEK1,
           cause cardiofaciocutaneous (CFC) syndrome, a condition
           leading to multiple congenital anomalies and mental
           retardation in patients. MEK1 also plays a role in cell
           cycle control.
          Length = 333

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 47/117 (40%)

Query: 106 NFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP--------------------- 144
           +++ PER+      ++Y ++SD+WS+G+SL+E+A GR+P                     
Sbjct: 167 SYMSPERL----QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP 222

Query: 145 --YDTWGSP--------------------FEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
              +T   P                    FE L  +V + PP+LP G F ++F+DF+
Sbjct: 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFV 279


>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, STK25 or Yeast
           Sps1/Ste20-related kinase 1.  Serine/threonine kinases
           (STKs), STK25 subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The STK25 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. STK25 is also called Ste20/oxidant stress
           response kinase 1 (SOK1) or yeast Sps1/Ste20-related
           kinase 1 (YSK1). STK25 is localized in the Golgi
           apparatus through its interaction with the Golgi matrix
           protein GM130. It may play a role in the regulation of
           cell migration and polarization. STK25 binds and
           phosphorylates CCM3 (cerebral cavernous malformation 3),
           also called PCD10 (programmed cell death 10), and may
           play a role in apoptosis. Human STK25 is a candidate
           gene responsible for pseudopseudohypoparathyroidism
           (PPHP), a disease that shares features with the Albright
           hereditary osteodystrophy (AHO) phenotype.
          Length = 277

 Score = 54.7 bits (131), Expect = 2e-09
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 8/100 (8%)

Query: 80  LFRFALSGNQDDLLIIRGLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELA 139
           L  F ++G   D  I R  +     P ++ PE I  S     YD ++D+WSLGI+ IELA
Sbjct: 142 LADFGVAGQLTDTQIKRNTFVGT--PFWMAPEVIKQSA----YDFKADIWSLGITAIELA 195

Query: 140 TGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
            G  P      P   L  + ++ PP L  G++S  FK+F+
Sbjct: 196 KGEPPNSDL-HPMRVLFLIPKNSPPTL-EGQYSKPFKEFV 233


>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine
           Kinase, p21-activated kinase.  Serine/threonine kinases
           (STKs), p21-activated kinase (PAK) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PAK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PAKs are Rho
           family GTPase-regulated kinases that serve as important
           mediators in the function of Cdc42 (cell division cycle
           42) and Rac. PAKs are implicated in the regulation of
           many cellular processes including growth factor
           receptor-mediated proliferation, cell polarity, cell
           motility, cell death and survival, and actin
           cytoskeleton organization. PAK deregulation is
           associated with tumor development. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           Group I PAKs contain a PBD (p21-binding domain)
           overlapping with an AID (autoinhibitory domain), a
           C-terminal catalytic domain, SH3 binding sites and a
           non-classical SH3 binding site for PIX (PAK-interacting
           exchange factor). Group II PAKs contain a PBD and a
           catalytic domain, but lack other motifs found in group I
           PAKs. Since group II PAKs do not contain an obvious AID,
           they may be regulated differently from group I PAKs.
           Group I PAKs interact with the SH3 containing proteins
           Nck, Grb2 and PIX; no such binding has been demonstrated
           for group II PAKs.
          Length = 286

 Score = 54.5 bits (132), Expect = 3e-09
 Identities = 23/61 (37%), Positives = 31/61 (50%), Gaps = 2/61 (3%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGE-FSSDFKDF 178
            +Y  + D+WSLGI  IE+A G  PY     P   L  +     P L   E +S +FKDF
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFKDF 249

Query: 179 I 179
           +
Sbjct: 250 L 250


>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine
           Kinase, Ste20-like kinase.  Serine/threonine kinases
           (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The SLK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. SLK promotes
           apoptosis through apoptosis signal-regulating kinase 1
           (ASK1) and the mitogen-activated protein kinase (MAPK)
           p38. It acts as a MAPK kinase kinase (MAPKKK) by
           phosphorylating ASK1, resulting in the phosphorylation
           of p38. SLK also plays a role in mediating actin
           reorganization. It is part of a microtubule-associated
           complex that is targeted at adhesion sites, and is
           required in focal adhesion turnover and in regulating
           cell migration.
          Length = 282

 Score = 53.9 bits (129), Expect = 4e-09
 Identities = 26/59 (44%), Positives = 39/59 (66%), Gaps = 2/59 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLP-PGEFSSDFKDFI 179
           YD ++DVWSLGI+LIE+A    P+    +P   L ++ + +PP L  P  +SS+FKDF+
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242


>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mammalian Ste20-like protein
           kinase 4.  Serine/threonine kinases (STKs), mammalian
           Ste20-like protein kinase 4 (MST4) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MST4 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. MST4 is sometimes
           referred to as MASK (MST3 and SOK1-related kinase). It
           plays a role in mitogen-activated protein kinase (MAPK)
           signaling during cytoskeletal rearrangement,
           morphogenesis, and apoptosis. It influences cell growth
           and transformation by modulating the extracellular
           signal-regulated kinase (ERK) pathway. MST4 may also
           play a role in tumor formation and progression. It
           localizes in the Golgi apparatus by interacting with the
           Golgi matrix protein GM130 and may play a role in cell
           migration.
          Length = 277

 Score = 52.7 bits (126), Expect = 1e-08
 Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 8/100 (8%)

Query: 80  LFRFALSGNQDDLLIIRGLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELA 139
           L  F ++G   D  I R  +     P ++ PE I  S     YD ++D+WSLGI+ IELA
Sbjct: 142 LADFGVAGQLTDTQIKRNTFVGT--PFWMAPEVIQQSA----YDSKADIWSLGITAIELA 195

Query: 140 TGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
            G  P ++   P   L  + +++PP L  GEFS  FK+FI
Sbjct: 196 KGE-PPNSDMHPMRVLFLIPKNNPPTL-TGEFSKPFKEFI 233


>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mitogen-Activated Protein
           Kinase Kinase Kinase.  Serine/threonine kinases (STKs),
           mitogen-activated protein kinase (MAPK) kinase kinase
           (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MAPKKK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called
           MAP/ERK kinase kinases (MEKKs) in some cases. They
           phosphorylate and activate MAPK kinases (MAPKKs or MKKs
           or MAP2Ks), which in turn phosphorylate and activate
           MAPKs during signaling cascades that are important in
           mediating cellular responses to extracellular signals.
           This subfamily is composed of the Apoptosis
           Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or
           MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant
           and fungal MAPKKKs. Also included in this subfamily are
           the cell division control proteins Schizosaccharomyces
           pombe Cdc7 and Saccharomyces cerevisiae Cdc15.
          Length = 260

 Score = 51.8 bits (125), Expect = 2e-08
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 6/76 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVV-QDDP 163
           P ++ PE I        Y   +D+WSLG ++IE+ATG+ P+   G+P   L ++    +P
Sbjct: 167 PYWMAPEVIRGEE----YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP 222

Query: 164 PRLPPGEFSSDFKDFI 179
           P +P    S + KDF+
Sbjct: 223 PEIPEH-LSEEAKDFL 237


>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein
           Serine/Threonine Kinase, STK10 or Lymphocyte-oriented
           kinase.  Serine/threonine kinases (STKs), STK10
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           STK10 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Other names for STK10 include
           lymphocyte-oriented kinase (LOK) and Xenopus polo-like
           kinase kinase 1 (xPlkk1). STK10 is highly expressed in
           lymphocytes and is responsible in regulating leukocyte
           function associated antigen (LFA-1)-mediated lymphocyte
           adhesion. It plays a role in regulating the CD28
           responsive element in T cells, and may also function as
           a regulator of polo-like kinase 1 (Plk1), a protein
           which is overexpressed in multiple tumor types.
          Length = 292

 Score = 52.0 bits (124), Expect = 2e-08
 Identities = 23/61 (37%), Positives = 40/61 (65%), Gaps = 2/61 (3%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRL-PPGEFSSDFKDF 178
           + YD ++D+WSLGI+LIE+A    P+    +P   L ++ + +PP L  P ++S +F+DF
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248

Query: 179 I 179
           +
Sbjct: 249 L 249


>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain. 
          Length = 260

 Score = 51.1 bits (123), Expect = 4e-08
 Identities = 23/81 (28%), Positives = 34/81 (41%), Gaps = 11/81 (13%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVV----- 159
           P ++ PE +   G    Y  + DVWSLG+ L EL TG+ P+   G       Q++     
Sbjct: 162 PWYMAPEVL--LGGN-GYGPKVDVWSLGVILYELLTGKPPF--SGENILDQLQLIRRILG 216

Query: 160 -QDDPPRLPPGEFSSDFKDFI 179
              +         S + KD I
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLI 237


>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein
           Serine/Threonine Kinase, Traf2- and Nck-interacting
           kinase.  Serine/threonine kinases (STKs), Traf2- and
           Nck-interacting kinase (TNIK) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The TNIK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Members of this
           subfamily contain an N-terminal catalytic domain and a
           C-terminal citron homology (CNH) regulatory domain,
           similar to mitogen-activated protein kinase (MAPK),
           kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks
           participate in some MAPK signaling pathways by
           activating a MAPK kinase kinase (MAPKKK or MAP3K or
           MKKK). TNIK is an effector of Rap2, a small GTP-binding
           protein from the Ras family. TNIK specifically activates
           the c-Jun N-terminal kinase (JNK) pathway and plays a
           role in regulating the actin cytoskeleton.
          Length = 272

 Score = 50.9 bits (121), Expect = 5e-08
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 2/76 (2%)

Query: 105 PNFIRPERIDPSGNP-SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDP 163
           P ++ PE I    NP + YD +SD+WSLGI+ IE+A G  P      P   L  + ++  
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 233

Query: 164 PRLPPGEFSSDFKDFI 179
           PRL   ++S  F+ FI
Sbjct: 234 PRLKSKKWSKKFQSFI 249


>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase;
           Provisional.
          Length = 353

 Score = 51.0 bits (122), Expect = 6e-08
 Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 10/81 (12%)

Query: 107 FIRPERIDPSGNPSNYD-IRSDVWSLGISLIELATGRFPYDT-----WGSPFEQLKQVVQ 160
           ++ PERI+   N   YD    D+WSLG+S++E   GRFP+       W S    +  +  
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS---LMCAICM 290

Query: 161 DDPPRLPPGEFSSDFKDFITL 181
             PP   P   S +F+ FI+ 
Sbjct: 291 SQPPE-APATASREFRHFISC 310


>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mammalian Ste20-like protein
           kinase 3.  Serine/threonine kinases (STKs), mammalian
           Ste20-like protein kinase 3 (MST3) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MST3 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. MST3
           phosphorylates the STK NDR and may play a role in cell
           cycle progression and cell morphology. It may also
           regulate paxillin and consequently, cell migration. MST3
           is present in human placenta, where it plays an
           essential role in the oxidative stress-induced apoptosis
           of trophoblasts in normal spontaneous delivery.
           Dysregulation of trophoblast apoptosis may result in
           pregnancy complications such as preeclampsia and
           intrauterine growth retardation.
          Length = 277

 Score = 50.5 bits (120), Expect = 8e-08
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 78  LHLFRFALSGNQDDLLIIRGLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIE 137
           + L  F ++G   D  I R  +     P ++ PE I  S     YD ++D+WSLGI+ IE
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFVGT--PFWMAPEVIKQSA----YDSKADIWSLGITAIE 193

Query: 138 LATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
           LA G  P+     P + L  + +++PP L  G +S   K+F+
Sbjct: 194 LAKGEPPHSEL-HPMKVLFLIPKNNPPTL-EGNYSKPLKEFV 233


>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein
           Serine/Threonine Kinase, Class IIIA myosin.
           Serine/threonine kinases (STKs), class IIIA myosin
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           class III myosin subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Class III myosins are motor
           proteins containing an N-terminal kinase catalytic
           domain and a C-terminal actin-binding domain. Class III
           myosins may play an important role in maintaining the
           structural integrity of photoreceptor cell microvilli.
           In photoreceptor cells, they may also function as cargo
           carriers during light-dependent translocation of
           proteins such as transducin and arrestin. Class IIIA
           myosin is highly expressed in retina and in inner ear
           hair cells. It is localized to the distal ends of
           actin-bundled structures. Mutations in human myosin IIIA
           are responsible for progressive nonsyndromic hearing
           loss. Human myosin IIIA possesses ATPase and kinase
           activities, and the ability to move actin filaments in a
           motility assay. It may function as a cellular
           transporter capable of moving along actin bundles in
           sensory cells.
          Length = 286

 Score = 48.9 bits (116), Expect = 3e-07
 Identities = 27/62 (43%), Positives = 35/62 (56%), Gaps = 2/62 (3%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRL-PPGEFSSDFKDF 178
           S YD R DVWSLGI+ IEL  G  P      P   L ++ ++ PP L  P  +S++F DF
Sbjct: 204 STYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPPTLHQPELWSNEFNDF 262

Query: 179 IT 180
           I 
Sbjct: 263 IR 264


>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 6.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek6 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek6 is required
           for the transition from metaphase to anaphase. It also
           plays important roles in mitotic spindle formation and
           cytokinesis.  Activated by Nek9 during mitosis, Nek6
           phosphorylates Eg5, a kinesin that is important for
           spindle bipolarity. Nek6 localizes to spindle
           microtubules during metaphase and anaphase, and to the
           midbody during cytokinesis.
          Length = 267

 Score = 48.1 bits (114), Expect = 5e-07
 Identities = 25/78 (32%), Positives = 43/78 (55%), Gaps = 5/78 (6%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP-YDTWGSPFEQLKQVVQDDP 163
           P ++ PERI  +G    Y+ +SD+WSLG  L E+A  + P Y    + F   +++ Q D 
Sbjct: 170 PYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY 225

Query: 164 PRLPPGEFSSDFKDFITL 181
           P LP   +S   ++ +++
Sbjct: 226 PPLPTEHYSEKLRELVSM 243


>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein
           Serine/Threonine Kinases, Never In Mitosis gene
           A-related kinase 6 and 7.  Serine/Threonine Kinases
           (STKs), Never In Mitosis gene A (NIMA)-related kinase 6
           (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The Nek6/7 subfamily is part of a family of 11 different
           Neks (Nek1-11) that are involved in cell cycle control.
           The Nek family is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Nek6 and Nek7 are the shortest Neks,
           consisting only of the catalytic domain and a very short
           N-terminal extension. They show distinct expression
           patterns and both appear to be downstream substrates of
           Nek9. They are required for mitotic spindle formation
           and cytokinesis. They may also be regulators of the p70
           ribosomal S6 kinase.
          Length = 267

 Score = 47.4 bits (113), Expect = 8e-07
 Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 19/85 (22%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQ--------LK 156
           P ++ PERI  +G    Y+ +SD+WSLG  L E+A  +       SPF           K
Sbjct: 170 PYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQ-------SPFYGDKMNLYSLCK 218

Query: 157 QVVQDDPPRLPPGEFSSDFKDFITL 181
           ++ + D P LP   +S + +D ++ 
Sbjct: 219 KIEKCDYPPLPADHYSEELRDLVSR 243


>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 7.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek7 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek7 is required
           for mitotic spindle formation and cytokinesis. It is
           enriched in the centrosome and is critical for
           microtubule nucleation. Nek7 is activated by Nek9 during
           mitosis, and may regulate the p70 ribosomal S6 kinase.
          Length = 267

 Score = 46.6 bits (110), Expect = 1e-06
 Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 5/78 (6%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP-YDTWGSPFEQLKQVVQDDP 163
           P ++ PERI  +G    Y+ +SD+WSLG  L E+A  + P Y    + +   K++ Q D 
Sbjct: 170 PYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 225

Query: 164 PRLPPGEFSSDFKDFITL 181
           P LP   +S + +  + +
Sbjct: 226 PPLPSDHYSEELRQLVNM 243


>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function
           prediction only / Signal transduction mechanisms /
           Transcription / DNA replication, recombination, and
           repair].
          Length = 384

 Score = 46.7 bits (109), Expect = 2e-06
 Identities = 20/82 (24%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 103 CDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPF--EQLKQVVQ 160
             P ++ PE +    + +     SD+WSLGI+L EL TG  P++   +     Q  +++ 
Sbjct: 170 GTPGYMAPEVL-LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228

Query: 161 DDPPRLPPGEFSSDFKDFITLW 182
           + P        S    + I+  
Sbjct: 229 ELPTPSLASPLSPSNPELISKA 250


>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein
           Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. 
           Serine/threonine kinases (STKs), plant MAP/ERK kinase
           kinase 1 (MEKK1)-like subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The plant MEKK1 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein STKs, protein tyrosine kinases, RIO
           kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. This subfamily is
           composed of plant mitogen-activated protein kinase
           (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks)
           including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1
           is a MAPKKK that phosphorylates and activates MAPK
           kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals. Arabidopsis thaliana
           MEKK1 activates MPK4, a MAPK that regulates systemic
           acquired resistance. MEKK1 also participates in the
           regulation of temperature-sensitive and tissue-specific
           cell death.
          Length = 258

 Score = 46.3 bits (110), Expect = 2e-06
 Identities = 27/80 (33%), Positives = 41/80 (51%), Gaps = 10/80 (12%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQ-DDP 163
           P ++ PE I   G    Y + +D+WSLG +++E+ATG+ P+    S  E +  V +    
Sbjct: 165 PYWMAPEVIAQQGG---YGLAADIWSLGCTVLEMATGKPPW----SQLEGVAAVFKIGRS 217

Query: 164 PRLP--PGEFSSDFKDFITL 181
             LP  P   S + KDFI  
Sbjct: 218 KELPPIPDHLSDEAKDFILK 237


>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine
           Kinase, Apoptosis signal-regulating kinase.
           Serine/threonine kinases (STKs), Apoptosis
           signal-regulating kinase (ASK) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The ASK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Subfamily members
           are mitogen-activated protein kinase (MAPK) kinase
           kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1,
           ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate
           MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals. ASK1 (also called
           MAPKKK5) functions in the c-Jun N-terminal kinase (JNK)
           and p38 MAPK signaling pathways by directly activating
           their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It
           plays important roles in cytokine and stress responses,
           as well as in reactive oxygen species (ROS)-mediated
           cellular responses. ASK1 is implicated in various
           diseases mediated by oxidative stress including
           inschemic heart disease, hypertension, vessel injury,
           brain ischemia, Fanconi anemia, asthma, and pulmonary
           edema, among others. ASK2 (also called MAPKKK6)
           functions only in a heteromeric complex with ASK1, and
           can activate ASK1 by direct phosphorylation. The
           function of MAPKKK15 is still unknown.
          Length = 268

 Score = 45.2 bits (107), Expect = 4e-06
 Identities = 25/75 (33%), Positives = 41/75 (54%), Gaps = 6/75 (8%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQV--VQDDPP 164
           ++ PE ID    P  Y   +D+WSLG +++E+ATG+ P+   G P   + +V   +  P 
Sbjct: 175 YMAPEVIDKG--PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232

Query: 165 RLPPGEFSSDFKDFI 179
              P   S++ K+FI
Sbjct: 233 --IPESLSAEAKNFI 245


>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein
           Serine/Threonine Kinase, Thousand-and-one amino acids 3.
            Serine/threonine kinases (STKs), thousand-and-one amino
           acids 3 (TAO3) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
           TAO3 is also known as JIK (JNK inhibitory kinase) or KFC
           (kinase from chicken). It specifically activates c-Jun
           N-terminal kinase (JNK), presumably by phosphorylating
           and activating MKK4/MKK7. In Saccharomyces cerevisiae,
           TAO3 is a component of the RAM (regulation of Ace2p
           activity and cellular morphogenesis) signaling pathway.
           TAO3 is upregulated in retinal ganglion cells after
           axotomy, and may play a role in apoptosis.
          Length = 313

 Score = 45.0 bits (106), Expect = 6e-06
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 2/75 (2%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  + +   YD + DVWSLGI+ IELA  + P     +    L  + Q+D P
Sbjct: 181 PYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNDSP 238

Query: 165 RLPPGEFSSDFKDFI 179
            L   E++  F+ F+
Sbjct: 239 TLQSNEWTDSFRGFV 253


>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein
           Serine/Threonine Kinases.  Serine/Threonine Kinases
           (STKs), AGC (Protein Kinases A, G and C) family,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The AGC family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and Phosphoinositide 3-Kinase (PI3K). Members of
           this family include cAMP-dependent Protein Kinase (PKA),
           cGMP-dependent Protein Kinase (PKG), Protein Kinase C
           (PKC), Protein Kinase B (PKB), G protein-coupled
           Receptor Kinase (GRK), Serum- and Glucocorticoid-induced
           Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase
           (p70S6K or S6K), among others. AGC kinases share an
           activation mechanism based on the phosphorylation of up
           to three sites: the activation loop (A-loop), the
           hydrophobic motif (HM) and the turn motif.
           Phosphorylation at the A-loop is required of most AGC
           kinases, which results in a disorder-to-order transition
           of the A-loop. The ordered conformation results in the
           access of substrates and ATP to the active site. A
           subset of AGC kinases with C-terminal extensions
           containing the HM also requires phosphorylation at this
           site. Phosphorylation at the HM allows the C-terminal
           extension to form an ordered structure that packs into
           the hydrophobic pocket of the catalytic domain, which
           then reconfigures the kinase into an active bi-lobed
           state. In addition, growth factor-activated AGC kinases
           such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require
           phosphorylation at the turn motif (also called tail or
           zipper site), located N-terminal to the HM at the
           C-terminal extension. AGC kinases regulate many cellular
           processes including division, growth, survival,
           metabolism, motility, and differentiation. Many are
           implicated in the development of various human diseases.
          Length = 250

 Score = 44.4 bits (106), Expect = 7e-06
 Identities = 18/59 (30%), Positives = 31/59 (52%), Gaps = 3/59 (5%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFIT 180
           Y    D WSLG+ L E+ TG+ P+  +    +++ + +  DP R P    S + +D I+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPF--YAEDRKEIYEKILKDPLRFPEF-LSPEARDLIS 225


>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 2.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek2 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. The Nek2
           subfamily includes Aspergillus nidulans NIMA kinase, the
           founding member of the Nek family, which was identified
           in a screen for cell cycle mutants prevented from
           entering mitosis. NIMA is essential for mitotic entry
           and progression through mitosis, and its degradation is
           essential for mitotic exit. NIMA is involved in nuclear
           membrane fission. Vertebrate Nek2 is a cell
           cycle-regulated STK, localized in centrosomes and
           kinetochores, that regulates centrosome splitting at the
           G2/M phase. It also interacts with other mitotic kinases
           such as Polo-like kinase 1 and may play a role in
           spindle checkpoint. An increase in the expression of the
           human NEK2 gene is strongly associated with the
           progression of non-Hodgkin lymphoma.
          Length = 265

 Score = 44.5 bits (106), Expect = 8e-06
 Identities = 21/77 (27%), Positives = 36/77 (46%), Gaps = 6/77 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE++  +     YD +SD+WSLG  + EL     P+        QL   +++   
Sbjct: 174 PYYMSPEQL--NHMS--YDEKSDIWSLGCLIYELCALSPPFT--ARNQLQLASKIKEGKF 227

Query: 165 RLPPGEFSSDFKDFITL 181
           R  P  +SS+  + I  
Sbjct: 228 RRIPYRYSSELNEVIKS 244


>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein
           Serine/Threonine Kinase, MAP/ERK kinase kinase 4.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4
           (MEKK4) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MEKK4 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MEKK4 is a mitogen-activated protein kinase
           (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
           phosphorylates and activates MAPK kinases (MAPKKs or
           MKKs or MAP2Ks), which in turn phosphorylate and
           activate MAPKs during signaling cascades that are
           important in mediating cellular responses to
           extracellular signals. MEKK4 activates the c-Jun
           N-terminal kinase (JNK) and p38 MAPK signaling pathways
           by directly activating their respective MAPKKs,
           MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively
           known as stress-activated MAPKs, as they are activated
           in response to a variety of environmental stresses and
           pro-inflammatory cytokines. MEKK4 also plays roles in
           the re-polarization of the actin cytoskeleton in
           response to osmotic stress, in the proper closure of the
           neural tube, in cardiovascular development, and in
           immune responses.
          Length = 264

 Score = 44.3 bits (105), Expect = 9e-06
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 4/77 (5%)

Query: 105 PNFIRPERIDPSGNPSNYDIRS-DVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDP 163
           P ++ PE I  +G       R+ D+WSLG  ++E+ATG+ P+    + F+ +  V     
Sbjct: 167 PAYMAPEVI--TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK 224

Query: 164 PRLP-PGEFSSDFKDFI 179
           P +P   + S + KDF+
Sbjct: 225 PPIPDSLQLSPEGKDFL 241


>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated
           protein kinase kinase kinase kinase-like Protein
           Serine/Threonine Kinases.  Serine/threonine kinases
           (STKs), mitogen-activated protein kinase (MAPK) kinase
           kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MAP4K3-like
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This subfamily includes MAP4K3, MAP4K1,
           MAP4K2, MAP4K5, and related proteins. Vertebrate members
           contain an N-terminal catalytic domain and a C-terminal
           citron homology (CNH) regulatory domain, similar to
           MAP4K4/6. MAP4Ks are involved in some MAPK signaling
           pathways that are important in mediating cellular
           responses to extracellular signals by activating a MAPK
           kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK
           cascade is activated either by a small GTP-binding
           protein or by an adaptor protein, which transmits the
           signal either directly to a MAP3K to start the triple
           kinase core cascade or indirectly through a mediator
           kinase, a MAP4K. MAP4K1, also called haematopoietic
           progenitor kinase 1 (HPK1), is a hematopoietic-specific
           STK involved in many cellular signaling cascades
           including MAPK, antigen receptor, apoptosis, growth
           factor, and cytokine signaling. It participates in the
           regulation of T cell receptor signaling and T
           cell-mediated immune responses. MAP4K2 was referred to
           as germinal center (GC) kinase because of its preferred
           location in GC B cells. MAP4K3 plays a role in the
           nutrient-responsive pathway of mTOR (mammalian target of
           rapamycin) signaling. It is required in the activation
           of S6 kinase by amino acids and for the phosphorylation
           of the mTOR-regulated inhibitor of eukaryotic initiation
           factor 4E. MAP4K5, also called germinal center
           kinase-related enzyme (GCKR), has been shown to activate
           the MAPK c-Jun N-terminal kinase (JNK).
          Length = 262

 Score = 43.8 bits (104), Expect = 1e-05
 Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 7/80 (8%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP-YDTWGSPFEQLKQVVQD-- 161
           P ++ PE          YD + D+W+LGI+ IELA  + P +D    P   L  + +   
Sbjct: 165 PYWMAPEVAAVERK-GGYDGKCDIWALGITAIELAELQPPMFDL--HPMRALFLISKSNF 221

Query: 162 DPPRLP-PGEFSSDFKDFIT 180
            PP+L    ++S  F DFI 
Sbjct: 222 PPPKLKDKEKWSPVFHDFIK 241


>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine
           Kinase, Never In Mitosis gene A-related kinase.
           Serine/Threonine Kinases (STKs), Never In Mitosis gene A
           (NIMA)-related kinase (Nek) family, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. The Nek family is
           composed of 11 different mammalian members (Nek1-11)
           with similarity to the catalytic domain of Aspergillus
           nidulans NIMA kinase, the founding member of the Nek
           family which was identified in a screen for cell cycle
           mutants that were prevented from entering mitosis. Neks
           contain a conserved N-terminal catalytic domain and a
           more divergent C-terminal regulatory region of various
           sizes and structures. They are involved in the
           regulation of downstream processes following the
           activation of Cdc2, and many of their functions are cell
           cycle-related. They play critical roles in microtubule
           dynamics during ciliogenesis and mitosis.
          Length = 258

 Score = 43.6 bits (104), Expect = 1e-05
 Identities = 18/59 (30%), Positives = 35/59 (59%), Gaps = 4/59 (6%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQL-KQVVQDDPPRLPPGEFSSDFKDFI 179
           Y+ +SD+WSLG  L EL T + P++  G    +L  ++++   P +P   +SS+ ++ +
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFE--GENLLELALKILKGQYPPIPSQ-YSSELRNLV 235


>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Thousand-and-one amino acids 1.
            Serine/threonine kinases (STKs), thousand-and-one amino
           acids 1 (TAO1) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
           TAO1 is sometimes referred to as prostate-derived
           sterile 20-like kinase 2 (PSK2). TAO1 activates the p38
           MAPK through direct interaction with and activation of
           MEK3. TAO1 is highly expressed in the brain and may play
           a role in neuronal apoptosis. TAO1 interacts with the
           checkpoint proteins BubR1 and Mad2, and plays an
           important role in regulating mitotic progression, which
           is required for both chromosome congression and
           checkpoint-induced anaphase delay. TAO1 may play a role
           in protecting genomic stability.
          Length = 317

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 2/75 (2%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  + +   YD + DVWSLGI+ IELA  + P     +    L  + Q++ P
Sbjct: 185 PYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESP 242

Query: 165 RLPPGEFSSDFKDFI 179
            L   E+S  F++F+
Sbjct: 243 TLQSNEWSDYFRNFV 257


>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein
           Serine/Threonine Kinase, Class IIIB myosin.
           Serine/threonine kinases (STKs), class IIIB myosin
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           class III myosin subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Class III myosins are motor
           proteins containing an N-terminal kinase catalytic
           domain and a C-terminal actin-binding domain. Class III
           myosins may play an important role in maintaining the
           structural integrity of photoreceptor cell microvilli.
           They may also function as cargo carriers during
           light-dependent translocation, in photoreceptor cells,
           of proteins such as transducin and arrestin. Class IIIB
           myosin is expressed highly in retina. It is also present
           in the brain and testis. The human class IIIB myosin
           gene maps to a region that overlaps the locus for
           Bardet-Biedl syndrome, which is characterized by
           dysmorphic extremities, retinal dystrophy, obesity, male
           hypogenitalism, and renal abnormalities.
          Length = 291

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 4/63 (6%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFP-YDTWGSPFEQLKQVVQDDPPRL-PPGEFSSDFKD 177
            +YD R DVWSLGI+ IEL  G  P +D    P + L ++ ++ PP L  P ++   F  
Sbjct: 208 YSYDARCDVWSLGITAIELGDGDPPLFDM--HPVKTLFKIPRNPPPTLLHPEKWCRSFNH 265

Query: 178 FIT 180
           FI+
Sbjct: 266 FIS 268


>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein
           Serine/Threonine Kinase, Group II p21-activated kinase. 
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) subfamily, Group II, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The PAK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           Group II PAKs, also called non-conventional PAKs,
           include PAK4, PAK5, and PAK6. Group II PAKs contain PBD
           (p21-binding domain) and catalytic domains, but lack
           other motifs found in group I PAKs, such as an AID
           (autoinhibitory domain) and SH3 binding sites. Since
           group II PAKs do not contain an obvious AID, they may be
           regulated differently from group I PAKs. While group I
           PAKs interact with the SH3 containing proteins Nck, Grb2
           and PIX, no such binding has been demonstrated for group
           II PAKs. Some known substrates of group II PAKs are also
           substrates of group I PAKs such as Raf, BAD, LIMK and
           GEFH1. Unique group II substrates include MARK/Par-1 and
           PDZ-RhoGEF. Group II PAKs play important roles in
           filopodia formation, neuron extension, cytoskeletal
           organization, and cell survival.
          Length = 285

 Score = 43.2 bits (102), Expect = 3e-05
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 6/78 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  S  P  Y    D+WSLGI +IE+  G  PY     P + +K++  + PP
Sbjct: 179 PYWMAPEVI--SRLP--YGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPP 233

Query: 165 RLP-PGEFSSDFKDFITL 181
           +L    + S   + F+  
Sbjct: 234 KLKNLHKVSPRLRSFLDR 251


>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein
           Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2,
            and similar domains.  Serine/Threonine Kinases (STKs),
           Chlamydomonas reinhardtii Never In Mitosis gene A
           (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Chlamydomonas
           reinhardtii CNK2-like subfamily belongs to the
           (NIMA)-related kinase (Nek) family. The Nek family
           includes seven different Chlamydomonas Neks (CNKs 1-6
           and Fa2). This subfamily includes CNK1, and -2.  The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase.  Chlamydomonas reinhardtii CNK2 has both
           cilliary and cell cycle functions. It influences
           flagellar length through promoting flagellar
           disassembly, and it regulates cell size, through
           influencing the size threshold at which cells commit to
           mitosis.
          Length = 256

 Score = 42.4 bits (100), Expect = 4e-05
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 4/59 (6%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDP-PRLPPGEFSSDFKDFI 179
           Y  +SD+WSLG  L E+AT   P++      + L+  VQ    P +PP  +S D ++FI
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFE--ARSMQDLRYKVQRGKYPPIPP-IYSQDLQNFI 233


>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Thousand-and-one amino acids 2.
            Serine/threonine kinases (STKs), thousand-and-one amino
           acids 2 (TAO2) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
           Human TAO2 is also known as prostate-derived Ste20-like
           kinase (PSK) and was identified in a screen for
           overexpressed RNAs in prostate cancer. TAO2 activates
           both p38 and c-Jun N-terminal kinase (JNK), by
           phosphorylating and activating the respective MAP/ERK
           kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6
           and MKK4/MKK7. TAO2 contains a long C-terminal extension
           with autoinhibitory segments. It is activated by the
           release of this inhibition and the phosphorylation of
           its activation loop serine. TAO2 functions as a
           regulator of actin cytoskeletal and microtubule
           organization. In addition, it regulates the transforming
           growth factor-activated kinase 1 (TAK1), which is a
           MAPKKK that plays an essential role in the signaling
           pathways of tumor necrosis factor (TNF), interleukin 1
           (IL-1), and Toll-like receptor (TLR).
          Length = 308

 Score = 42.0 bits (98), Expect = 6e-05
 Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 2/75 (2%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  + +   YD + DVWSLGI+ IELA  + P     +    L  + Q++ P
Sbjct: 175 PYWMAPEVI-LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESP 232

Query: 165 RLPPGEFSSDFKDFI 179
            L  G +S  F++F+
Sbjct: 233 ALQSGHWSEYFRNFV 247


>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase
           3-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
           (MEKK3)-like subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The MEKK3-like subfamily is part of a larger superfamily
           that includes the catalytic domains of other protein
           STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. This subfamily is composed of
           MEKK3, MEKK2, and related proteins, all containing an
           N-terminal PB1 domain, which mediates oligomerization,
           and a C-terminal catalytic domain. MEKK2 and MEKK3 are
           mitogen-activated protein kinase (MAPK) kinase kinases
           (MAPKKKs or MKKKs or MAP3Ks), proteins that
           phosphorylate and activate MAPK kinases (MAPKKs or MKKs
           or MAP2Ks), which in turn phosphorylate and activate
           MAPKs during signaling cascades that are important in
           mediating cellular responses to extracellular signals.
           MEKK2 and MEKK3 activate MEK5 (also called MKK5), which
           activates extracellular signal-regulated kinase 5
           (ERK5). The ERK5 cascade plays roles in promoting cell
           proliferation, differentiation, neuronal survival, and
           neuroprotection. MEKK3 plays an essential role in
           embryonic angiogenesis and early heart development.
           MEKK2 and MEKK3 can also activate the MAPKs, c-Jun
           N-terminal kinase (JNK) and p38, through their
           respective MAPKKs.
          Length = 263

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 5/77 (6%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I   G    Y  ++DVWS+G +++E+ T + P+  + +     K   Q   P
Sbjct: 171 PYWMSPEVISGEG----YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 226

Query: 165 RLPPGEFSSDFKDFITL 181
           +LP    S D ++F+  
Sbjct: 227 QLPS-HVSPDARNFLRR 242


>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein
           Serine/Threonine Kinase, Group I p21-activated kinase.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) subfamily, Group I, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The PAK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs are
           implicated in the regulation of many cellular processes
           including growth factor receptor-mediated proliferation,
           cell polarity, cell motility, cell death and survival,
           and actin cytoskeleton organization. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           Group I PAKs, also called conventional PAKs, include
           PAK1, PAK2, and PAK3. Group I PAKs contain a PBD
           (p21-binding domain) overlapping with an AID
           (autoinhibitory domain), a C-terminal catalytic domain,
           SH3 binding sites and a non-classical SH3 binding site
           for PIX (PAK-interacting exchange factor). They interact
           with the SH3 domain containing proteins Nck, Grb2 and
           PIX. Binding of group I PAKs to activated GTPases leads
           to conformational changes that destabilize the AID,
           allowing autophosphorylation and full activation of the
           kinase domain. Known group I PAK substrates include
           MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc,
           Stat5a, and Aurora A, among others.
          Length = 293

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 21/59 (35%), Positives = 31/59 (52%), Gaps = 2/59 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLP-PGEFSSDFKDFI 179
           Y  + D+WSLGI  IE+  G  PY    +P   L  +  +  P L  P + S+ F+DF+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249


>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein
           Serine/Threonine Kinase, Mitogen and stress-activated
           kinase.  Serine/Threonine Kinases (STKs), Mitogen and
           stress-activated kinase (MSK) subfamily, N-terminal
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MSK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. MSKs contain an
           N-terminal kinase domain (NTD) from the AGC family and a
           C-terminal kinase domain (CTD) from the CAMK family,
           similar to 90 kDa ribosomal protein S6 kinases (RSKs).
           MSKs are activated by two major signaling cascades, the
           Ras-MAPK and p38 stress kinase pathways, in response to
           various stimuli such as growth factors, hormones,
           neurotransmitters, cellular stress, and pro-inflammatory
           cytokines. This triggers phosphorylation in the
           activation loop (A-loop) of the CTD of MSK. The active
           CTD phosphorylates the hydrophobic motif (HM) in the
           C-terminal extension of NTD, which facilitates the
           phosphorylation of the A-loop and activates the NTD,
           which in turn phosphorylates downstream targets. MSKs
           are predominantly nuclear proteins. They are widely
           expressed in many tissues including heart, brain, lung,
           liver, kidney, and pancreas. There are two isoforms of
           MSK, called MSK1 and MSK2.
          Length = 288

 Score = 40.9 bits (96), Expect = 1e-04
 Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 7/76 (9%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWG---SPFEQLKQVVQDDP 163
           ++ PE I   G    +D   D WSLG+   EL TG  P+   G   S  E  +++++  P
Sbjct: 172 YMAPEVI--RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP 229

Query: 164 PRLPPGEFSSDFKDFI 179
           P   P   S++ +DFI
Sbjct: 230 PF--PKTMSAEARDFI 243


>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein
           Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase
           4.  Serine/threonine kinases (STKs), yeast
           Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The YSK4 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. YSK4 is a
           putative MAPKKK, whose mammalian gene has been isolated.
           MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate
           MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals.
          Length = 265

 Score = 40.7 bits (95), Expect = 1e-04
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 15/100 (15%)

Query: 84  ALSGNQDDLLIIRGLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRF 143
            L G   ++L  + ++G    P ++ PE I+ SG    Y  +SD+WS+G ++ E+ATG+ 
Sbjct: 156 GLHGTHSNML--KSMHGT---PYWMAPEVINESG----YGRKSDIWSIGCTVFEMATGKP 206

Query: 144 PYDTWGS--PFEQLKQVVQDDPPRLP-PGEFSSDFKDFIT 180
           P     S      +  +          P  FS+   DF+T
Sbjct: 207 P---LASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243


>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine
           Kinase, Protein Kinase C.  Serine/Threonine Kinases
           (STKs), Protein Kinase C (PKC) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, classical PKCs depend on
           calcium, DAG (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. Novel PKCs are
           calcium-independent, but require DAG and PS for
           activity, while atypical PKCs only require PS. PKCs
           phosphorylate and modify the activities of a wide
           variety of cellular proteins including receptors,
           enzymes, cytoskeletal proteins, transcription factors,
           and other kinases. They play a central role in signal
           transduction pathways that regulate cell migration and
           polarity, proliferation, differentiation, and apoptosis.
           Also included in this subfamily are the PKC-like
           proteins, called PKNs.
          Length = 318

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 7/76 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P++I PE +  S  P  Y    D W+LG+ L E+  G+ P++  G   ++L Q + +D  
Sbjct: 160 PDYIAPEIL--SYQP--YGPAVDWWALGVLLYEMLAGQSPFE--GDDEDELFQSILEDEV 213

Query: 165 RLPPGEFSSDFKDFIT 180
           R P    S + K  + 
Sbjct: 214 RYPRW-LSKEAKSILK 228


>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase. 
          Length = 258

 Score = 40.2 bits (95), Expect = 2e-04
 Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 4/48 (8%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDDPPRLPP 168
           +  +SDVWS G+ L E+ T G  PY    S  E L+ +      RLP 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLEDG--YRLPR 225


>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like
           Protein Tyrosine Kinases.  Protein Tyrosine Kinase (PTK)
           family; Human Fyn-related kinase (Frk) and similar
           proteins; catalytic (c) domain. The PTKc family is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Frk and
           Srk are members of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases contain an N-terminal SH4 domain with a
           myristoylation site, followed by SH3 and SH2 domains, a
           tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr. They are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Src
           proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Frk, also known as Rak, is specifically
           expressed in liver, lung, kidney, intestine, mammary
           glands, and the islets of Langerhans. Rodent homologs
           were previously referred to as GTK (gastrointestinal tyr
           kinase), BSK (beta-cell Src-like kinase), or IYK
           (intestinal tyr kinase). Studies in mice reveal that Frk
           is not essential for viability. It plays a role in the
           signaling that leads to cytokine-induced beta-cell death
           in Type I diabetes. It also regulates beta-cell number
           during embryogenesis and early in life.
          Length = 261

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 25/64 (39%), Positives = 31/64 (48%), Gaps = 10/64 (15%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQD----DPP 164
           PE        + + I+SDVWS GI L E+ T GR PY    +  E L+QV Q      PP
Sbjct: 173 PEAA----LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQVDQGYRMPCPP 227

Query: 165 RLPP 168
             P 
Sbjct: 228 GCPK 231


>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Phosphoinositide-dependent
           kinase 1.  Serine/Threonine Kinases (STKs),
           Phosphoinositide-dependent kinase 1 (PDK1) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PDK1 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase (PI3K). PDK1
           carries an N-terminal catalytic domain and a C-terminal
           pleckstrin homology (PH) domain that binds
           phosphoinositides. It phosphorylates the activation loop
           of AGC kinases that are regulated by PI3K such as PKB,
           SGK, and PKC, among others, and is crucial for their
           activation. Thus, it contributes in regulating many
           processes including metabolism, growth, proliferation,
           and survival. PDK1 also has the ability to
           autophosphorylate and is constitutively active in
           mammalian cells. PDK1 is essential for normal embryo
           development and is important in regulating cell volume.
          Length = 280

 Score = 39.9 bits (94), Expect = 3e-04
 Identities = 18/76 (23%), Positives = 38/76 (50%), Gaps = 7/76 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
             ++ PE +  +  P+     SD+W+LG  + ++ TG+ P+    + +   +++++ +  
Sbjct: 186 AEYVSPELL--NEKPAGKS--SDLWALGCIIYQMLTGKPPFRG-SNEYLTFQKILKLEYS 240

Query: 165 RLPPGEFSSDFKDFIT 180
             PP  F  D KD I 
Sbjct: 241 -FPPN-FPPDAKDLIE 254


>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Src kinase subfamily; catalytic (c) domain. Src
           subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr,
           Fyn, Yrk, and Yes. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Src (or c-Src) proteins are cytoplasmic (or
           non-receptor) tyr kinases which are anchored to the
           plasma membrane. They contain an N-terminal SH4 domain
           with a myristoylation site, followed by SH3 and SH2
           domains, a tyr kinase domain, and a regulatory
           C-terminal region containing a conserved tyr. They are
           activated by autophosphorylation at the tyr kinase
           domain, but are negatively regulated by phosphorylation
           at the C-terminal tyr by Csk (C-terminal Src Kinase).
           Src proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. They were identified as the first
           proto-oncogene products, and they regulate cell
           adhesion, invasion, and motility in cancer cells and
           tumor vasculature, contributing to cancer progression
           and metastasis. Src kinases are overexpressed in a
           variety of human cancers, making them attractive targets
           for therapy. They are also implicated in acute
           inflammatory responses and osteoclast function. Src,
           Fyn, Yes, and Yrk are widely expressed, while Blk, Lck,
           Hck, Fgr, and Lyn show a limited expression pattern.
          Length = 261

 Score = 39.2 bits (92), Expect = 4e-04
 Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 5/37 (13%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELAT-GRFPY 145
           PE      N   + I+SDVWS GI L E+ T GR PY
Sbjct: 173 PEAA----NYGRFTIKSDVWSFGILLTEIVTYGRVPY 205


>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 6.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 6, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK6 belongs to group II. Group II PAKs contain a PBD
           (p21-binding domain) and a C-terminal catalytic domain,
           but do not harbor an AID (autoinhibitory domain) or SH3
           binding sites. PAK6 may play a role in stress responses
           through its activation by the mitogen-activated protein
           kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6
           is highly expressed in the brain. It is not required for
           viability, but together with PAK5, it is required for
           normal levels of locomotion and activity, and for
           learning and memory. Increased expression of PAK6 is
           found in primary and metastatic prostate cancer. PAK6
           may play a role in the regulation of motility.
          Length = 297

 Score = 39.2 bits (91), Expect = 6e-04
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 5/62 (8%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I    + + Y    D+WSLGI +IE+  G  PY +  SP + +K++    PP
Sbjct: 181 PYWMAPEVI----SRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP 235

Query: 165 RL 166
           +L
Sbjct: 236 KL 237


>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein
           Serine/Threonine Kinase, MAP/ERK kinase kinase 3.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
           (MEKK3) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MEKK3 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MEKK3 is a mitogen-activated protein kinase
           (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
           phosphorylates and activates the MAPK kinase MEK5 (or
           MKK5), which in turn phosphorylates and activates
           extracellular signal-regulated kinase 5 (ERK5). The ERK5
           cascade plays roles in promoting cell proliferation,
           differentiation, neuronal survival, and neuroprotection.
           MEKK3 plays an essential role in embryonic angiogenesis
           and early heart development. In addition, MEKK3 is
           involved in interleukin-1 receptor and Toll-like
           receptor 4 signaling. It is also a specific regulator of
           the proinflammatory cytokines IL-6 and GM-CSF in some
           immune cells. MEKK3 also regulates calcineurin, which
           plays a critical role in T cell activation, apoptosis,
           skeletal myocyte differentiation, and cardiac
           hypertrophy.
          Length = 266

 Score = 38.9 bits (90), Expect = 6e-04
 Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 5/83 (6%)

Query: 97  GLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLK 156
           G+      P ++ PE I   G    Y  ++DVWSLG +++E+ T + P+  + +     K
Sbjct: 165 GIRSVTGTPYWMSPEVISGEG----YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220

Query: 157 QVVQDDPPRLPPGEFSSDFKDFI 179
              Q   P+L P   S   +DF+
Sbjct: 221 IATQPTNPQL-PSHISEHARDFL 242


>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein
           Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2
           and similar domains.  Serine/Threonine Kinases (STKs),
           Chlamydomonas reinhardtii FA2-like subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Chlamydomonas
           reinhardtii FA2-like subfamily belongs to the
           (NIMA)-related kinase (Nek) family. The Nek family
           includes seven different Chlamydomonas Neks (CNKs 1-6
           and Fa2). This subfamily includes FA2 and CNK4.  The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase.  Chlamydomonas reinhardtii FA2 was discovered
           in a genetic screen for deflagellation-defective
           mutants. It is essential for
           basal-body/centriole-associated microtubule severing,
           and plays a role in cell cycle progression. No cellular
           function has yet been ascribed to CNK4.
          Length = 256

 Score = 38.6 bits (90), Expect = 7e-04
 Identities = 19/60 (31%), Positives = 27/60 (45%), Gaps = 2/60 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFITL 181
           Y+ +SDVW+LG+ L E  TG+ P+D        LK +    PP      +S      I  
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--SQMYSQQLAQLIDQ 235


>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein
           Serine/Threonine Kinase, MAP/ERK kinase kinase 2.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2
           (MEKK2) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MEKK2 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MEKK2 is a mitogen-activated protein kinase
           (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
           phosphorylates and activates the MAPK kinase MEK5 (or
           MKK5), which in turn phosphorylates and activates
           extracellular signal-regulated kinase 5 (ERK5). The ERK5
           cascade plays roles in promoting cell proliferation,
           differentiation, neuronal survival, and neuroprotection.
           MEKK2 also activates ERK1/2, c-Jun N-terminal kinase
           (JNK) and p38 through their respective MAPKKs MEK1/2,
           JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays
           roles in T cell receptor signaling, immune synapse
           formation, cytokine gene expression, as well as in EGF
           and FGF receptor signaling.
          Length = 265

 Score = 38.5 bits (89), Expect = 8e-04
 Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)

Query: 97  GLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLK 156
           G+      P ++ PE I   G    Y  ++D+WS+G +++E+ T + P+  + +     K
Sbjct: 165 GMKSVTGTPYWMSPEVISGEG----YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220

Query: 157 QVVQDDPPRLPPGEFSSDFKDFI 179
              Q   P LPP   S   +DF+
Sbjct: 221 IATQPTNPVLPP-HVSDHCRDFL 242


>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 1.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 1, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK1 belongs to group I. Group I PAKs contain a PBD
           (p21-binding domain) overlapping with an AID
           (autoinhibitory domain), a C-terminal catalytic domain,
           SH3 binding sites and a non-classical SH3 binding site
           for PIX (PAK-interacting exchange factor). PAK1 is
           important in the regulation of many cellular processes
           including cytoskeletal dynamics, cell motility, growth,
           and proliferation. Although PAK1 has been regarded
           mainly as a cytosolic protein, recent reports indicate
           that PAK1 also exists in significant amounts in the
           nucleus, where it is involved in transcription
           modulation and in cell cycle regulatory events. PAK1 is
           also involved in transformation and tumorigenesis. Its
           overexpression, hyperactivation and increased nuclear
           accumulation is correlated to breast cancer invasiveness
           and progression. Nuclear accumulation is also linked to
           tamoxifen resistance in breast cancer cells.
          Length = 296

 Score = 38.6 bits (89), Expect = 9e-04
 Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 6/76 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE +        Y  + D+WSLGI  IE+  G  PY    +P   L  +  +  P
Sbjct: 180 PYWMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP 234

Query: 165 RLP-PGEFSSDFKDFI 179
            L  P + S+ F+DF+
Sbjct: 235 ELQNPEKLSAIFRDFL 250


>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine
           Kinases, Lymphocyte-specific kinase and Blk.  Protein
           Tyrosine Kinase (PTK) family; Lck and Blk kinases;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Lck (lymphocyte-specific
           kinase) and Blk are members of the Src subfamily of
           proteins, which are cytoplasmic (or non-receptor) tyr
           kinases. Src kinases contain an N-terminal SH4 domain
           with a myristoylation site, followed by SH3 and SH2
           domains, a tyr kinase domain, and a regulatory
           C-terminal region containing a conserved tyr. They are
           activated by autophosphorylation at the tyr kinase
           domain, but are negatively regulated by phosphorylation
           at the C-terminal tyr by Csk (C-terminal Src Kinase).
           Src proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Lck is expressed in T-cells and natural
           killer (NK) cells. It plays a critical role in T-cell
           maturation, activation, and T-cell receptor (TCR)
           signaling. Lck phosphorylates ITAM (immunoreceptor tyr
           activation motif) sequences on several subunits of TCRs,
           leading to the activation of different second messenger
           cascades. Phosphorylated ITAMs serve as binding sites
           for other signaling factor such as Syk and ZAP-70,
           leading to their activation and propagation of
           downstream events. In addition, Lck regulates
           drug-induced apoptosis by interfering with the
           mitochondrial death pathway. The apototic role of Lck is
           independent of its primary function in T-cell signaling.
           Blk is expressed specifically in B-cells. It is involved
           in pre-BCR (B-cell receptor) signaling.
          Length = 260

 Score = 38.3 bits (89), Expect = 0.001
 Identities = 19/37 (51%), Positives = 22/37 (59%), Gaps = 5/37 (13%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELAT-GRFPY 145
           PE I    N   + I+SDVWS GI L E+ T GR PY
Sbjct: 172 PEAI----NYGTFTIKSDVWSFGILLTEIVTYGRIPY 204


>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 3.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 3, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK3 belongs to group I. Group I PAKs contain a PBD
           (p21-binding domain) overlapping with an AID
           (autoinhibitory domain), a C-terminal catalytic domain,
           SH3 binding sites and a non-classical SH3 binding site
           for PIX (PAK-interacting exchange factor). PAK3 is
           highly expressed in the brain. It is implicated in
           neuronal plasticity, synapse formation, dendritic spine
           morphogenesis, cell cycle progression, neuronal
           migration, and apoptosis. Inactivating mutations in the
           PAK3 gene cause X-linked non-syndromic mental
           retardation, the severity of which depends on the site
           of the mutation.
          Length = 297

 Score = 38.2 bits (88), Expect = 0.001
 Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 6/76 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE +        Y  + D+WSLGI  IE+  G  PY    +P   L  +  +  P
Sbjct: 179 PYWMAPEVVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP 233

Query: 165 RLP-PGEFSSDFKDFI 179
            L  P   S+ F+DF+
Sbjct: 234 ELQNPERLSAVFRDFL 249


>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 2.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 2, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK2 belongs to group I. Group I PAKs contain a PBD
           (p21-binding domain) overlapping with an AID
           (autoinhibitory domain), a C-terminal catalytic domain,
           SH3 binding sites and a non-classical SH3 binding site
           for PIX (PAK-interacting exchange factor). PAK2 plays a
           role in pro-apoptotic signaling. It is cleaved and
           activated by caspases leading to morphological changes
           during apoptosis. PAK2 is also activated in response to
           a variety of stresses including DNA damage,
           hyperosmolarity, serum starvation, and contact
           inhibition, and may play a role in coordinating the
           stress response. PAK2 also contributes to cancer cell
           invasion through a mechanism distinct from that of PAK1.
          Length = 296

 Score = 38.2 bits (88), Expect = 0.001
 Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 6/76 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE +        Y  + D+WSLGI  IE+  G  PY    +P   L  +  +  P
Sbjct: 179 PYWMAPEVVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP 233

Query: 165 RLP-PGEFSSDFKDFI 179
            L  P + S  F+DF+
Sbjct: 234 ELQNPEKLSPIFRDFL 249


>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase
           kinase 3-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
           (MEKK3)-like subfamily, catalytic (c) domain,
           functionally uncharacterized subgroup 1. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MEKK3-like subfamily is part of a larger superfamily
           that includes the catalytic domains of other protein
           STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. The MEKK3-like subfamily is
           composed of MEKK3, MEKK2, and related proteins, all
           containing an N-terminal PB1 domain, which mediates
           oligomerization, and a C-terminal catalytic domain.
           MEKK2 and MEKK3 are mitogen-activated protein kinase
           (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks),
           proteins that phosphorylate and activate MAPK kinases
           (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
           and activate MAPKs during signaling cascades that are
           important in mediating cellular responses to
           extracellular signals. MEKK2 and MEKK3 activate MEK5
           (also called MKK5), which activates extracellular
           signal-regulated kinase 5 (ERK5). The ERK5 cascade plays
           roles in promoting cell proliferation, differentiation,
           neuronal survival, and neuroprotection. MEKK3 plays an
           essential role in embryonic angiogenesis and early heart
           development. MEKK2 and MEKK3 can also activate the
           MAPKs, c-Jun N-terminal kinase (JNK) and p38, through
           their respective MAPKKs.
          Length = 264

 Score = 38.1 bits (88), Expect = 0.001
 Identities = 22/75 (29%), Positives = 37/75 (49%), Gaps = 5/75 (6%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I   G    Y  ++DVWS+  +++E+ T + P+  + +     K   Q   P
Sbjct: 173 PYWMSPEVISGEG----YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228

Query: 165 RLPPGEFSSDFKDFI 179
            LP G  S   +DF+
Sbjct: 229 MLPDG-VSDACRDFL 242


>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 5.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 5, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK5 belongs to group II. Group II PAKs contain a PBD
           (p21-binding domain) and a C-terminal catalytic domain,
           but do not harbor an AID (autoinhibitory domain) or SH3
           binding sites. PAK5 is mainly expressed in the brain. It
           is not required for viability, but together with PAK6,
           it is required for normal levels of locomotion and
           activity, and for learning and memory. PAK5 cooperates
           with Inca (induced in neural crest by AP2) in the
           regulation of cell adhesion and cytoskeletal
           organization in the embryo and in neural crest cells
           during craniofacial development. PAK5 may also play a
           role in controlling the signaling of Raf-1, an effector
           of Ras, at the mitochondria.
          Length = 292

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 6/78 (7%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  S  P  Y    D+WSLGI +IE+  G  PY     P + ++++  + PP
Sbjct: 182 PYWMAPEVI--SRLP--YGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPP 236

Query: 165 RLPPG-EFSSDFKDFITL 181
           R+    + SS  + F+ L
Sbjct: 237 RVKDSHKVSSVLRGFLDL 254


>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine
           Kinase, G protein-coupled Receptor Kinase.
           Serine/Threonine Kinases (STKs), G protein-coupled
           Receptor Kinase (GRK) subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The GRK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. GRKs phosphorylate and
           regulate G protein-coupled receptors (GPCRs), the
           largest superfamily of cell surface receptors, which
           regulate some part of nearly all physiological
           functions. Phosphorylated GPCRs bind to arrestins, which
           prevents further G protein signaling despite the
           presence of activating ligand. GRKs contain a central
           catalytic domain, flanked by N- and C-terminal
           extensions. The N-terminus contains an RGS (regulator of
           G protein signaling) homology (RH) domain and several
           motifs. The C-terminus diverges among different groups
           of GRKs. There are seven types of GRKs, named GRK1 to
           GRK7. They are subdivided into three main groups: visual
           (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and
           GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is
           widespread while GRK1/4/7 show a limited tissue
           distribution. The substrate spectrum of the widely
           expressed GRKs partially overlaps. GRKs play important
           roles in the cardiovascular, immune, respiratory,
           skeletal, and nervous systems.
          Length = 277

 Score = 37.5 bits (87), Expect = 0.002
 Identities = 18/59 (30%), Positives = 28/59 (47%), Gaps = 3/59 (5%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPF--EQLKQVVQDDPPRLPPGEFSSDFKDF 178
           YD   D ++LG +L E+  GR P+         E+LK+   +     P  +FS + KD 
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD-KFSPEAKDL 228


>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein
           Serine/Threonine Kinase, Atypical Protein Kinase C.
           Serine/Threonine Kinases (STKs), Atypical Protein Kinase
           C (aPKC) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           aPKC subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PKCs are classified into three groups
           (classical, atypical, and novel) depending on their mode
           of activation and the structural characteristics of
           their regulatory domain. aPKCs only require
           phosphatidylserine (PS) for activation. They contain a
           C2-like region, instead of a calcium-binding (C2) region
           found in classical PKCs, in their regulatory domain.
           There are two aPKC isoforms, zeta and iota. aPKCs are
           involved in many cellular functions including
           proliferation, migration, apoptosis, polarity
           maintenance and cytoskeletal regulation. They also play
           a critical role in the regulation of glucose metabolism
           and in the pathogenesis of type 2 diabetes.
          Length = 329

 Score = 37.5 bits (87), Expect = 0.002
 Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 11/70 (15%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGS--PFEQ-----LKQ 157
           PN+I PE +       +Y    D W+LG+ + E+  GR P+D  G     +Q     L Q
Sbjct: 160 PNYIAPEIL----RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215

Query: 158 VVQDDPPRLP 167
           V+ +   R+P
Sbjct: 216 VILEKQIRIP 225


>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase,
           Src.  Protein Tyrosine Kinase (PTK) family; Src kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Src (or c-Src) is a
           cytoplasmic (or non-receptor) tyr kinase, containing an
           N-terminal SH4 domain with a myristoylation site,
           followed by SH3 and SH2 domains, a tyr kinase domain,
           and a regulatory C-terminal region with a conserved tyr.
           It is activated by autophosphorylation at the tyr kinase
           domain, and is negatively regulated by phosphorylation
           at the C-terminal tyr by Csk (C-terminal Src Kinase).
           c-Src is the vertebrate homolog of the oncogenic protein
           (v-Src) from Rous sarcoma virus. Together with other Src
           subfamily proteins, it is involved in signaling pathways
           that regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Src also play a role in regulating cell
           adhesion, invasion, and motility in cancer cells and
           tumor vasculature, contributing to cancer progression
           and metastasis. Elevated levels of Src kinase activity
           have been reported in a variety of human cancers.
           Several inhibitors of Src have been developed as
           anti-cancer drugs. Src is also implicated in acute
           inflammatory responses and osteoclast function.
          Length = 262

 Score = 37.0 bits (85), Expect = 0.003
 Identities = 16/25 (64%), Positives = 18/25 (72%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           + I+SDVWS GI L EL T GR PY
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPY 204


>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein
           Serine/Threonine Kinase, cGMP-dependent protein kinase. 
           Serine/Threonine Kinases (STKs), cGMP-dependent protein
           kinase (cGK or PKG) subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The cGK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Mammals have two cGK isoforms
           from different genes, cGKI and cGKII. cGKI exists as two
           splice variants, cGKI-alpha and cGKI-beta. cGK consists
           of an N-terminal regulatory domain containing a
           dimerization and an autoinhibitory pseudosubstrate
           region, two cGMP-binding domains, and a C-terminal
           catalytic domain. Binding of cGMP to both binding sites
           releases the inhibition of the catalytic center by the
           pseudosubstrate region, allowing autophosphorylation and
           activation of the kinase. cGKI is a  soluble protein
           expressed in all smooth muscles, platelets, cerebellum,
           and kidney. It is also expressed at lower concentrations
           in other tissues. cGKII is a membrane-bound protein that
           is most abundantly expressed in the intestine. It is
           also present in the brain nuclei, adrenal cortex,
           kidney, lung, and prostate. cGKI is involved in the
           regulation of smooth muscle tone, smooth cell
           proliferation, and platelet activation. cGKII plays a
           role in the regulation of secretion, such as renin
           secretion by the kidney and aldosterone secretion by the
           adrenal. It also regulates bone growth and the circadian
           rhythm.
          Length = 262

 Score = 36.8 bits (86), Expect = 0.003
 Identities = 20/41 (48%), Positives = 23/41 (56%), Gaps = 4/41 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P ++ PE I   G    YD   D WSLGI L EL TGR P+
Sbjct: 156 PEYVAPEIILNKG----YDFSVDYWSLGILLYELLTGRPPF 192


>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, G protein-coupled Receptor
           Kinase 1.  Serine/Threonine Kinases (STKs), G
           protein-coupled Receptor Kinase (GRK) subfamily, GRK1
           isoform, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The GRK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. GRKs phosphorylate and regulate G
           protein-coupled receptors (GPCRs), the largest
           superfamily of cell surface receptors, which regulate
           some part of nearly all physiological functions.
           Phosphorylated GPCRs bind to arrestins, which prevents
           further G protein signaling despite the presence of
           activating ligand. There are seven types of GRKs, named
           GRK1 to GRK7. GRK1, also called rhodopsin kinase,
           belongs to the visual group of GRKs and is expressed in
           retinal cells. It phosphorylates rhodopsin in rod cells,
           which leads to termination of the phototransduction
           cascade. Mutations in GRK1 are associated to a
           recessively inherited form of stationary nightblindness
           called Oguchi disease.
          Length = 280

 Score = 37.1 bits (86), Expect = 0.003
 Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 7/76 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFE--QLKQVVQDD 162
           P F+ PE +        YD   D ++LG++L E+   R P+   G   E  +LKQ + +D
Sbjct: 161 PGFMAPELL----QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND 216

Query: 163 PPRLPPGEFSSDFKDF 178
               P  +FS   K F
Sbjct: 217 SVTYPD-KFSPASKSF 231


>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 4.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 4, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK4 belongs to group II. Group II PAKs contain a PBD
           (p21-binding domain) and a C-terminal catalytic domain,
           but do not harbor an AID (autoinhibitory domain) or SH3
           binding sites. PAK4 regulates cell morphology and
           cytoskeletal organization. It is essential for embryonic
           viability and proper neural development. Mice lacking
           PAK4 die due to defects in the fetal heart. In addition,
           their spinal cord motor neurons showed failure to
           differentiate and migrate. PAK4 also plays a role in
           cell survival and tumorigenesis. It is overexpressed in
           many primary tumors including colon, esophageal, and
           mammary tumors. PAK4 has also been implicated in viral
           and bacterial infection pathways.
          Length = 292

 Score = 36.9 bits (85), Expect = 0.003
 Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 5/62 (8%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE I  S  P  Y    D+WSLGI +IE+  G  PY     P + +K +  + PP
Sbjct: 180 PYWMAPELI--SRLP--YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPP 234

Query: 165 RL 166
           +L
Sbjct: 235 KL 236


>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases.
           Protein Tyrosine Kinase (PTK) family, catalytic domain.
           This PTKc family is part of a larger superfamily that
           includes the catalytic domains of protein
           serine/threonine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. They can be classified
           into receptor and non-receptor tyr kinases. PTKs play
           important roles in many cellular processes including,
           lymphocyte activation, epithelium growth and
           maintenance, metabolism control, organogenesis
           regulation, survival, proliferation, differentiation,
           migration, adhesion, motility, and morphogenesis.
           Receptor tyr kinases (RTKs) are integral membrane
           proteins which contain an extracellular ligand-binding
           region, a transmembrane segment, and an intracellular
           tyr kinase domain. RTKs are usually activated through
           ligand binding, which causes dimerization and
           autophosphorylation of the intracellular tyr kinase
           catalytic domain, leading to intracellular signaling.
           Some RTKs are orphan receptors with no known ligands.
           Non-receptor (or cytoplasmic) tyr kinases are
           distributed in different intracellular compartments and
           are usually multi-domain proteins containing a catalytic
           tyr kinase domain as well as various regulatory domains
           such as SH3 and SH2. PTKs are usually autoinhibited and
           require a mechanism for activation. In many PTKs, the
           phosphorylation of tyr residues in the activation loop
           is essential for optimal activity. Aberrant expression
           of PTKs is associated with many development
           abnormalities and cancers.
          Length = 262

 Score = 36.7 bits (86), Expect = 0.003
 Identities = 13/42 (30%), Positives = 22/42 (52%), Gaps = 3/42 (7%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDD 162
           +  +SDVWS G+ L E+ T G  PY       E++ + ++  
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKG 223


>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Atypical Protein Kinase C zeta.
            Serine/Threonine Kinases (STKs), Atypical Protein
           Kinase C (aPKC) subfamily, zeta isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The aPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           aPKCs only require phosphatidylserine (PS) for
           activation. There are two aPKC isoforms, zeta and iota.
           PKC-zeta plays a critical role in activating the glucose
           transport response. It is activated by glucose, insulin,
           and exercise through diverse pathways. PKC-zeta also
           plays a central role in maintaining cell polarity in
           yeast and mammalian cells. In addition, it affects actin
           remodeling in muscle cells.
          Length = 327

 Score = 36.5 bits (84), Expect = 0.004
 Identities = 21/68 (30%), Positives = 33/68 (48%), Gaps = 9/68 (13%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWG-----SPFEQLKQVV 159
           PN+I PE +        Y    D W+LG+ + E+  GR P+D        +  + L QV+
Sbjct: 160 PNYIAPEIL----RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215

Query: 160 QDDPPRLP 167
            + P R+P
Sbjct: 216 LEKPIRIP 223


>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase,
           Hematopoietic cell kinase.  Protein Tyrosine Kinase
           (PTK) family; Hematopoietic cell kinase (Hck); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Hck is a member of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases contain an N-terminal SH4 domain with a
           myristoylation site, followed by SH3 and SH2 domains, a
           tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr. They are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Src
           proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Hck is present in myeloid and lymphoid
           cells that play a role in the development of cancer. It
           may be important in the oncogenic signaling of the
           protein Tel-Abl, which induces a chronic myelogenous
           leukemia (CML)-like disease. Hck also acts as a negative
           regulator of granulocyte colony-stimulating factor
           (G-CSF)-induced proliferation of granulocytic
           precursors, suggesting a possible role in the
           development of acute myeloid leukemia (AML). In
           addition, Hck is essential in regulating the
           degranulation of polymorphonuclear leukocytes (PMNs).
           Genetic polymorphisms affect the expression level of
           Hck, which affects PMN mediator release and influences
           the development of chronic obstructive pulmonary disease
           (COPD).
          Length = 260

 Score = 36.5 bits (84), Expect = 0.004
 Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 5/53 (9%)

Query: 100 GADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELAT-GRFPYDTWGSP 151
           GA     +  PE I    N  ++ I+SDVWS GI L+E+ T GR PY    +P
Sbjct: 162 GAKFPIKWTAPEAI----NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210


>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase
           adapter protein beta.  Protein Kinase family,
           STE20-related kinase adapter protein (STRAD) beta
           subfamily, pseudokinase domain. The STRAD-beta subfamily
           is part of a larger superfamily that includes the
           catalytic domains of serine/threonine kinases (STKs),
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The pseudokinase domain shows similarity to
           protein kinases but lacks crucial residues for catalytic
           activity. STRAD forms a complex with the scaffolding
           protein MO25, and the STK, LKB1, resulting in the
           activation of the kinase. In the complex, LKB1
           phosphorylates and activates adenosine
           monophosphate-activated protein kinases (AMPKs), which
           regulate cell energy metabolism and cell polarity. LKB1
           is a tumor suppressor linked to the rare inherited
           disease, Peutz-Jeghers syndrome, which is characterized
           by a predisposition to benign polyps and
           hyperpigmentation of the buccal mucosa. There are two
           forms of STRAD, alpha and beta, that complex with LKB1
           and MO25. STRAD-beta is also referred to as ALS2CR2
           (Amyotrophic lateral sclerosis 2 chromosomal region
           candidate gene 2 protein), since the human gene encoding
           it is located within the juvenile ALS2 critical region
           on chromosome 2q33-q34. It is not linked to the
           development of ALS2.
          Length = 328

 Score = 36.5 bits (84), Expect = 0.005
 Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 13/50 (26%)

Query: 105 PNF-------IRPE--RIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P F       + PE  R D  G    Y+++SD++S+GI+  ELATGR P+
Sbjct: 165 PQFSTSVLPWLSPELLRQDLYG----YNVKSDIYSVGITACELATGRVPF 210


>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Yank1.  Serine/Threonine
           Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Yank1 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. This subfamily
           contains uncharacterized STKs with similarity to the
           human protein designated Yank1 or STK32A.
          Length = 258

 Score = 36.1 bits (84), Expect = 0.006
 Identities = 19/75 (25%), Positives = 31/75 (41%), Gaps = 4/75 (5%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE +        Y +  D WSLG++  E   G+ PY           +  Q+   
Sbjct: 163 PGYMAPEVL----CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218

Query: 165 RLPPGEFSSDFKDFI 179
            L P  +S++  D I
Sbjct: 219 VLYPATWSTEAIDAI 233


>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein
           Serine/Threonine Kinase, Atypical Protein Kinase C iota.
            Serine/Threonine Kinases (STKs), Atypical Protein
           Kinase C (aPKC) subfamily, iota isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The aPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           aPKCs only require phosphatidylserine (PS) for
           activation. There are two aPKC isoforms, zeta and iota.
           PKC-iota is directly implicated in carcinogenesis. It is
           critical to oncogenic signaling mediated by Ras and
           Bcr-Abl. The PKC-iota gene is the target of
           tumor-specific gene amplification in many human cancers,
           and has been identified as a human oncogene. In addition
           to its role in transformed growth, PKC-iota also
           promotes invasion, chemoresistance, and tumor cell
           survival. Expression profiling of PKC-iota is a
           prognostic marker of poor clinical outcome in several
           human cancers. PKC-iota also plays a role in
           establishing cell polarity, and has critical embryonic
           functions.
          Length = 329

 Score = 36.2 bits (83), Expect = 0.006
 Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 11/70 (15%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSP-------FEQLKQ 157
           PN+I PE +       +Y    D W+LG+ + E+  GR P+D  GS         + L Q
Sbjct: 160 PNYIAPEIL----RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215

Query: 158 VVQDDPPRLP 167
           V+ +   R+P
Sbjct: 216 VILEKQIRIP 225


>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein
           Serine/Threonine Kinase, Large Tumor Suppressor.
           Serine/Threonine Kinases (STKs), Large Tumor Suppressor
           (LATS) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           LATS subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. LATS was originally identified in Drosophila
           using a screen for genes whose inactivation led to
           overproliferation of cells. In tetrapods, there are two
           LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in
           mice results in the development of various tumors,
           including sarcomas and ovarian cancer. LATS functions as
           a tumor suppressor and is implicated in cell cycle
           regulation.
          Length = 376

 Score = 35.9 bits (83), Expect = 0.006
 Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFE-QLKQVVQDDP 163
           PN+I PE +  +G    Y    D WS+G+ L E+  G+ P+    +P E QLK +  +  
Sbjct: 208 PNYIAPEVLLRTG----YTQLCDWWSVGVILYEMLVGQPPFLA-DTPAETQLKVINWETT 262

Query: 164 PRLPP-GEFSSDFKDFIT 180
             +P   + S +  D I 
Sbjct: 263 LHIPSQAKLSREASDLIL 280


>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein
           Serine/Threonine Kinase, Mitogen and stress-activated
           kinase 1.  Serine/Threonine Kinases (STKs), Mitogen and
           stress-activated kinase (MSK) subfamily, MSK1,
           N-terminal catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The MSK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MSKs contain an N-terminal kinase domain (NTD)
           from the AGC family and a C-terminal kinase domain (CTD)
           from the CAMK family, similar to 90 kDa ribosomal
           protein S6 kinases (RSKs). MSKs are activated by two
           major signaling cascades, the Ras-MAPK and p38 stress
           kinase pathways, which trigger phosphorylation in the
           activation loop (A-loop) of the CTD of MSK. The active
           CTD phosphorylates the hydrophobic motif (HM) of NTD,
           which facilitates the phosphorylation of the A-loop and
           activates the NTD, which in turn phosphorylates
           downstream targets. MSK1 plays a role in the regulation
           of translational control and transcriptional activation.
           It phosphorylates the transcription factors, CREB and
           NFkappaB. It also phosphorylates the nucleosomal
           proteins H3 and HMG-14. Increased phosphorylation of
           MEK1 is associated with the development of cerebral
           ischemic/hypoxic preconditioning.
          Length = 290

 Score = 35.7 bits (82), Expect = 0.007
 Identities = 23/76 (30%), Positives = 39/76 (51%), Gaps = 7/76 (9%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWG---SPFEQLKQVVQDDP 163
           ++ P+ +   G    +D   D WS+G+ + EL TG  P+   G   S  E  +++++ +P
Sbjct: 172 YMAPDIV--RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229

Query: 164 PRLPPGEFSSDFKDFI 179
           P   P E S+  KD I
Sbjct: 230 PY--PQEMSALAKDII 243


>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine
           Kinases, Fyn and Yrk.  Protein Tyrosine Kinase (PTK)
           family; Fyn and Yrk kinases; catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Fyn and
           Yrk are members of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases contain an N-terminal SH4 domain with a
           myristoylation site, followed by SH3 and SH2 domains, a
           tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr. They are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Src
           proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Fyn, together with Lck, plays a
           critical role in T-cell signal transduction by
           phosphorylating ITAM (immunoreceptor tyr activation
           motif) sequences on T-cell receptors, ultimately leading
           to the proliferation and differentiation of T-cells. In
           addition, Fyn is involved in the myelination of neurons,
           and is implicated in Alzheimer's and Parkinson's
           diseases. Yrk has been detected only in chickens. It is
           primarily found in neuronal and epithelial cells and in
           macrophages. It may play a role in inflammation and in
           response to injury.
          Length = 260

 Score = 35.4 bits (81), Expect = 0.008
 Identities = 16/25 (64%), Positives = 18/25 (72%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           + I+SDVWS GI L EL T GR PY
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPY 204


>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related
           kinase adapter protein alpha.  Protein Kinase family,
           STE20-related kinase adapter protein (STRAD) alpha
           subfamily, pseudokinase domain. The STRAD alpha
           subfamily is part of a larger superfamily that includes
           the catalytic domains of serine/threonine kinases
           (STKs), protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. The pseudokinase domain shows
           similarity to protein kinases but lacks crucial residues
           for catalytic activity. STRAD forms a complex with the
           scaffolding protein MO25, and the STK, LKB1, resulting
           in the activation of the kinase. In the complex, LKB1
           phosphorylates and activates adenosine
           monophosphate-activated protein kinases (AMPKs), which
           regulate cell energy metabolism and cell polarity. LKB1
           is a tumor suppressor linked to the rare inherited
           disease, Peutz-Jeghers syndrome, which is characterized
           by a predisposition to benign polyps and
           hyperpigmentation of the buccal mucosa. There are two
           forms of STRAD, alpha and beta, that complex with LKB1
           and MO25. The structure of STRAD-alpha is available and
           shows that this protein binds ATP, has an ordered
           activation loop, and adopts a closed conformation
           typical of fully active protein kinases. It does not
           possess activity due to nonconservative substitutions of
           essential catalytic residues. ATP binding enhances the
           affinity of STRAD for MO25.  The conformation of
           STRAD-alpha, stabilized through ATP and MO25, may be
           needed to activate LKB1. A mutation which results in a
           truncation of a C-terminal part of the human STRAD-alpha
           pseudokinase domain and disrupts its association with
           LKB1, leads to PMSE (polyhydramnios, megalencephaly,
           symptomatic epilepsy) syndrome. Several splice variants
           of STRAD-alpha exist which exhibit different effects on
           the localization and activation of LKB1.
          Length = 327

 Score = 35.7 bits (82), Expect = 0.009
 Identities = 13/28 (46%), Positives = 19/28 (67%)

Query: 118 NPSNYDIRSDVWSLGISLIELATGRFPY 145
           N   YD +SD++S+GI+  ELA G  P+
Sbjct: 183 NLQGYDAKSDIYSVGITACELANGHVPF 210


>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Tyrosine kinase expressed in hepatocellular carcinoma
           (Tec) subfamily; catalytic (c) domain. The Tec subfamily
           is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk
           (Txk), and similar proteins. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tec kinases are
           cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with
           similarity to Src kinases in that they contain Src
           homology protein interaction domains (SH3, SH2)
           N-terminal to the catalytic tyr kinase domain. Unlike
           Src kinases, most Tec subfamily members (except Rlk)
           also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. In addition, some
           members contain the Tec homology (TH) domain, which
           contains proline-rich and zinc-binding regions. Tec
           kinases form the second largest subfamily of nRTKs and
           are expressed mainly by haematopoietic cells, although
           Tec and Bmx are also found in endothelial cells. B-cells
           express Btk and Tec, while T-cells express Itk, Txk, and
           Tec. Collectively, Tec kinases are expressed in a
           variety of myeloid cells such as mast cells, platelets,
           macrophages, and dendritic cells. Each Tec kinase shows
           a distinct cell-type pattern of expression. The function
           of Tec kinases in lymphoid cells have been studied
           extensively. They play important roles in the
           development, differentiation, maturation, regulation,
           survival, and function of B-cells and T-cells. Mutations
           in Btk cause the severe B-cell immunodeficiency,
           X-linked agammaglobulinaemia (XLA).
          Length = 256

 Score = 35.5 bits (82), Expect = 0.009
 Identities = 16/54 (29%), Positives = 28/54 (51%), Gaps = 3/54 (5%)

Query: 120 SNYDIRSDVWSLGISLIELAT-GRFPYDTW--GSPFEQLKQVVQDDPPRLPPGE 170
           S +  +SDVWS G+ + E+ + G+ PY+ +      E +    +   P+L P E
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE 229


>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, MAP/ERK kinase kinase 1.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1
           (MEKK1) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MEKK1 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MEKK1 is a mitogen-activated protein kinase
           (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
           phosphorylates and activates MAPK kinases (MAPKKs or
           MKKs or MAP2Ks), which in turn phosphorylate and
           activate MAPKs during signaling cascades that are
           important in mediating cellular responses to
           extracellular signals. MEKK1 activates the extracellular
           signal-regulated kinase 1/2 (ERK1/2) and c-Jun
           N-terminal kinase (JNK) pathways by activating their
           respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively.
           MEKK1 is important in regulating cell survival and
           apoptosis. MEKK1 also plays a role in cell migration,
           tissue maintenance and homeostasis, and wound healing.
          Length = 268

 Score = 35.2 bits (81), Expect = 0.011
 Identities = 11/26 (42%), Positives = 17/26 (65%)

Query: 121 NYDIRSDVWSLGISLIELATGRFPYD 146
            Y    DVWS+G  +IE+AT + P++
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWN 209


>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional.
          Length = 283

 Score = 34.7 bits (80), Expect = 0.015
 Identities = 12/27 (44%), Positives = 20/27 (74%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFPYD 146
           S Y I+ D++SLG+ L E+ TG+ P++
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFE 223


>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase
           1-like Protein Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Yeast protein kinase 1
           (YPK1)-like subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The YPK1-like subfamily is part of a larger superfamily
           that includes the catalytic domains of other protein
           STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. This subfamily is composed of
           fungal proteins with similarity to the AGC STKs,
           Saccharomyces cerevisiae YPK1 and Schizosaccharomyces
           pombe Gad8p. YPK1 is required for cell growth and acts
           as a downstream kinase in the sphingolipid-mediated
           signaling pathway of yeast. It also plays a role in
           efficient endocytosis and in the maintenance of cell
           wall integrity. Gad8p is a downstream target of Tor1p,
           the fission yeast homolog of mTOR. It plays a role in
           cell growth and sexual development.
          Length = 312

 Score = 34.1 bits (78), Expect = 0.023
 Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 7/76 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE +   G    Y    D W+LG+ L E+ TG  P+       E  ++++Q +P 
Sbjct: 157 PEYLAPELLLGHG----YTKAVDWWTLGVLLYEMLTGLPPFYDENVN-EMYRKILQ-EPL 210

Query: 165 RLPPGEFSSDFKDFIT 180
           R P G F  D KD + 
Sbjct: 211 RFPDG-FDRDAKDLLI 225


>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase,
           Yes.  Protein Tyrosine Kinase (PTK) family; Yes kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Yes (or c-Yes) is a
           member of the Src subfamily of proteins, which are
           cytoplasmic (or non-receptor) tyr kinases. Src kinases
           contain an N-terminal SH4 domain with a myristoylation
           site, followed by SH3 and SH2 domains, a tyr kinase
           domain, and a regulatory C-terminal region containing a
           conserved tyr. They are activated by autophosphorylation
           at the tyr kinase domain, but are negatively regulated
           by phosphorylation at the C-terminal tyr by Csk
           (C-terminal Src Kinase). Src proteins are involved in
           signaling pathways that regulate cytokine and growth
           factor responses, cytoskeleton dynamics, cell
           proliferation, survival, and differentiation. c-Yes
           kinase is the cellular homolog of the oncogenic protein
           (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma
           viruses. It displays functional overlap with other Src
           subfamily members, particularly Src. It also shows some
           unique functions such as binding to occludins,
           transmembrane proteins that regulate extracellular
           interactions in tight junctions. Yes also associates
           with a number of proteins in different cell types that
           Src does not interact with, like JAK2 and gp130 in
           pre-adipocytes, and Pyk2 in treated pulmonary vein
           endothelial cells. Although the biological function of
           Yes remains unclear, it appears to have a role in
           regulating cell-cell interactions and vesicle
           trafficking in polarized cells.
          Length = 260

 Score = 33.9 bits (77), Expect = 0.029
 Identities = 16/25 (64%), Positives = 18/25 (72%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           + I+SDVWS GI L EL T GR PY
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPY 204


>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase,
           Lyn.  Protein Tyrosine Kinase (PTK) family; Lyn kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Lyn is a member of the
           Src subfamily of proteins, which are cytoplasmic (or
           non-receptor) tyr kinases. Src kinases contain an
           N-terminal SH4 domain with a myristoylation site,
           followed by SH3 and SH2 domains, a tyr kinase domain,
           and a regulatory C-terminal region containing a
           conserved tyr. They are activated by autophosphorylation
           at the tyr kinase domain, but are negatively regulated
           by phosphorylation at the C-terminal tyr by Csk
           (C-terminal Src Kinase). Src proteins are involved in
           signaling pathways that regulate cytokine and growth
           factor responses, cytoskeleton dynamics, cell
           proliferation, survival, and differentiation. Lyn is
           expressed in B lymphocytes and myeloid cells. It
           exhibits both positive and negative regulatory roles in
           B cell receptor (BCR) signaling. Lyn, as well as Fyn and
           Blk, promotes B cell activation by phosphorylating ITAMs
           (immunoreceptor tyr activation motifs) in CD19 and in Ig
           components of BCR. It negatively regulates signaling by
           its unique ability to phosphorylate ITIMs
           (immunoreceptor tyr inhibition motifs) in cell surface
           receptors like CD22 and CD5. Lyn also plays an important
           role in G-CSF receptor signaling by phosphorylating a
           variety of adaptor molecules.
          Length = 261

 Score = 33.8 bits (77), Expect = 0.030
 Identities = 20/47 (42%), Positives = 26/47 (55%), Gaps = 5/47 (10%)

Query: 100 GADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELAT-GRFPY 145
           GA     +  PE I    N  ++ I+SDVWS GI L E+ T G+ PY
Sbjct: 163 GAKFPIKWTAPEAI----NFGSFTIKSDVWSFGILLYEIVTYGKIPY 205


>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity.
           Phosphotransferases. The specificity of this class of
           kinases can not be predicted. Possible dual-specificity
           Ser/Thr/Tyr kinase.
          Length = 258

 Score = 33.7 bits (78), Expect = 0.030
 Identities = 17/53 (32%), Positives = 26/53 (49%), Gaps = 8/53 (15%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDD-----PPRLPP 168
           +  +SDVWS G+ L E+ T G  PY   G    ++ + ++       PP  PP
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPY--PGMSNAEVLEYLKKGYRLPKPPNCPP 231


>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 8.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek8 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek8 contains an
           N-terminal kinase catalytic domain and a C-terminal RCC1
           (regulator of chromosome condensation) domain. A double
           point mutation in Nek8 causes cystic kidney disease in
           mice that genetically resembles human autosomal
           recessive polycystic kidney disease (ARPKD). Nek8 is
           also associated with a rare form of juvenile renal
           cystic disease, nephronophthisis type 9. It has been
           suggested that a defect in the ciliary localization of
           Nek8 contributes to the development of cysts manifested
           by these diseases.
          Length = 256

 Score = 33.7 bits (77), Expect = 0.034
 Identities = 16/36 (44%), Positives = 23/36 (63%), Gaps = 4/36 (11%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELAT 140
           P +I PE  +  G P  Y+ +SD+W+LG  L ELA+
Sbjct: 165 PCYISPELCE--GKP--YNQKSDIWALGCVLYELAS 196


>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases.  Protein Kinases
           (PKs), catalytic (c) domain. PKs catalyze the transfer
           of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The PK family is part of a larger
           superfamily that includes the catalytic domains of RIO
           kinases, aminoglycoside phosphotransferase, choline
           kinase, phosphoinositide 3-kinase (PI3K), and
           actin-fragmin kinase. PKs make up a large family of
           serine/threonine kinases, protein tyrosine kinases
           (PTKs), and dual-specificity PKs that phosphorylate both
           serine/threonine and tyrosine residues of target
           proteins. Majority of protein phosphorylation, about
           95%, occurs on serine residues while only 1% occurs on
           tyrosine residues. Protein phosphorylation is a
           mechanism by which a wide variety of cellular proteins,
           such as enzymes and membrane channels, are reversibly
           regulated in response to certain stimuli. PKs often
           function as components of signal transduction pathways
           in which one kinase activates a second kinase, which in
           turn, may act on other kinases; this sequential action
           transmits a signal from the cell surface to target
           proteins, which results in cellular responses. The PK
           family is one of the largest known protein families with
           more than 100 homologous yeast enzymes and 550 human
           proteins. A fraction of PK family members are
           pseudokinases that lack crucial residues for catalytic
           activity. The mutiplicity of kinases allows for specific
           regulation according to substrate, tissue distribution,
           and cellular localization. PKs regulate many cellular
           processes including proliferation, division,
           differentiation, motility, survival, metabolism,
           cell-cycle progression, cytoskeletal rearrangement,
           immunity, and neuronal functions. Many kinases are
           implicated in the development of various human diseases
           including different types of cancer.
          Length = 215

 Score = 33.4 bits (77), Expect = 0.036
 Identities = 13/34 (38%), Positives = 19/34 (55%), Gaps = 3/34 (8%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIEL 138
           P ++ PE +        Y  +SD+WSLG+ L EL
Sbjct: 157 PAYMAPEVLL---GKGYYSEKSDIWSLGVILYEL 187


>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain.
           Phosphotransferases. Tyrosine-specific kinase subfamily.
          Length = 257

 Score = 33.7 bits (78), Expect = 0.036
 Identities = 18/53 (33%), Positives = 28/53 (52%), Gaps = 8/53 (15%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDD-----PPRLPP 168
           +  +SDVWS G+ L E+ T G  PY   G   E++ + +++      PP  PP
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPY--PGMSNEEVLEYLKNGYRLPQPPNCPP 230


>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed.
          Length = 932

 Score = 34.0 bits (78), Expect = 0.037
 Identities = 14/41 (34%), Positives = 27/41 (65%), Gaps = 4/41 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P+++ PER+   G P++    +D+++LG+ L ++ T  FPY
Sbjct: 195 PDYMAPERL--LGVPAS--ESTDIYALGVILYQMLTLSFPY 231


>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src
           kinase-like Protein Tyrosine Kinases.  Protein Tyrosine
           Kinase (PTK) family; C-terminal Src kinase (Csk)
           subfamily; catalytic (c) domain. The Csk subfamily is
           composed of Csk, Chk, and similar proteins. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Csk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing the Src homology domains, SH3 and
           SH2, N-terminal to the catalytic tyr kinase domain. They
           negatively regulate the activity of Src kinases that are
           anchored to the plasma membrane. To inhibit Src kinases,
           Csk and Chk are translocated to the membrane via binding
           to specific transmembrane proteins, G-proteins, or
           adaptor proteins near the membrane. Csk catalyzes the
           tyr phosphorylation of the regulatory C-terminal tail of
           Src kinases, resulting in their inactivation. Chk
           inhibit Src kinases using a noncatalytic mechanism by
           simply binding to them. As negative regulators of Src
           kinases, Csk and Chk play important roles in cell
           proliferation, survival, and differentiation, and
           consequently, in cancer development and progression.
          Length = 256

 Score = 33.5 bits (77), Expect = 0.038
 Identities = 18/36 (50%), Positives = 21/36 (58%), Gaps = 6/36 (16%)

Query: 125 RSDVWSLGISLIEL-ATGRFPYDTWGSPFEQLKQVV 159
           +SDVWS GI L E+ + GR PY     P   LK VV
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVV 209


>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase
           adapter protein.  Protein Kinase family, STE20-related
           kinase adapter protein (STRAD) subfamily, pseudokinase
           domain. The STRAD subfamily is part of a larger
           superfamily that includes the catalytic domains of
           serine/threonine kinases (STKs), protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           pseudokinase domain shows similarity to protein kinases
           but lacks crucial residues for catalytic activity. STRAD
           forms a complex with the scaffolding protein MO25, and
           the STK, LKB1, resulting in the activation of the
           kinase. In the complex, LKB1 phosphorylates and
           activates adenosine monophosphate-activated protein
           kinases (AMPKs), which regulate cell energy metabolism
           and cell polarity. LKB1 is a tumor suppressor linked to
           the rare inherited disease, Peutz-Jeghers syndrome,
           which is characterized by a predisposition to benign
           polyps and hyperpigmentation of the buccal mucosa. There
           are two forms of STRAD, alpha and beta, that complex
           with LKB1 and MO25. The structure of STRAD-alpha is
           available and shows that this protein binds ATP, has an
           ordered activation loop, and adopts a closed
           conformation typical of fully active protein kinases. It
           does not possess activity due to nonconservative
           substitutions of essential catalytic residues. ATP
           binding enhances the affinity of STRAD for MO25.  The
           conformation of STRAD-alpha stabilized through ATP and
           MO25 may be needed to activate LKB1.
          Length = 314

 Score = 33.5 bits (77), Expect = 0.040
 Identities = 12/28 (42%), Positives = 19/28 (67%)

Query: 118 NPSNYDIRSDVWSLGISLIELATGRFPY 145
           N   Y+ +SD++S+GI+  ELA G  P+
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVPF 210


>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like
           Protein Tyrosine Kinases.  Protein Tyrosine Kinase (PTK)
           family; Insulin Receptor (InsR) subfamily; catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). The InsR subfamily
           is composed of InsR, Insulin-like Growth Factor-1
           Receptor (IGF-1R), and similar proteins. PTKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. InsR and
           IGF-1R are receptor tyr kinases (RTKs) composed of two
           alphabeta heterodimers. Binding of the ligand (insulin,
           IGF-1, or IGF-2) to the extracellular alpha subunit
           activates the intracellular tyr kinase domain of the
           transmembrane beta subunit. Receptor activation leads to
           autophosphorylation, stimulating downstream kinase
           activities, which initiate signaling cascades and
           biological function. InsR and IGF-1R, which share 84%
           sequence identity in their kinase domains, display
           physiologically distinct yet overlapping functions in
           cell growth, differentiation, and metabolism. InsR
           activation leads primarily to metabolic effects while
           IGF-1R activation stimulates mitogenic pathways. In
           cells expressing both receptors, InsR/IGF-1R hybrids are
           found together with classical receptors. Both receptors
           can interact with common adaptor molecules such as IRS-1
           and IRS-2.
          Length = 277

 Score = 33.5 bits (77), Expect = 0.042
 Identities = 12/25 (48%), Positives = 16/25 (64%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           +  +SDVWS G+ L E+AT    PY
Sbjct: 198 FTTKSDVWSFGVVLWEMATLAEQPY 222


>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Rho-associated coiled-coil
           containing protein kinase 2.  Serine/Threonine Kinases
           (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The ROCK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. ROCK contains an
           N-terminal extension, a catalytic kinase domain, and a
           C-terminal extension, which contains a coiled-coil
           region encompassing a Rho-binding domain (RBD) and a
           pleckstrin homology (PH) domain. ROCK is auto-inhibited
           by the RBD and PH domain interacting with the catalytic
           domain, and is activated via interaction with Rho
           GTPases. ROCK2 was the first identified target of
           activated RhoA, and was found to play a role in stress
           fiber and focal adhesion formation. It is prominently
           expressed in the brain, heart, and skeletal muscles. It
           is implicated in vascular and neurological disorders,
           such as hypertension and vasospasm of the coronary and
           cerebral arteries. ROCK2 is also activated by caspase-2
           cleavage, resulting in thrombin-induced microparticle
           generation in response to cell activation. Mice
           deficient in ROCK2 show intrauterine growth retardation
           and embryonic lethality because of placental
           dysfunction.
          Length = 370

 Score = 33.5 bits (76), Expect = 0.046
 Identities = 14/41 (34%), Positives = 21/41 (51%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P++I PE +   G    Y    D WS+G+ L E+  G  P+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247


>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase,
           Interleukin-2-inducible T-cell Kinase.  Protein Tyrosine
           Kinase (PTK) family; Interleukin-2 (IL-2)-inducible
           T-cell kinase (Itk); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Itk (also
           known as Tsk or Emt) is a member of the Tec subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases with similarity to Src kinases in that they
           contain Src homology protein interaction domains (SH3,
           SH2) N-terminal to the catalytic tyr kinase domain.
           Unlike Src kinases, most Tec subfamily members (except
           Rlk) also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. In addition, Itk
           contains the Tec homology (TH) domain containing one
           proline-rich region and a zinc-binding region. Tec
           kinases are expressed mainly by haematopoietic cells.
           Itk is expressed in T-cells and mast cells, and is
           important in their development and differentiation. Of
           the three Tec kinases expressed in T-cells, Itk plays
           the predominant role in T-cell receptor (TCR) signaling.
           It is activated by phosphorylation upon TCR crosslinking
           and is involved in the pathway resulting in
           phospholipase C-gamma1 activation and actin
           polymerization. It also plays a role in the downstream
           signaling of the T-cell costimulatory receptor CD28, the
           T-cell surface receptor CD2, and the chemokine receptor
           CXCR4. In addition, Itk is crucial for the development
           of T-helper(Th)2 effector responses.
          Length = 256

 Score = 33.4 bits (76), Expect = 0.048
 Identities = 12/28 (42%), Positives = 19/28 (67%), Gaps = 1/28 (3%)

Query: 120 SNYDIRSDVWSLGISLIEL-ATGRFPYD 146
           S Y  +SDVWS G+ + E+ + G+ PY+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYE 203


>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain.  It is an
           interaction domain identified as being similar to the
           C-terminal protein kinase catalytic fold (C lobe). Its
           presence at the N terminus of signalling proteins and
           the absence of the active-site residues in the catalytic
           and activation loops suggest that it folds independently
           and is likely to be non-catalytic. The occurrence of
           KIND only in metazoa implies that it has evolved from
           the catalytic protein kinase domain into an interaction
           domain possibly by keeping the substrate-binding
           features.
          Length = 176

 Score = 32.8 bits (75), Expect = 0.060
 Identities = 34/131 (25%), Positives = 52/131 (39%), Gaps = 27/131 (20%)

Query: 71  HQRLQFLLHLFRFALSGNQDD----LLIIRGLYGADCDPN------FIRPERIDPSGNPS 120
            Q L  L  L R A SGN       LL + G               F+ PE I       
Sbjct: 24  LQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPDPYFMAPEVIQGQ---- 79

Query: 121 NYDIRSDVWSLGISLIELATGRFPYDTWGSPFE--QLKQVVQDDPPRLPPGEFSSD---- 174
           +Y  ++D++SLGI+L E      PY+      E   + +++ +  P   P + S+     
Sbjct: 80  SYTEKADIYSLGITLYEALDYELPYN---EERELSAILEILLNGMPADDPRDRSNLEGVS 136

Query: 175 ----FKDFITL 181
               F+DF+ L
Sbjct: 137 AARSFEDFMRL 147


>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Large Tumor Suppressor 2.
           Serine/Threonine Kinases (STKs), Large Tumor Suppressor
           (LATS) subfamily, LATS2 isoform, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The LATS subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. LATS functions as a tumor
           suppressor and is implicated in cell cycle regulation.
           LATS2 is an essential mitotic regulator responsible for
           coordinating accurate cytokinesis completion and
           governing the stabilization of other mitotic regulators.
           It is also critical in the maintenance of proper
           chromosome number, genomic stability, mitotic fidelity,
           and the integrity of centrosome duplication.
           Downregulation of LATS2 is associated with poor
           prognosis in acute lymphoblastic leukemia and breast
           cancer.
          Length = 381

 Score = 33.1 bits (75), Expect = 0.061
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 5/77 (6%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           PN+I PE +   G    Y    D WS+G+ L E+  G+ P+        QLK +  ++  
Sbjct: 212 PNYIAPEVLLRKG----YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267

Query: 165 RLPPG-EFSSDFKDFIT 180
            +PP  + S +  D IT
Sbjct: 268 HIPPQVKLSPEAVDLIT 284


>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine
           Kinase, Epidermal Growth Factor Receptor.  Protein
           Tyrosine Kinase (PTK) family; Epidermal Growth Factor
           Receptor (EGFR); catalytic (c) domain. The PTKc family
           is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EGFR
           (HER1, ErbB1) is a member of the EGFR (HER, ErbB)
           subfamily of proteins, which are receptor tyr kinases
           (RTKs) containing an extracellular EGF-related
           ligand-binding region, a transmembrane helix, and a
           cytoplasmic region with a tyr kinase domain and a
           regulatory C-terminal tail. Unlike other tyr kinases,
           phosphorylation of the activation loop of EGFR proteins
           is not critical to their activation. Instead, they are
           activated by ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. Ligands for EGFR include EGF, heparin binding
           EGF-like growth factor (HBEGF), epiregulin,
           amphiregulin, TGFalpha, and betacellulin. Upon ligand
           binding, EGFR can form homo- or heterodimers with other
           EGFR subfamily members. The EGFR signaling pathway is
           one of the most important pathways regulating cell
           proliferation, differentiation, survival, and growth.
           Overexpression and mutation in the kinase domain of EGFR
           have been implicated in the development and progression
           of a variety of cancers. A number of monoclonal
           antibodies and small molecule inhibitors have been
           developed that target EGFR, including the antibodies
           Cetuximab and Panitumumab, which are used in combination
           with other therapies for the treatment of colorectal
           cancer and non-small cell lung carcinoma (NSCLC). The
           small molecule inhibitors Gefitinib (Iressa) and
           Erlotinib (Tarceva), already used for NSCLC, are
           undergoing clinical trials for other types of cancer
           including gastrointestinal, breast, head and neck, and
           bladder.
          Length = 316

 Score = 33.0 bits (75), Expect = 0.064
 Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 4/47 (8%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDDPPRLP 167
           Y  +SDVWS G+++ EL T G  PYD  G P  ++  +++    RLP
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSILEKG-ERLP 231


>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 11.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 11 (Nek11)
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           Nek11 subfamily is one of a family of 11 different Neks
           (Nek1-11) that are involved in cell cycle control. The
           Nek family is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Nek11 is involved, through direct
           phosphorylation, in regulating the degradation of Cdc25A
           (Cell Division Cycle 25 homolog A), which plays a role
           in cell cycle progression and in activating cyclin
           dependent kinases. Nek11 is activated by CHK1
           (CHeckpoint Kinase 1) and may be involved in the G2/M
           checkpoint. Nek11 may also play a role in the S-phase
           checkpoint as well as in DNA replication and genotoxic
           stress responses.
          Length = 260

 Score = 32.6 bits (74), Expect = 0.071
 Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 7/64 (10%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLK-QVVQDDP 163
           P ++ PE +   G    YD +SD+WSLG  L E+      ++  G  F  +  ++V+   
Sbjct: 169 PYYMSPEALKHQG----YDSKSDIWSLGCILYEMCCLAHAFE--GQNFLSVVLRIVEGPT 222

Query: 164 PRLP 167
           P LP
Sbjct: 223 PSLP 226


>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 4.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek4 subfamily is
           one of a family of 11 different Neks (Nek1-11). The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Neks are involved in the regulation of
           downstream processes following the activation of Cdc2,
           and many of their functions are cell cycle-related. They
           play critical roles in microtubule dynamics during
           ciliogenesis and mitosis. Nek4 is highly abundant in the
           testis. Its specific function is unknown.
          Length = 257

 Score = 32.6 bits (74), Expect = 0.073
 Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 4/42 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYD 146
           P ++ PE    S  P NY  +SDVW+LG  + E+AT +  ++
Sbjct: 166 PYYMSPELF--SNKPYNY--KSDVWALGCCVYEMATLKHAFN 203


>gnl|CDD|184642 PRK14353, glmU, bifunctional N-acetylglucosamine-1-phosphate
           uridyltransferase/glucosamine-1-phosphate
           acetyltransferase; Provisional.
          Length = 446

 Score = 32.9 bits (76), Expect = 0.076
 Identities = 25/98 (25%), Positives = 37/98 (37%), Gaps = 25/98 (25%)

Query: 17  VSSVKTTDDKKVVLVTGKGEAEKVQKELETLRC---IYIQDYHLCVRSTRYFSVDTFHQR 73
           +++  +    +V +V G G AE V      +     I++Q   L           T H  
Sbjct: 40  LAAAASLGPSRVAVVVGPG-AEAVAAAAAKIAPDAEIFVQKERL----------GTAHAV 88

Query: 74  LQFLLHLFRFALSGNQDDLLIIRGLYGADCDPNFIRPE 111
           L       R AL+G   D+L+   LYG   D   I  E
Sbjct: 89  LAA-----REALAGGYGDVLV---LYG---DTPLITAE 115


>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Rho-associated coiled-coil
           containing protein kinase 1.  Serine/Threonine Kinases
           (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The ROCK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. ROCK contains an
           N-terminal extension, a catalytic kinase domain, and a
           C-terminal extension, which contains a coiled-coil
           region encompassing a Rho-binding domain (RBD) and a
           pleckstrin homology (PH) domain. ROCK is auto-inhibited
           by the RBD and PH domain interacting with the catalytic
           domain, and is activated via interaction with Rho
           GTPases. ROCK1 is preferentially expressed in the liver,
           lung, spleen, testes, and kidney. It mediates signaling
           from Rho to the actin cytoskeleton. It is implicated in
           the development of cardiac fibrosis, cardiomyocyte
           apoptosis, and hyperglycemia. Mice deficient with ROCK1
           display eyelids open at birth (EOB) and omphalocele
           phenotypes due to the disorganization of actin filaments
           in the eyelids and the umbilical ring.
          Length = 371

 Score = 32.7 bits (74), Expect = 0.080
 Identities = 14/41 (34%), Positives = 21/41 (51%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P++I PE +   G    Y    D WS+G+ L E+  G  P+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247


>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated
           serine/threonine kinase-like proteins.  Serine/Threonine
           Kinases (STKs), Microtubule-associated serine/threonine
           (MAST) kinase subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The MAST kinase subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. The MAST kinase subfamily
           includes MAST kinases, MAST-like (MASTL) kinases, and
           fungal kinases with similarity to Saccharomyces
           cerevisiae Rim15 and Schizosaccharomyces pombe cek1.
           MAST kinases contain an N-terminal domain of unknown
           function, a central catalytic domain, and a C-terminal
           PDZ domain that mediates protein-protein interactions.
           MASTL kinases carry only a catalytic domain which
           contains a long insert relative to other kinases. The
           fungal kinases in this subfamily harbor other domains in
           addition to a central catalytic domain, which also
           contains an insert relative to MAST kinases like MASTL.
           Rim15 contains a C-terminal signal receiver (REC) domain
           while cek1 contains an N-terminal PAS domain. MAST
           kinases are cytoskeletal associated kinases of unknown
           function that are also expressed at neuromuscular
           junctions and postsynaptic densities. The fungal
           proteins Rim15 and cek1 are involved in the regulation
           of meiosis and mitosis, respectively.
          Length = 265

 Score = 32.6 bits (75), Expect = 0.081
 Identities = 21/80 (26%), Positives = 31/80 (38%), Gaps = 9/80 (11%)

Query: 103 CDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY--DTWGSPFEQLKQVVQ 160
             P++I PE I        +    D WSLG  L E   G  P+  +T   P E  + ++ 
Sbjct: 163 GTPDYIAPEVI----LGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILN 215

Query: 161 DDPPRLPPGEFSSDFKDFIT 180
                    E S +  D I+
Sbjct: 216 GKIEWPEDVEVSDEAIDLIS 235


>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase,
           C-terminal Src kinase.  Protein Tyrosine Kinase (PTK)
           family; C-terminal Src kinase (Csk); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. The Csk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing the Src homology domains, SH3 and
           SH2, N-terminal to the catalytic tyr kinase domain. They
           negatively regulate the activity of Src kinases that are
           anchored to the plasma membrane. To inhibit Src kinases,
           Csk is translocated to the membrane via binding to
           specific transmembrane proteins, G-proteins, or adaptor
           proteins near the membrane. Csk catalyzes the tyr
           phosphorylation of the regulatory C-terminal tail of Src
           kinases, resulting in their inactivation. Csk is
           expressed in a wide variety of tissues. As a negative
           regulator of Src, Csk plays a role in cell
           proliferation, survival, and differentiation, and
           consequently, in cancer development and progression. In
           addition, Csk also shows Src-independent functions. It
           is a critical component in G-protein signaling, and
           plays a role in cytoskeletal reorganization and cell
           migration.
          Length = 256

 Score = 32.6 bits (74), Expect = 0.083
 Identities = 21/49 (42%), Positives = 26/49 (53%), Gaps = 10/49 (20%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDDPPRLPPG 169
           +  +SDVWS GI L E+ + GR PY     P   LK VV    PR+  G
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVV----PRVEKG 215


>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 5.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek5 subfamily is
           one of a family of 11 different Neks (Nek1-11). The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Neks are involved in the regulation of
           downstream processes following the activation of Cdc2,
           and many of their functions are cell cycle-related. They
           play critical roles in microtubule dynamics during
           ciliogenesis and mitosis. The specific function of Nek5
           is unknown.
          Length = 257

 Score = 32.2 bits (73), Expect = 0.092
 Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 4/60 (6%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLK-QVVQDDPPRLPPGEFSSDFKDFIT 180
           Y+ ++D+WSLG  L EL T + P++  G+   QL  ++ Q     + P  FS D +  I+
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFE--GNNLHQLVLKICQGYFAPISPN-FSRDLRSLIS 235


>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional.
          Length = 1021

 Score = 32.8 bits (74), Expect = 0.098
 Identities = 15/43 (34%), Positives = 26/43 (60%), Gaps = 1/43 (2%)

Query: 121 NYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDP 163
           +YD +SD+W+LG  + EL +G+ P+    + F QL   ++  P
Sbjct: 219 SYDDKSDMWALGCIIYELCSGKTPFHK-ANNFSQLISELKRGP 260


>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Novel Protein Kinase C theta.
           Serine/Threonine Kinases (STKs), Novel Protein Kinase C
           (nPKC), theta isoform, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The nPKC subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PKCs are classified into three groups
           (classical, atypical, and novel) depending on their mode
           of activation and the structural characteristics of
           their regulatory domain. nPKCs are calcium-independent,
           but require DAG (1,2-diacylglycerol) and
           phosphatidylserine (PS) for activity. There are four
           nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta
           is selectively expressed in T-cells and plays an
           important and non-redundant role in several aspects of
           T-cell biology. Although T-cells also express other PKC
           isoforms, PKC-theta is unique in that upon antigen
           stimulation, it is translocated to the plasma membrane
           at the immunological synapse, where it mediates signals
           essential for T-cell activation. It is essential for
           TCR-induced proliferation, cytokine production, T-cell
           survival, and the differentiation and effector function
           of T-helper (Th) cells, particularly Th2 and Th17.
           PKC-theta is being developed as a therapeutic target for
           Th2-mediated allergic inflammation and Th17-mediated
           autoimmune diseases.
          Length = 316

 Score = 32.2 bits (73), Expect = 0.10
 Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 6/63 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P++I PE +   G   N  +  D WS G+ L E+  G+ P+   G   E+L Q ++ D P
Sbjct: 160 PDYIAPEIL--LGQKYNTSV--DWWSFGVLLYEMLIGQSPFH--GHDEEELFQSIRMDNP 213

Query: 165 RLP 167
             P
Sbjct: 214 CYP 216


>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase,
           Axl.  Protein Tyrosine Kinase (PTK) family; Axl;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Axl is a member of the
           Axl subfamily, which is composed of receptor tyr kinases
           (RTKs) containing an extracellular ligand-binding region
           with two immunoglobulin-like domains followed by two
           fibronectin type III repeats, a transmembrane segment,
           and an intracellular catalytic domain. Binding to their
           ligands, Gas6 and protein S, leads to receptor
           dimerization, autophosphorylation, activation, and
           intracellular signaling. Axl is widely expressed in a
           variety of organs and cells including epithelial,
           mesenchymal, hematopoietic, as well as non-transformed
           cells. Axl signaling is important in many cellular
           functions such as survival, anti-apoptosis,
           proliferation, migration, and adhesion. Axl was
           originally isolated from patients with chronic
           myelogenous leukemia and a chronic myeloproliferative
           disorder. Axl is overexpressed in many human cancers
           including colon, squamous cell, thyroid, breast, and
           lung carcinomas.
          Length = 272

 Score = 32.3 bits (73), Expect = 0.10
 Identities = 13/25 (52%), Positives = 19/25 (76%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y  +SDVWS G+++ E+AT G+ PY
Sbjct: 191 YTTKSDVWSFGVTMWEIATRGQTPY 215


>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine
           Kinases, Srm and Brk.  Protein Tyrosine Kinase (PTK)
           family; Src-related kinase lacking C-terminal regulatory
           tyrosine and N-terminal myristylation sites (Srm) and
           breast tumor kinase (Brk, also called protein tyrosine
           kinase 6); catalytic (c) domains. The PTKc family is
           part of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Srm and
           Brk are a member of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases in general contain an N-terminal SH4 domain with
           a myristoylation site, followed by SH3 and SH2 domains,
           a tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr; they are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Srm and
           Brk however, lack the N-terminal myristylation sites.
           Src proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Brk has been found to be overexpressed
           in a majority of breast tumors.
          Length = 261

 Score = 32.0 bits (73), Expect = 0.11
 Identities = 13/25 (52%), Positives = 17/25 (68%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           +  +SDVWS GI L E+ T G+ PY
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPY 205


>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine
           Kinases, Apoptosis-associated tyrosine kinases.  Protein
           Tyrosine Kinase (PTK) family; Apoptosis-associated
           tyrosine kinase (Aatyk) subfamily; catalytic (c) domain.
           The Aatyk subfamily is also referred to as the lemur
           tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1
           (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and
           similar proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Aatyk proteins are mostly receptor tyr kinases (RTKs)
           containing a transmembrane segment and a long C-terminal
           cytoplasmic tail with a catalytic domain. Aatyk1 does
           not contain a transmembrane segment and is a cytoplasmic
           (or nonreceptor) kinase. Aatyk proteins are classified
           as tyr kinases based on overall sequence similarity and
           the phylogenetic tree. However, analysis of catalytic
           residues suggests that Aatyk proteins may be
           multispecific kinases, functioning also as
           serine/threonine kinases. They are involved in neural
           differentiation, nerve growth factor (NGF) signaling,
           apoptosis, and spermatogenesis.
          Length = 269

 Score = 32.2 bits (73), Expect = 0.11
 Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 5/65 (7%)

Query: 107 FIRPERIDPSGN---PSNYDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDD 162
           ++ PE ++  G    P +   +S++WSLG+++ EL T    PY    S  + LKQVV++ 
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVLKQVVREQ 226

Query: 163 PPRLP 167
             +LP
Sbjct: 227 DIKLP 231


>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth
           Factor Receptor-like Protein Tyrosine Kinases.  Protein
           Tyrosine Kinase (PTK) family; Epidermal Growth Factor
           Receptor (EGFR) subfamily; catalytic (c) domain. EGFR
           (HER, ErbB) subfamily members include EGFR (HER1,
           ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and
           similar proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           The EGFR proteins are receptor tyr kinases (RTKs)
           containing an extracellular EGF-related ligand-binding
           region, a transmembrane helix, and a cytoplasmic region
           with a tyr kinase domain and a regulatory C-terminal
           tail. Unlike other tyr kinases, phosphorylation of the
           activation loop of EGFR proteins is not critical to
           their activation. Instead, they are activated by
           ligand-induced dimerization, resulting in the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. Collectively, they can recognize a variety of
           ligands including EGF, TGFalpha, and neuregulins, among
           others. All four subfamily members can form homo- or
           heterodimers. HER3 contains an impaired kinase domain
           and depends on its heterodimerization partner for
           activation. EGFR subfamily members are involved in
           signaling pathways leading to a broad range of cellular
           responses including cell proliferation, differentiation,
           migration, growth inhibition, and apoptosis. Gain of
           function alterations, through their overexpression,
           deletions, or point mutations in their kinase domains,
           have been implicated in various cancers. These receptors
           are targets of many small molecule inhibitors and
           monoclonal antibodies used in cancer therapy.
          Length = 279

 Score = 32.0 bits (73), Expect = 0.12
 Identities = 13/26 (50%), Positives = 18/26 (69%), Gaps = 1/26 (3%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYD 146
           Y  +SDVWS G+++ EL T G  PY+
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYE 213


>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase,
           Csk homologous kinase.  Protein Tyrosine Kinase (PTK)
           family; Csk homologous kinase (Chk); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Csk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing the Src homology domains, SH3 and
           SH2, N-terminal to the catalytic tyr kinase domain. They
           negatively regulate the activity of Src kinases that are
           anchored to the plasma membrane. Chk is also referred to
           as megakaryocyte-associated tyrosine kinase (Matk). To
           inhibit Src kinases, Chk is translocated to the membrane
           via binding to specific transmembrane proteins,
           G-proteins, or adaptor proteins near the membrane. Chk
           inhibit Src kinases using a noncatalytic mechanism by
           simply binding to them. As a negative regulator of Src
           kinases, Chk may play important roles in cell
           proliferation, survival, and differentiation, and
           consequently, in cancer development and progression. Chk
           is expressed in brain and hematopoietic cells. Studies
           in mice reveal that Chk is not functionally redundant
           with Csk and that it plays an important role as a
           regulator of immune responses. Chk also plays a role in
           neural differentiation in a manner independent of Src by
           enhancing Mapk activation via Ras-mediated signaling.
          Length = 254

 Score = 31.9 bits (72), Expect = 0.12
 Identities = 16/48 (33%), Positives = 26/48 (54%), Gaps = 3/48 (6%)

Query: 125 RSDVWSLGISLIEL-ATGRFPYD--TWGSPFEQLKQVVQDDPPRLPPG 169
           +SDVWS G+ L E+ + GR PY   +     E +++  + +PP   P 
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA 224


>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine
           Kinases.  Protein Tyrosine Kinase (PTK) family; Tie
           subfamily; catalytic (c) domain. The Tie subfamily
           consists of Tie1 and Tie2. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tie proteins are
           receptor tyr kinases (RTKs) containing an extracellular
           region, a transmembrane segment, and an intracellular
           catalytic domain. The extracellular region contains an
           immunoglobulin (Ig)-like domain, three epidermal growth
           factor (EGF)-like domains, a second Ig-like domain, and
           three fibronectin type III repeats. Tie receptors are
           specifically expressed in endothelial cells and
           hematopoietic stem cells. The angiopoietins (Ang-1 to
           Ang-4) serve as ligands for Tie2, while no specific
           ligand has been identified for Tie1. The binding of
           Ang-1 to Tie2 leads to receptor autophosphorylation and
           activation, promoting cell migration and survival. In
           contrast, Ang-2 binding to Tie2 does not result in the
           same response, suggesting that Ang-2 may function as an
           antagonist. In vivo studies of Tie1 show that it is
           critical in vascular development.
          Length = 270

 Score = 32.0 bits (72), Expect = 0.13
 Identities = 20/53 (37%), Positives = 27/53 (50%), Gaps = 3/53 (5%)

Query: 116 SGNPSNYDIRSDVWSLGISLIELAT-GRFPY--DTWGSPFEQLKQVVQDDPPR 165
           S N S Y   SDVWS G+ L E+ + G  PY   T    +E+L Q  + + P 
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234


>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein
           Serine/Threonine Kinase, Citron Rho-interacting kinase. 
           Serine/Threonine Kinases (STKs), Citron Rho-interacting
           kinase (CRIK) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The CRIK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. CRIK is also called citron kinase. It contains
           a catalytic domain, a central coiled-coil domain, and a
           C-terminal region containing a Rho-binding domain (RBD),
           a zinc finger, and a pleckstrin homology (PH) domain, in
           addition to other motifs. CRIK, an effector of the small
           GTPase Rho, plays an important function during
           cytokinesis and affects its contractile process.
           CRIK-deficient mice show severe ataxia and epilepsy as a
           result of abnormal cytokinesis and massive apoptosis in
           neuronal precursors. A Down syndrome critical region
           protein TTC3 interacts with CRIK and inhibits
           CRIK-dependent neuronal differentiation and neurite
           extension.
          Length = 330

 Score = 32.1 bits (73), Expect = 0.13
 Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 4/44 (9%)

Query: 105 PNFIRPE---RIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P++I PE    ++  G    Y +  D WSLG+   E+  GR P+
Sbjct: 167 PDYIAPEVLTTMNGDGK-GTYGVECDWWSLGVIAYEMIYGRSPF 209


>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 3.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek3 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek3 is primarily
           localized in the cytoplasm and shows no cell
           cycle-dependent changes in its activity. It is present
           in the axons of neurons and affects morphogenesis and
           polarity through its regulation of microtubule
           acetylation. Nek3 modulates the signaling of the
           prolactin receptor through its activation of Vav2 and
           contributes to prolactin-mediated motility of breast
           cancer cells.
          Length = 255

 Score = 31.9 bits (72), Expect = 0.13
 Identities = 13/29 (44%), Positives = 20/29 (68%), Gaps = 2/29 (6%)

Query: 122 YDIRSDVWSLGISLIELATGRFPY--DTW 148
           Y+ +SD+WSLG  L EL T + P+  ++W
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANSW 205


>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein
           Serine/Threonine Kinase, Mitogen and stress-activated
           kinase 2.  Serine/Threonine Kinases (STKs), Mitogen and
           stress-activated kinase (MSK) subfamily, MSK2,
           N-terminal catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The MSK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MSKs contain an N-terminal kinase domain (NTD)
           from the AGC family and a C-terminal kinase domain (CTD)
           from the CAMK family, similar to 90 kDa ribosomal
           protein S6 kinases (RSKs). MSKs are activated by two
           major signaling cascades, the Ras-MAPK and p38 stress
           kinase pathways, which trigger phosphorylation in the
           activation loop (A-loop) of the CTD of MSK. The active
           CTD phosphorylates the hydrophobic motif (HM) of NTD,
           which facilitates the phosphorylation of the A-loop and
           activates the NTD, which in turn phosphorylates
           downstream targets. MSK2 and MSK1 play nonredundant
           roles in activating histone H3 kinases, which play
           pivotal roles in compaction of the chromatin fiber. MSK2
           is the required H3 kinase in response to stress stimuli
           and activation of the p38 MAPK pathway. MSK2 also plays
           a role in the pathogenesis of psoriasis.
          Length = 332

 Score = 31.8 bits (72), Expect = 0.14
 Identities = 17/45 (37%), Positives = 25/45 (55%), Gaps = 4/45 (8%)

Query: 127 DVWSLGISLIELATGRFPYDTWG---SPFEQLKQVVQDDPPRLPP 168
           D WSLGI + EL TG  P+   G   +  E  +++++ DPP  P 
Sbjct: 189 DWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-FPS 232


>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein
           Serine/Threonine Kinase, G protein-coupled Receptor
           Kinase 7.  Serine/Threonine Kinases (STKs), G
           protein-coupled Receptor Kinase (GRK) subfamily, GRK7
           isoform, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The GRK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. GRKs phosphorylate and regulate G
           protein-coupled receptors (GPCRs), the largest
           superfamily of cell surface receptors, which regulate
           some part of nearly all physiological functions.
           Phosphorylated GPCRs bind to arrestins, which prevents
           further G protein signaling despite the presence of
           activating ligand. There are seven types of GRKs, named
           GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs
           to the visual group of GRKs. It is primarily found in
           the retina and plays a role in the regulation of opsin
           light receptors. GRK7 is located in retinal cone outer
           segments and plays an important role in regulating
           photoresponse of the cones.
          Length = 277

 Score = 31.8 bits (72), Expect = 0.15
 Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 2/63 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPF--EQLKQVVQDDPPRLPPGEFSSDFKDFI 179
           Y    D +++G S+ E+  GR P+         E+LK+   +D  +     F+ + KD  
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230

Query: 180 TLW 182
            L+
Sbjct: 231 RLF 233


>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to
           tyrosine kinase).  Protein Tyrosine Kinase (PTK) family;
           Receptor related to tyrosine kinase (Ryk); pseudokinase
           domain. The PTKc (catalytic domain) family to which this
           subfamily belongs, is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Ryk is a
           receptor tyr kinase (RTK) containing an extracellular
           region with two leucine-rich motifs, a transmembrane
           segment, and an intracellular inactive pseudokinase
           domain. The extracellular region of Ryk shows homology
           to the N-terminal domain of Wnt inhibitory factor-1
           (WIF) and serves as the ligand (Wnt) binding domain of
           Ryk. Ryk is expressed in many different tissues both
           during development and in adults, suggesting a
           widespread function. It acts as a chemorepulsive axon
           guidance receptor of Wnt glycoproteins and is
           responsible for the establishment of axon tracts during
           the development of the central nervous system. In
           addition, studies in mice reveal that Ryk is essential
           in skeletal, craniofacial, and cardiac development.
           Thus, it appears Ryk is involved in signal transduction
           despite its lack of kinase activity. Ryk may function as
           an accessory protein that modulates the signals coming
           from catalytically active partner RTKs such as the Eph
           receptors.
          Length = 280

 Score = 31.6 bits (72), Expect = 0.15
 Identities = 17/33 (51%), Positives = 19/33 (57%), Gaps = 2/33 (6%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFE 153
           Y   SDVWS G+ L EL T G+ PY     PFE
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPYVEI-DPFE 227


>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Ephrin Receptor (EphR) subfamily; catalytic (c) domain.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). They can be classified into two classes (EphA
           and EphB), according to their extracellular sequences,
           which largely correspond to binding preferences for
           either GPI-anchored ephrin-A ligands or transmembrane
           ephrin-B ligands. Vertebrates have ten EphA and six EhpB
           receptors, which display promiscuous ligand interactions
           within each class. EphRs contain an ephrin binding
           domain and two fibronectin repeats extracellularly, a
           transmembrane segment, and a cytoplasmic tyr kinase
           domain. Binding of the ephrin ligand to EphR requires
           cell-cell contact since both are anchored to the plasma
           membrane. This allows ephrin/EphR dimers to form,
           leading to the activation of the intracellular tyr
           kinase domain. The resulting downstream signals occur
           bidirectionally in both EphR-expressing cells (forward
           signaling) and ephrin-expressing cells (reverse
           signaling). The main effect of ephrin/EphR interaction
           is cell-cell repulsion or adhesion. Ephrin/EphR
           signaling is important in neural development and
           plasticity, cell morphogenesis and proliferation,
           cell-fate determination, embryonic development, tissue
           patterning, and angiogenesis.
          Length = 266

 Score = 31.5 bits (72), Expect = 0.15
 Identities = 18/44 (40%), Positives = 25/44 (56%), Gaps = 4/44 (9%)

Query: 126 SDVWSLGISLIE-LATGRFPYDTWGSPFEQLKQVVQDDPPRLPP 168
           SDVWS GI + E ++ G  PY  W    + + + V+D   RLPP
Sbjct: 189 SDVWSFGIVMWEVMSYGERPY--WDMSNQDVIKAVEDG-YRLPP 229


>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine
           Kinase, Tie1.  Protein Tyrosine Kinase (PTK) family;
           Tie1; catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tie1 is a receptor tyr
           kinase (RTK) containing an extracellular region, a
           transmembrane segment, and an intracellular catalytic
           domain. The extracellular region contains an
           immunoglobulin (Ig)-like domain, three epidermal growth
           factor (EGF)-like domains, a second Ig-like domain, and
           three fibronectin type III repeats. Tie receptors are
           specifically expressed in endothelial cells and
           hematopoietic stem cells. No specific ligand has been
           identified for Tie1, although the angiopoietin, Ang-1,
           binds to Tie1 through integrins at high concentrations.
           In vivo studies of Tie1 show that it is critical in
           vascular development.
          Length = 297

 Score = 31.9 bits (72), Expect = 0.17
 Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 3/53 (5%)

Query: 116 SGNPSNYDIRSDVWSLGISLIELAT-GRFPY--DTWGSPFEQLKQVVQDDPPR 165
           S N S Y  +SDVWS G+ L E+ + G  PY   T    +E+L Q  + + PR
Sbjct: 189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR 241


>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal
           Byr2-like MAP Kinase Kinase Kinases.  Serine/threonine
           kinases (STKs), mitogen-activated protein kinase (MAPK)
           kinase kinase (MAPKKK) subfamily, fungal Byr2-like
           proteins, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MAPKKK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this group include the MAPKKKs
           Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae
           and Cryptococcus neoformans Ste11, and related proteins.
           They contain an N-terminal SAM (sterile alpha-motif)
           domain, which mediates protein-protein interaction, and
           a C-terminal catalytic domain. MAPKKKs phosphorylate and
           activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which
           in turn phosphorylate and activate MAPKs during
           signaling cascades that are important in mediating
           cellular responses to extracellular signals. Fission
           yeast Byr2 is regulated by Ras1. It responds to
           pheromone signaling and controls mating through the MAPK
           pathway. Budding yeast Ste11 functions in MAPK cascades
           that regulate mating, high osmolarity glycerol, and
           filamentous growth responses.
          Length = 267

 Score = 31.4 bits (71), Expect = 0.20
 Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 6/60 (10%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLP--PGEFSSDFKDFI 179
           Y  ++D+WSLG  ++E+ TG+ P+        QL+ + +      P  P   SS+  DF+
Sbjct: 189 YTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKIGENASPEIPSNISSEAIDFL 244


>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. 
           Serine/Threonine Kinases (STKs), NDR kinase subfamily,
           NDR1 isoform, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The NDR
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. NDR kinase contains an N-terminal regulatory
           (NTR) domain and an insert within the catalytic domain
           that contains an auto-inhibitory sequence. Like many
           other AGC kinases, NDR kinase requires phosphorylation
           at two sites, the activation loop (A-loop) and the
           hydrophobic motif (HM), for activity. Higher eukaryotes
           contain two NDR isoforms, NDR1 and NDR2. Both isoforms
           play a role in proper centrosome duplication. NDR1 is
           highly expressed in thymus, muscle, lung and spleen. It
           is not an essential protein because mice deficient of
           NDR1 remain viable and fertile. However, these mice
           develop T-cell lymphomas and appear to be hypersenstive
           to carcinogenic treatment. NDR1 appears to act as a
           tumor suppressor. NDR1 is also called STK38.
          Length = 363

 Score = 31.6 bits (71), Expect = 0.20
 Identities = 23/76 (30%), Positives = 37/76 (48%), Gaps = 10/76 (13%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDD-- 162
           P++I PE    +G    Y+   D WSLG+ + E+  G  P+ +  +P E  K+V+     
Sbjct: 200 PDYIAPEVFMQTG----YNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKET 254

Query: 163 ---PPRLPPGEFSSDF 175
              PP +P  E + D 
Sbjct: 255 LIFPPEVPISEKAKDL 270


>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase,
           Abelson kinase.  Protein Tyrosine Kinase (PTK) family;
           Abelson (Abl) kinase; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Abl (or
           c-Abl) is a ubiquitously-expressed cytoplasmic (or
           nonreceptor) tyr kinase that contains SH3, SH2, and tyr
           kinase domains in its N-terminal region, as well as
           nuclear localization motifs, a putative DNA-binding
           domain, and F- and G-actin binding domains in its
           C-terminal tail. It also contains a short autoinhibitory
           cap region in its N-terminus. Abl is normally inactive
           and requires phosphorylation and myristoylation for
           activation. Abl function depends on its subcellular
           localization. In the cytoplasm, Abl plays a role in cell
           proliferation and survival. In response to DNA damage or
           oxidative stress, Abl is transported to the nucleus
           where it induces apoptosis. In chronic myelogenous
           leukemia (CML) patients, an aberrant translocation
           results in the replacement of the first exon of Abl with
           the BCR (breakpoint cluster region) gene. The resulting
           BCR-Abl fusion protein is constitutively active and
           associates into tetramers, resulting in a hyperactive
           kinase sending a continuous signal. This leads to
           uncontrolled proliferation, morphological transformation
           and anti-apoptotic effects. BCR-Abl is the target of
           selective inhibitors, such as imatinib (Gleevec), used
           in the treatment of CML. Abl2, also known as ARG
           (Abelson-related gene), is thought to play a cooperative
           role with Abl in the proper development of the nervous
           system. The Tel-ARG fusion protein, resulting from
           reciprocal translocation between chromosomes 1 and 12,
           is associated with acute myeloid leukemia (AML). The TEL
           gene is a frequent fusion partner of other tyr kinase
           oncogenes, including Tel/Abl, Tel/PDGFRbeta, and
           Tel/Jak2, found in patients with leukemia and
           myeloproliferative disorders.
          Length = 263

 Score = 31.4 bits (71), Expect = 0.22
 Identities = 20/56 (35%), Positives = 27/56 (48%), Gaps = 14/56 (25%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQ--------DDPPRLPP 168
           + I+SDVW+ G+ L E+AT G  PY     P   L QV +        + P   PP
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKGYRMERPEGCPP 232


>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine
           Kinase, Zeta-chain-associated protein of 70kDa.  Protein
           Tyrosine Kinase (PTK) family; Zeta-chain-associated
           protein of 70kDa (Zap-70); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Zap-70 is
           a member of the Syk subfamily of kinases, which are
           cytoplasmic (or nonreceptor) tyr kinases containing two
           Src homology 2 (SH2) domains N-terminal to the catalytic
           tyr kinase domain. Zap-70 is primarily expressed in
           T-cells and NK cells, and is a crucial component in
           T-cell receptor (TCR) signaling. Zap-70 binds the
           phosphorylated ITAM (immunoreceptor tyr activation
           motif) sequences of the activated TCR zeta-chain through
           its SH2 domains, leading to its phosphorylation and
           activation. It then phosphorylates target proteins,
           which propagate the signals to downstream pathways.
           Zap-70 is hardly detected in normal peripheral B-cells,
           but is present in some B-cell malignancies. It is used
           as a diagnostic marker for chronic lymphocytic leukemia
           (CLL) as it is associated with the more aggressive
           subtype of the disease.
          Length = 257

 Score = 31.1 bits (70), Expect = 0.22
 Identities = 20/50 (40%), Positives = 26/50 (52%), Gaps = 8/50 (16%)

Query: 125 RSDVWSLGISLIE-LATGRFPYDTWGSP-----FEQLKQVVQDDPPRLPP 168
           RSDVWS GI++ E  + G+ PY     P      EQ K++  D P   PP
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--DCPAECPP 225


>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein
           Serine/Threonine Kinase, Microtubule-associated
           serine/threonine kinase.  Serine/Threonine Kinases
           (STKs), Microtubule-associated serine/threonine (MAST)
           kinase subfamily, MAST, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The MAST kinase subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. MAST kinases contain an
           N-terminal domain of unknown function, a central
           catalytic domain, and a C-terminal PDZ domain that
           mediates protein-protein interactions. There are four
           mammalian MAST kinases, named MAST1-MAST4. MAST1 is also
           referred to as syntrophin-associated STK (SAST), while
           MAST2 is also called MAST205. MAST kinases are
           cytoskeletal associated kinases of unknown function that
           are also expressed at neuromuscular junctions and
           postsynaptic densities. MAST1, MAST2, and MAST3 bind and
           phosphorylate the tumor suppressor PTEN, and may
           contribute to the regulation and stabilization of PTEN.
           MAST2 is involved in the regulation of the Fc-gamma
           receptor of the innate immune response in macrophages,
           and may also be involved in the regulation of the Na+/H+
           exchanger NHE3.
          Length = 305

 Score = 31.3 bits (71), Expect = 0.23
 Identities = 28/80 (35%), Positives = 37/80 (46%), Gaps = 12/80 (15%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY--DTWGSPFEQLKQVVQDD 162
           P +I PE I   G    Y    D W++GI L E   G  P+  DT   P E   QV+ DD
Sbjct: 180 PEYIAPEVILRQG----YGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISDD 232

Query: 163 PPRLPPGE--FSSDFKDFIT 180
               P G+    +D +D I+
Sbjct: 233 -IEWPEGDEALPADAQDLIS 251


>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Axl subfamily; catalytic (c) domain. The PTKc family is
           part of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). The Axl subfamily
           consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and
           similar proteins. PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Axl subfamily members
           are receptor tyr kinases (RTKs) containing an
           extracellular ligand-binding region with two
           immunoglobulin-like domains followed by two fibronectin
           type III repeats, a transmembrane segment, and an
           intracellular catalytic domain. Binding to their
           ligands, Gas6 and protein S, leads to receptor
           dimerization, autophosphorylation, activation, and
           intracellular signaling. Axl subfamily members are
           implicated in a variety of cellular effects including
           survival, proliferation, migration, and phagocytosis.
           They are also associated with several types of cancer as
           well as inflammatory, autoimmune, vascular, and kidney
           diseases. Mer is named after its original reported
           expression pattern (monocytes, epithelial, and
           reproductive tissues). It is required for the ingestion
           of apoptotic cells by phagocytes such as macrophages,
           retinal pigment epithelial cells, and dendritic cells.
           Mer is also important in maintaining immune homeostasis.
          Length = 273

 Score = 31.3 bits (71), Expect = 0.25
 Identities = 12/25 (48%), Positives = 19/25 (76%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y  +SDVW+ G+++ E+AT G+ PY
Sbjct: 192 YTSKSDVWAFGVTMWEIATRGQTPY 216


>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and
           Dbf2p-like Protein Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), ROCK- and NDR-like
           subfamily, fungal Sid2p- and Dbf2p-like proteins,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Sid2p- and
           Dbf2p-like group is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This group contains fungal kinases including
           Schizosaccharomyces pombe Sid2p and Saccharomyces
           cerevisiae Dbf2p. Group members show similarity to NDR
           kinases in that they contain an N-terminal regulatory
           (NTR) domain and an insert within the catalytic domain
           that contains an auto-inhibitory sequence. Sid2p plays a
           crucial role in the septum initiation network (SIN) and
           in the initiation of cytokinesis. Dbf2p is important in
           regulating the mitotic exit network (MEN) and in
           cytokinesis.
          Length = 333

 Score = 30.8 bits (70), Expect = 0.31
 Identities = 26/85 (30%), Positives = 36/85 (42%), Gaps = 17/85 (20%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY------DTWGSPF---EQL 155
           P+++ PE +        YD   D WSLG  L E   G  P+      +TW +     E L
Sbjct: 162 PDYMAPEVL----RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217

Query: 156 KQVVQDDPPRLPPGEFSSDFKDFIT 180
           ++ V DDP        S +  D IT
Sbjct: 218 QRPVYDDPRF----NLSDEAWDLIT 238


>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Large Tumor Suppressor 1.
           Serine/Threonine Kinases (STKs), Large Tumor Suppressor
           (LATS) subfamily, LATS1 isoform, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The LATS subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. LATS functions as a tumor
           suppressor and is implicated in cell cycle regulation.
           Inactivation of LATS1 in mice results in the development
           of various tumors, including sarcomas and ovarian
           cancer. Promoter methylation, loss of heterozygosity,
           and missense mutations targeting the LATS1 gene have
           also been found in human sarcomas and ovarian cancers.
           In addition, decreased expression of LATS1 is associated
           with an aggressive phenotype and poor prognosis. LATS1
           induces G2 arrest and promotes cytokinesis. It may be a
           component of the mitotic exit network in higher
           eukaryotes.
          Length = 382

 Score = 31.1 bits (70), Expect = 0.32
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 7/77 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFE-QLKQVVQDDP 163
           PN+I PE +  +G    Y    D WS+G+ L E+  G+ P+    +P E Q+K +     
Sbjct: 212 PNYIAPEVLLRTG----YTQLCDWWSVGVILYEMLVGQPPFLA-QTPLETQMKVINWQTS 266

Query: 164 PRLPP-GEFSSDFKDFI 179
             +PP  + S +  D I
Sbjct: 267 LHIPPQAKLSPEASDLI 283


>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal
           Bck1-like MAP Kinase Kinase Kinases.  Serine/threonine
           kinases (STKs), mitogen-activated protein kinase (MAPK)
           kinase kinase (MAPKKK) subfamily, fungal Bck1-like
           proteins, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MAPKKK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this group include the MAPKKKs
           Saccharomyces cerevisiae Bck1 and Schizosaccharomyces
           pombe Mkh1, and related proteins. MAPKKKs phosphorylate
           and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks),
           which in turn phosphorylate and activate MAPKs during
           signaling cascades that are important in mediating
           cellular responses to extracellular signals. Budding
           yeast Bck1 is part of the cell integrity MAPK pathway,
           which is activated by stresses and aggressions to the
           cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and
           the MAPK Slt2 make up the cascade that is important in
           the maintenance of cell wall homeostasis. Fission yeast
           Mkh1 is involved in MAPK cascades regulating cell
           morphology, cell wall integrity, salt resistance, and
           filamentous growth in response to stress.
          Length = 272

 Score = 30.9 bits (70), Expect = 0.33
 Identities = 13/38 (34%), Positives = 19/38 (50%), Gaps = 2/38 (5%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDT 147
           PE I        Y  + D+WSLG  ++E+  GR P+  
Sbjct: 179 PEVIHSYSQ--GYSAKVDIWSLGCVVLEMFAGRRPWSD 214


>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine
           Kinase, Colony-Stimulating Factor-1 Receptor.  Protein
           Tyrosine Kinase (PTK) family; Colony-Stimulating
           Factor-1 Receptor (CSF-1R); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. CSF-1R,
           also called c-Fms, is a member of the Platelet Derived
           Growth Factor Receptor (PDGFR) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular ligand-binding region with five
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding of
           CSF-1R to its ligand, CSF-1, leads to receptor
           dimerization, trans phosphorylation and activation, and
           intracellular signaling. CSF-1R signaling is critical in
           the regulation of macrophages and osteoclasts. It leads
           to increases in gene transcription and protein
           translation, and induces cytoskeletal remodeling. CSF-1R
           signaling leads to a variety of cellular responses
           including survival, proliferation, and differentiation
           of target cells. It plays an important role in innate
           immunity, tissue development and function, and the
           pathogenesis of some diseases including atherosclerosis
           and cancer. CSF-1R signaling is also implicated in
           mammary gland development during pregnancy and
           lactation. Aberrant CSF-1/CSF-1R expression correlates
           with tumor cell invasiveness, poor clinical prognosis,
           and bone metastasis in breast cancer. Although the
           structure of the human CSF-1R catalytic domain is known,
           it is excluded from this specific alignment model
           because it contains a deletion in its sequence.
          Length = 374

 Score = 31.0 bits (70), Expect = 0.33
 Identities = 13/25 (52%), Positives = 18/25 (72%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIEL-ATGRFPY 145
           Y ++SDVWS GI L E+ + G+ PY
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPY 315


>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like
           Protein Serine/Threonine Kinases.  Serine/Threonine
           Kinases (STKs), Microtubule-associated serine/threonine
           (MAST) kinase subfamily, fungal Rim15-like kinases,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MAST kinase
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this group include Saccharomyces
           cerevisiae Rim15, Schizosaccharomyces pombe cek1, and
           similar fungal proteins. They contain a central
           catalytic domain, which contains an insert relative to
           MAST kinases. In addition, Rim15 contains a C-terminal
           signal receiver (REC) domain while cek1 contains an
           N-terminal PAS domain. Rim15 (or Rim15p) functions as a
           regulator of meiosis. It acts as a downstream effector
           of PKA and regulates entry into stationary phase (G0).
           Thus, it plays a crucial role in regulating yeast
           proliferation, differentiation, and aging. Cek1 may
           facilitate progression of mitotic anaphase.
          Length = 260

 Score = 30.5 bits (69), Expect = 0.34
 Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 9/79 (11%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDD-- 162
           P+++ PE I   G     D  SD WSLG  + E   G  P+    +P      ++     
Sbjct: 157 PDYLAPETIL--GVGD--DKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRIN 211

Query: 163 -PPRLPPGEFSSDFKDFIT 180
            P  +     S +  D I 
Sbjct: 212 WPEEVKEFC-SPEAVDLIN 229


>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine
           Kinases, Fibroblast Growth Factor Receptors.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor (FGFR) subfamily; catalytic (c) domain. The
           FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4,
           and similar proteins. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K).PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. FGFR subfamily members
           are receptor tyr kinases (RTKs) containing an
           extracellular ligand-binding region with three
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding of
           FGFRs to their ligands, the FGFs, and to heparin/heparan
           sulfate (HS) results in the formation of a ternary
           complex, which leads to receptor dimerization and
           activation, and intracellular signaling. There are at
           least 23 FGFs and four types of FGFRs. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. FGF/FGFR signaling is
           important in the regulation of embryonic development,
           homeostasis, and regenerative processes. Depending on
           the cell type and stage, FGFR signaling produces diverse
           cellular responses including proliferation, growth
           arrest, differentiation, and apoptosis. Aberrant
           signaling leads to many human diseases such as skeletal,
           olfactory, and metabolic disorders, as well as cancer.
          Length = 293

 Score = 30.8 bits (70), Expect = 0.36
 Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 3/52 (5%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSP--FEQLKQVVQDDPPRLPPGE 170
           Y  +SDVWS G+ L E+ T G  PY        F+ LK+  + + P+    E
Sbjct: 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQE 262


>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional.
          Length = 267

 Score = 30.6 bits (70), Expect = 0.36
 Identities = 14/37 (37%), Positives = 21/37 (56%), Gaps = 4/37 (10%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYD 146
           PE+I       NYD+  D W++G+   EL TG+ P+ 
Sbjct: 175 PEKI----KGHNYDVSFDWWAVGVLTYELLTGKHPFK 207


>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine
           Kinase, Tyro3.  Protein Tyrosine Kinase (PTK) family;
           Tyro3; catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tyro3 (or Sky) is a
           member of the Axl subfamily, which is composed of
           receptor tyr kinases (RTKs) containing an extracellular
           ligand-binding region with two immunoglobulin-like
           domains followed by two fibronectin type III repeats, a
           transmembrane segment, and an intracellular catalytic
           domain. Binding to their ligands, Gas6 and protein S,
           leads to receptor dimerization, autophosphorylation,
           activation, and intracellular signaling. Tyro3 is
           predominantly expressed in the central nervous system
           and the brain, and functions as a neurotrophic factor.
           It is also expressed in osteoclasts and has a role in
           bone resorption.
          Length = 273

 Score = 30.7 bits (69), Expect = 0.37
 Identities = 11/25 (44%), Positives = 17/25 (68%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y   SDVW+ G+++ E+ T G+ PY
Sbjct: 192 YTTHSDVWAFGVTMWEIMTRGQTPY 216


>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Fes subfamily; catalytic (c) domain. Fes subfamily
           members include Fes (or Fps), Fer, and similar proteins.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Fes
           subfamily proteins are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal region with FCH
           (Fes/Fer/CIP4 homology) and coiled-coil domains,
           followed by a SH2 domain, and a C-terminal catalytic
           domain. The genes for Fes (feline sarcoma) and Fps
           (Fujinami poultry sarcoma) were first isolated from
           tumor-causing retroviruses. The viral oncogenes encode
           chimeric Fes proteins consisting of Gag sequences at the
           N-termini, resulting in unregulated tyr kinase activity.
           Fes and Fer kinases play roles in haematopoiesis,
           inflammation and immunity, growth factor signaling,
           cytoskeletal regulation, cell migration and adhesion,
           and the regulation of cell-cell interactions. Fes and
           Fer show redundancy in their biological functions.
          Length = 251

 Score = 30.5 bits (69), Expect = 0.38
 Identities = 14/32 (43%), Positives = 15/32 (46%), Gaps = 1/32 (3%)

Query: 118 NPSNYDIRSDVWSLGISLIELAT-GRFPYDTW 148
           N   Y   SDVWS GI L E  + G  PY   
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199


>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein
           Serine/Threonine Kinase, Protein Kinase B gamma.
           Serine/Threonine Kinases (STKs), Protein Kinase B (PKB)
           or Akt subfamily, gamma (or Akt3) isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PKB subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. There are three
           PKB isoforms from different genes, PKB-alpha (or Akt1),
           PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
           contains an N-terminal pleckstrin homology (PH) domain
           and a C-terminal catalytic domain. PKB-gamma is
           predominantly expressed in neuronal tissues. Mice
           deficient in PKB-gamma show a reduction in brain weight
           due to the decreases in cell size and cell number.
           PKB-gamma has also been shown to be upregulated in
           estrogen-deficient breast cancer cells,
           androgen-independent prostate cancer cells, and primary
           ovarian tumors. It acts as a key mediator in the genesis
           of ovarian cancer.
          Length = 328

 Score = 30.4 bits (68), Expect = 0.42
 Identities = 18/76 (23%), Positives = 38/76 (50%), Gaps = 7/76 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE ++ +    +Y    D W LG+ + E+  GR P+  +    E+L +++  +  
Sbjct: 159 PEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEDI 212

Query: 165 RLPPGEFSSDFKDFIT 180
           + P    S+D K  ++
Sbjct: 213 KFPR-TLSADAKSLLS 227


>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein
           Tyrosine Kinase, Tyrosine kinase 2.  Protein Tyrosine
           Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic
           (c) domain (repeat 2). The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tyk2 is a member of the
           Janus kinase (Jak) subfamily of proteins, which are
           cytoplasmic (or nonreceptor) tyr kinases containing an
           N-terminal FERM domain, followed by a Src homology 2
           (SH2) domain, a pseudokinase domain, and a C-terminal
           tyr kinase catalytic domain. Jaks are crucial for
           cytokine receptor signaling. They are activated by
           autophosphorylation upon cytokine-induced receptor
           aggregation, and subsequently trigger downstream
           signaling events such as the phosphorylation of signal
           transducers and activators of transcription (STATs).
           Tyk2 is widely expressed in many tissues. It is involved
           in signaling via the cytokine receptors IFN-alphabeta,
           IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell
           surface urokinase receptor (uPAR) signaling and plays a
           role in modulating vascular smooth muscle cell (VSMC)
           functional behavior in response to injury. Tyk2 is also
           important in dendritic cell function and T helper (Th)1
           cell differentiation. A homozygous mutation of Tyk2 was
           found in a patient with hyper-IgE syndrome (HIES), a
           primary immunodeficiency characterized by recurrent skin
           abscesses, pneumonia, and elevated serum IgE. This
           suggests that Tyk2 may play important roles in multiple
           cytokine signaling involved in innate and adaptive
           immunity.
          Length = 283

 Score = 30.3 bits (68), Expect = 0.51
 Identities = 13/35 (37%), Positives = 18/35 (51%)

Query: 126 SDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQ 160
           SDVWS G++L EL T      +    FE++    Q
Sbjct: 191 SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225


>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. 
           Serine/Threonine Kinases (STKs), NDR kinase subfamily,
           NDR2 isoform, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The NDR
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. NDR kinase contains an N-terminal regulatory
           (NTR) domain and an insert within the catalytic domain
           that contains an auto-inhibitory sequence. Like many
           other AGC kinases, NDR kinase requires phosphorylation
           at two sites, the activation loop (A-loop) and the
           hydrophobic motif (HM), for activity. Higher eukaryotes
           contain two NDR isoforms, NDR1 and NDR2. Both isoforms
           play a role in proper centrosome duplication. In
           addition, NDR2 plays a role in regulating neuronal
           growth and differentiation, as well as in facilitating
           neurite outgrowth. It is also implicated in fear
           conditioning as it contributes to the coupling of
           neuronal morphological changes with fear-memory
           consolidation. NDR2 is also referred to as STK38-like.
          Length = 360

 Score = 30.4 bits (68), Expect = 0.55
 Identities = 22/76 (28%), Positives = 37/76 (48%), Gaps = 10/76 (13%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDD-- 162
           P++I PE    +G    Y+   D WSLG+ + E+  G  P+ +  +P E  ++V+     
Sbjct: 200 PDYIAPEVFMQTG----YNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYRKVMNWKET 254

Query: 163 ---PPRLPPGEFSSDF 175
              PP +P  E + D 
Sbjct: 255 LVFPPEVPISEKAKDL 270


>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase,
           p38 Mitogen-Activated Protein Kinase.  Serine/Threonine
           Kinases (STKs), p38 subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The p38 subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. p38 kinases are
           mitogen-activated protein kinases (MAPKs), serving as
           important mediators of cellular responses to
           extracellular signals. They function in the regulation
           of the cell cycle, cell development, cell
           differentiation, senescence, tumorigenesis, apoptosis,
           pain development and pain progression, and immune
           responses. p38 kinases are activated by the MAPK kinases
           MKK3 and MKK6, which in turn are activated by upstream
           MAPK kinase kinases including TAK1, ASK1, and MLK3, in
           response to cellular stresses or inflammatory cytokines.
           p38 substrates include other protein kinases and factors
           that regulate transcription, nuclear export, mRNA
           stability and translation. p38 kinases are drug targets
           for the inflammatory diseases psoriasis, rheumatoid
           arthritis, and chronic pulmonary disease. Vertebrates
           contain four isoforms of p38, named alpha, beta, gamma,
           and delta, which show varying substrate specificity and
           expression patterns. p38alpha and p38beta are
           ubiquitously expressed, p38gamma is predominantly found
           in skeletal muscle, and p38delta is found in the heart,
           lung, testis, pancreas, and small intestine.
          Length = 343

 Score = 30.0 bits (68), Expect = 0.63
 Identities = 15/37 (40%), Positives = 23/37 (62%), Gaps = 7/37 (18%)

Query: 127 DVWSLGISLIELATGR--FPYDTWGS-PFEQLKQVVQ 160
           D+WS+G  + EL TG+  FP    GS   +QLK+++ 
Sbjct: 198 DIWSVGCIMAELLTGKTLFP----GSDHIDQLKRIMN 230


>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 1.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 1 (FGFR1); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR1 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. Alternative splicing of
           FGFR1 transcripts produces a variety of isoforms, which
           are differentially expressed in cells. FGFR1 binds the
           ligands, FGF1 and FGF2, with high affinity and has also
           been reported to bind FGF4, FGF6, and FGF9. FGFR1
           signaling is critical in the control of cell migration
           during embryo development. It promotes cell
           proliferation in fibroblasts. Nuclear FGFR1 plays a role
           in the regulation of transcription. Mutations,
           insertions or deletions of FGFR1 have been identified in
           patients with Kallman's syndrome (KS), an inherited
           disorder characterized by hypogonadotropic hypogonadism
           and loss of olfaction. Aberrant FGFR1 expression has
           been found in some human cancers including 8P11
           myeloproliferative syndrome (EMS), breast cancer, and
           pancreatic adenocarcinoma.
          Length = 307

 Score = 30.0 bits (67), Expect = 0.66
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQD 161
           Y  +SDVWS G+ L E+ T G  PY   G P E+L +++++
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYP--GVPVEELFKLLKE 257


>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional.
          Length = 467

 Score = 29.9 bits (67), Expect = 0.67
 Identities = 11/22 (50%), Positives = 16/22 (72%)

Query: 126 SDVWSLGISLIELATGRFPYDT 147
           +D+WS+G  + EL TG+  YDT
Sbjct: 326 TDMWSMGCIIYELYTGKLLYDT 347


>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein
           Serine/Threonine Kinase, Protein Kinase B alpha.
           Serine/Threonine Kinases (STKs), Protein Kinase B (PKB)
           or Akt subfamily, alpha (or Akt1) isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PKB subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. There are three
           PKB isoforms from different genes, PKB-alpha (or Akt1),
           PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
           contains an N-terminal pleckstrin homology (PH) domain
           and a C-terminal catalytic domain. PKB-alpha is
           predominantly expressed in endothelial cells. It is
           critical for the regulation of angiogenesis and the
           maintenance of vascular integrity. It also plays a role
           in adipocyte differentiation. Mice deficient in
           PKB-alpha exhibit perinatal morbidity, growth
           retardation, reduction in body weight accompanied by
           reduced sizes of multiple organs, and enhanced apoptosis
           in some cell types. PKB-alpha activity has been reported
           to be frequently elevated in breast and prostate
           cancers. In some cancer cells, PKB-alpha may act as a
           suppressor of metastasis.
          Length = 325

 Score = 30.0 bits (67), Expect = 0.73
 Identities = 16/63 (25%), Positives = 32/63 (50%), Gaps = 6/63 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE ++ +    +Y    D W LG+ + E+  GR P+  +    E+L +++  +  
Sbjct: 160 PEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEI 213

Query: 165 RLP 167
           R P
Sbjct: 214 RFP 216


>gnl|CDD|192241 pfam09280, XPC-binding, XPC-binding domain.  Members of this family
           adopt a structure consisting of four alpha helices,
           arranged in an array. They bind specifically and
           directly to the xeroderma pigmentosum group C protein
           (XPC) to initiate nucleotide excision repair.
          Length = 59

 Score = 27.6 bits (62), Expect = 0.75
 Identities = 10/17 (58%), Positives = 14/17 (82%)

Query: 152 FEQLKQVVQDDPPRLPP 168
           F+QL+Q+VQ +P  LPP
Sbjct: 10  FQQLRQMVQQNPELLPP 26


>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein
           Serine/Threonine Kinase, Rho-associated coiled-coil
           containing protein kinase.  Serine/Threonine Kinases
           (STKs), Rho-associated coiled-coil containing protein
           kinase (ROCK) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The ROCK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. ROCK is also referred to as Rho-associated
           kinase or simply as Rho kinase. It contains an
           N-terminal extension, a catalytic kinase domain, and a
           long C-terminal extension, which contains a coiled-coil
           region encompassing a Rho-binding domain (RBD) and a
           pleckstrin homology (PH) domain. ROCK is auto-inhibited
           by the RBD and PH domain interacting with the catalytic
           domain. It is activated via interaction with Rho GTPases
           and is involved in many cellular functions including
           contraction, adhesion, migration, motility,
           proliferation, and apoptosis. The ROCK subfamily
           consists of two isoforms, ROCK1 and ROCK2, which may be
           functionally redundant in some systems, but exhibit
           different tissue distributions. Both isoforms are
           ubiquitously expressed in most tissues, but ROCK2 is
           more prominent in brain and skeletal muscle while ROCK1
           is more pronounced in the liver, testes, and kidney.
           Studies in knockout mice result in different phenotypes,
           suggesting that the two isoforms do not compensate for
           each other during embryonic development.
          Length = 370

 Score = 29.7 bits (67), Expect = 0.76
 Identities = 14/41 (34%), Positives = 21/41 (51%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P++I PE +   G    Y    D WS+G+ L E+  G  P+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247


>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine
           Kinase, Ephrin Receptor A10.  Protein Tyrosine Kinase
           (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10
           receptor; catalytic (c) domain. The PTKc family is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). In general, class EphA receptors bind
           GPI-anchored ephrin-A ligands. There are ten vertebrate
           EphA receptors (EphA1-10), which display promiscuous
           interactions with six ephrin-A ligands. EphRs contain an
           ephrin binding domain and two fibronectin repeats
           extracellularly, a transmembrane segment, and a
           cytoplasmic tyr kinase domain. Binding of the ephrin
           ligand to EphR requires cell-cell contact since both are
           anchored to the plasma membrane. The resulting
           downstream signals occur bidirectionally in both
           EphR-expressing cells (forward signaling) and
           ephrin-expressing cells (reverse signaling). EphA10,
           which contains an inactive tyr kinase domain, may
           function to attenuate signals of co-clustered active
           receptors. EphA10 is mainly expressed in the testis.
           Ephrin/EphR interaction results in cell-cell repulsion
           or adhesion, making it important in neural development
           and plasticity, cell morphogenesis, cell-fate
           determination, embryonic development, tissue patterning,
           and angiogenesis.
          Length = 266

 Score = 29.5 bits (66), Expect = 0.78
 Identities = 17/44 (38%), Positives = 24/44 (54%), Gaps = 4/44 (9%)

Query: 126 SDVWSLGISLIE-LATGRFPYDTWGSPFEQLKQVVQDDPPRLPP 168
           SDVWS GI + E ++ G  PY  W    + + + V+D   RLP 
Sbjct: 189 SDVWSFGIVMWEVMSYGERPY--WDMSGQDVIKAVEDG-FRLPA 229


>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine
           Kinases, Met and Ron.  Protein Tyrosine Kinase (PTK)
           family; Met and Ron; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Met and
           Ron are receptor tyr kinases (RTKs) composed of an
           alpha-beta heterodimer. The extracellular alpha chain is
           disulfide linked to the beta chain, which contains an
           extracellular ligand-binding region with a sema domain,
           a PSI domain and four IPT repeats, a transmembrane
           segment, and an intracellular catalytic domain. Binding
           to their ligands leads to receptor dimerization,
           autophosphorylation, activation, and intracellular
           signaling. Met binds to the ligand, hepatocyte growth
           factor/scatter factor (HGF/SF), and is also called the
           HGF receptor. HGF/Met signaling plays a role in growth,
           transformation, cell motility, invasion, metastasis,
           angiogenesis, wound healing, and tissue regeneration.
           Aberrant expression of Met through mutations or gene
           amplification is associated with many human cancers
           including hereditary papillary renal and gastric
           carcinomas. The ligand for Ron is macrophage stimulating
           protein (MSP). Ron signaling is important in regulating
           cell motility, adhesion, proliferation, and apoptosis.
           Aberrant Ron expression is implicated in tumorigenesis
           and metastasis.
          Length = 262

 Score = 29.7 bits (67), Expect = 0.79
 Identities = 13/25 (52%), Positives = 16/25 (64%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           +  +SDVWS G+ L EL T G  PY
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPY 203


>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine
           Kinase, cAMP-dependent protein kinase.  Serine/Threonine
           Kinases (STKs), cAMP-dependent protein kinase (PKA)
           subfamily, catalytic (c) subunit. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PKA
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase (PI3K). This subfamily is composed of the
           cAMP-dependent proteins kinases, PKA and PRKX. The
           inactive PKA holoenzyme is a heterotetramer composed of
           two phosphorylated and active catalytic (C) subunits
           with a dimer of regulatory (R) subunits. Activation is
           achieved through the binding of the important second
           messenger cAMP to the R subunits, which leads to the
           dissociation of PKA into the R dimer and two active C
           subunits. PKA is present ubiquitously in cells and
           interacts with many different downstream targets. It
           plays a role in the regulation of diverse processes such
           as growth, development, memory, metabolism, gene
           expression, immunity, and lipolysis.
          Length = 290

 Score = 29.4 bits (67), Expect = 0.82
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 9/77 (11%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP-YDTWGSPFEQLKQVVQDDP 163
           P ++ PE I   G    Y    D W+LGI + E+  G  P +D   +P +  +++++   
Sbjct: 162 PEYLAPEIILSKG----YGKAVDWWALGILIYEMLAGYPPFFDD--NPIQIYEKILEGK- 214

Query: 164 PRLPPGEFSSDFKDFIT 180
            R P   FS D KD I 
Sbjct: 215 VRFPS-FFSPDAKDLIR 230


>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine
           Kinase, HER4.  Protein Tyrosine Kinase (PTK) family;
           HER4 (ErbB4); catalytic (c) domain. The PTKc family is
           part of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. HER4 is a
           member of the EGFR (HER, ErbB) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular EGF-related ligand-binding region, a
           transmembrane helix, and a cytoplasmic region with a tyr
           kinase domain and a regulatory C-terminal tail. Unlike
           other tyr kinases, phosphorylation of the activation
           loop of EGFR proteins is not critical to their
           activation. Instead, they are activated by
           ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. Ligands that bind HER4 fall into two groups,
           the neuregulins (or heregulins) and some EGFR (HER1)
           ligands including betacellulin, HBEGF, and epiregulin.
           All four neuregulins (NRG1-4) interact with HER4. Upon
           ligand binding, HER4 forms homo- or heterodimers with
           other HER proteins. HER4 is essential in embryonic
           development. It is implicated in mammary gland, cardiac,
           and neural development. As a postsynaptic receptor of
           NRG1, HER4 plays an important role in synaptic
           plasticity and maturation. The impairment of NRG1/HER4
           signaling may contribute to schizophrenia.
          Length = 303

 Score = 29.6 bits (66), Expect = 0.82
 Identities = 18/44 (40%), Positives = 27/44 (61%), Gaps = 4/44 (9%)

Query: 125 RSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQDDPPRLP 167
           +SDVWS G+++ EL T G  PYD  G P  ++  +++    RLP
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYD--GIPTREIPDLLEKG-ERLP 231


>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent
           protein Kinase 9-like Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Cyclin-Dependent
           protein Kinase 9 (CDK9)-like subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The CDK9-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. CDKs belong to a large family of STKs that are
           regulated by their cognate cyclins. Together, they are
           involved in the control of cell-cycle progression,
           transcription, and neuronal function. This subfamily is
           composed of CDK9 and CDK12 from higher eukaryotes, yeast
           BUR1, C-type plant CDKs (CdkC), and similar proteins.
           CDK9, BUR1, and CdkC are functionally equivalent. They
           act as a kinase for the C-terminal domain of RNA
           polymerase II and participate in regulating mutliple
           steps of gene expression including transcription
           elongation and RNA processing. CDK9 and CdkC associate
           with T-type cyclins while BUR1 associates with the
           cyclin BUR2. CDK12 is a unique CDK that contains an
           arginine/serine-rich (RS) domain, which is predominantly
           found in splicing factors. CDK12 interacts with cyclins
           L1 and L2, and participates in regulating transcription
           and alternative splicing.
          Length = 287

 Score = 29.4 bits (67), Expect = 0.84
 Identities = 18/80 (22%), Positives = 25/80 (31%), Gaps = 20/80 (25%)

Query: 121 NYDIRSDVWSLGISLIELATGR--FP-----------YDTWGSP-------FEQLKQVVQ 160
            Y    D+WS+G  L EL  G+  F            ++  GSP         +L     
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237

Query: 161 DDPPRLPPGEFSSDFKDFIT 180
             P +         FK  I 
Sbjct: 238 LKPKKPYKRRLREFFKHLID 257


>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine
           Kinases, Platelet Derived Growth Factor Receptors.
           Protein Tyrosine Kinase (PTK) family; Platelet Derived
           Growth Factor Receptor (PDGFR) subfamily; catalytic (c)
           domain. The PDGFR subfamily consists of PDGFR alpha,
           PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar
           proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           PDGFR subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           five immunoglobulin-like domains, a transmembrane
           segment, and an intracellular catalytic domain. PDGFR
           kinase domains are autoinhibited by their juxtamembrane
           regions containing tyr residues. The binding to their
           ligands leads to receptor dimerization, trans
           phosphorylation and activation, and intracellular
           signaling. PDGFR subfamily receptors are important in
           the development of a variety of cells. PDGFRs are
           expressed in a many cells including fibroblasts,
           neurons, endometrial cells, mammary epithelial cells,
           and vascular smooth muscle cells. PDGFR signaling is
           critical in normal embryonic development, angiogenesis,
           and wound healing. PDGFRs transduce mitogenic signals
           for connective tissue cells and are important for cell
           shape and motility. Kit is important in the development
           of melanocytes, germ cells, mast cells, hematopoietic
           stem cells, the interstitial cells of Cajal, and the
           pacemaker cells of the GI tract. CSF-1R signaling is
           critical in the regulation of macrophages and
           osteoclasts. Mammalian FLT3 plays an important role in
           the survival, proliferation, and differentiation of stem
           cells.
          Length = 302

 Score = 29.4 bits (66), Expect = 0.86
 Identities = 13/25 (52%), Positives = 15/25 (60%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y   SDVWS GI L E+ + G  PY
Sbjct: 220 YTFESDVWSYGILLWEIFSLGSNPY 244


>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase,
           Fes.  Protein Tyrosine Kinase (PTK) family; Fes (or Fps)
           kinase subfamily; catalytic (c) domain. The PTKc family
           is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Fes
           subfamily proteins are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal region with FCH
           (Fes/Fer/CIP4 homology) and coiled-coil domains,
           followed by a SH2 domain, and a C-terminal catalytic
           domain. The genes for Fes (feline sarcoma) and Fps
           (Fujinami poultry sarcoma) were first isolated from
           tumor-causing retroviruses. The viral oncogenes encode
           chimeric Fes proteins consisting of Gag sequences at the
           N-termini, resulting in unregulated tyr kinase activity.
           Fes kinase is expressed in myeloid, vascular
           endothelial, epithelial, and neuronal cells. It plays
           important roles in cell growth and differentiation,
           angiogenesis, inflammation and immunity, and
           cytoskeletal regulation. A recent study implicates Fes
           kinase as a tumor suppressor in colorectal cancer.
          Length = 252

 Score = 29.2 bits (65), Expect = 1.0
 Identities = 20/58 (34%), Positives = 27/58 (46%), Gaps = 4/58 (6%)

Query: 118 NPSNYDIRSDVWSLGISLIE-LATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSD 174
           N   Y   SDVWS GI L E  + G  PY    +  +Q ++ ++    RLP  E   D
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAIEQG-VRLPCPELCPD 223


>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein
           Serine/Threonine Kinase, Classical Protein Kinase C.
           Serine/Threonine Kinases (STKs), Classical (or
           Conventional) Protein Kinase C (cPKC) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The cPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase (PI3K). PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, cPKCs depend on calcium, DAG
           (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. cPKCs contain a
           calcium-binding C2 region in their regulatory domain.
           There are four cPKC isoforms, named alpha, betaI,
           betaII, and gamma. cPKCs are potent kinases for
           histones, myelin basic protein, and protamine. PKC-gamma
           is mainly expressed in neuronal tissues. It plays a role
           in protection from ischemia.
          Length = 324

 Score = 29.4 bits (66), Expect = 1.1
 Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 6/63 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P++I PE I  +  P  Y    D W+ G+ L E+  G+ P+D  G   ++L Q + +   
Sbjct: 165 PDYIAPEII--AYQP--YGKSVDWWAFGVLLYEMLAGQPPFD--GEDEDELFQSIMEHNV 218

Query: 165 RLP 167
             P
Sbjct: 219 SYP 221


>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of
           cAMP-dependent protein kinase-like Protein
           Serine/Threonine Kinases.  Serine/Threonine Kinases
           (STKs), Fission yeast Suppressor of loss of
           cAMP-dependent protein kinase (Sck1)-like subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Sck1-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This subfamily is composed of fungal proteins
           with similarity to the Schizosaccharomyces pombe STK
           Sck1. Sck1 plays a role in trehalase activation
           triggered by glucose and a nitrogen source. Trehalase
           catalyzes the cleavage of the disaccharide trehalose to
           glucose. Trehalose, as a carbohydrate reserve and stress
           metabolite, plays an important role in the response of
           yeast to environmental changes.
          Length = 330

 Score = 29.1 bits (65), Expect = 1.2
 Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 2/58 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFI 179
           Y    D WSLG+ + E+  G  P+  +    +Q+ + +     R P    S + + F+
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFV 229


>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine
           Kinase-like Protein Tyrosine Kinases.  Protein Tyrosine
           Kinase (PTK) family; Spleen Tyrosine Kinase (Syk)
           subfamily; catalytic (c) domain. The Syk subfamily is
           composed of Syk, ZAP-70, Shark, and similar proteins.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Syk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing two Src homology 2 (SH2) domains
           N-terminal to the catalytic tyr kinase domain. They are
           involved in the signaling downstream of activated
           receptors (including B-cell, T-cell, and Fc receptors)
           that contain ITAMs (immunoreceptor tyr activation
           motifs), leading to processes such as cell
           proliferation, differentiation, survival, adhesion,
           migration, and phagocytosis. Syk is important in B-cell
           receptor (BCR) signaling, while Zap-70 is primarily
           expressed in T-cells and NK cells, and is a crucial
           component in T-cell receptor (TCR) signaling. Syk also
           plays a central role in Fc receptor-mediated
           phagocytosis in the adaptive immune system. Shark is
           exclusively expressed in ectodermally derived epithelia,
           and is localized preferentially to the apical surface of
           the epithelial cells, it may play a role in a signaling
           pathway for epithelial cell polarity.
          Length = 257

 Score = 28.9 bits (65), Expect = 1.2
 Identities = 15/37 (40%), Positives = 20/37 (54%), Gaps = 5/37 (13%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELAT-GRFPY 145
           PE I    N   +  +SDVWS G++L E  + G  PY
Sbjct: 167 PECI----NYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199


>gnl|CDD|184643 PRK14354, glmU, bifunctional N-acetylglucosamine-1-phosphate
          uridyltransferase/glucosamine-1-phosphate
          acetyltransferase; Provisional.
          Length = 458

 Score = 29.4 bits (67), Expect = 1.2
 Identities = 13/29 (44%), Positives = 17/29 (58%), Gaps = 1/29 (3%)

Query: 17 VSSVKTTDDKKVVLVTGKGEAEKVQKELE 45
          V SVK     K+V V G G AE+V++ L 
Sbjct: 37 VDSVKKAGIDKIVTVVGHG-AEEVKEVLG 64


>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Novel Protein Kinase C delta.
           Serine/Threonine Kinases (STKs), Novel Protein Kinase C
           (nPKC), delta isoform, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The nPKC subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PKCs are classified into three groups
           (classical, atypical, and novel) depending on their mode
           of activation and the structural characteristics of
           their regulatory domain. nPKCs are calcium-independent,
           but require DAG (1,2-diacylglycerol) and
           phosphatidylserine (PS) for activity. There are four
           nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta
           plays a role in cell cycle regulation and programmed
           cell death in many cell types. It slows down cell
           proliferation, inducing cell cycle arrest and enhancing
           cell differentiation. PKC-delta is also involved in the
           regulation of transcription as well as immune and
           inflammatory responses. It plays a central role in the
           genotoxic stress response that leads to DNA
           damaged-induced apoptosis.
          Length = 316

 Score = 29.1 bits (65), Expect = 1.2
 Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 6/63 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P++I PE +        Y    D WS G+ L E+  G+ P+   G   ++L + ++ D P
Sbjct: 160 PDYIAPEIL----QGLKYTFSVDWWSFGVLLYEMLIGQSPFH--GDDEDELFESIRVDTP 213

Query: 165 RLP 167
             P
Sbjct: 214 HYP 216


>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine
           Kinases, Bruton's tyrosine kinase and Bone marrow kinase
           on the X chromosome.  Protein Tyrosine Kinase (PTK)
           family; Bruton's tyrosine kinase (Btk) and Bone marrow
           kinase on the X chromosome (Bmx); catalytic (c) domain.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Btk and
           Bmx (also named Etk) are members of the Tec subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases with similarity to Src kinases in that they
           contain Src homology protein interaction domains (SH3,
           SH2) N-terminal to the catalytic tyr kinase domain.
           Unlike Src kinases, most Tec subfamily members (except
           Rlk) also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. In addition, Btk
           contains the Tec homology (TH) domain with proline-rich
           and zinc-binding regions. Tec kinases are expressed
           mainly by haematopoietic cells. Btk is expressed in
           B-cells, and a variety of myeloid cells including mast
           cells, platelets, neutrophils, and dendrictic cells. It
           interacts with a variety of partners, from cytosolic
           proteins to nuclear transcription factors, suggesting a
           diversity of functions. Stimulation of a diverse array
           of cell surface receptors, including antigen engagement
           of the B-cell receptor (BCR), leads to PH-mediated
           membrane translocation of Btk and subsequent
           phosphorylation by Src kinase and activation. Btk plays
           an important role in the life cycle of B-cells including
           their development, differentiation, proliferation,
           survival, and apoptosis. Mutations in Btk cause the
           primary immunodeficiency disease, X-linked
           agammaglobulinaemia (XLA) in humans. Bmx is primarily
           expressed in bone marrow and the arterial endothelium,
           and plays an important role in ischemia-induced
           angiogenesis. It facilitates arterial growth, capillary
           formation, vessel maturation, and bone marrow-derived
           endothelial progenitor cell mobilization.
          Length = 256

 Score = 29.1 bits (65), Expect = 1.2
 Identities = 10/28 (35%), Positives = 19/28 (67%), Gaps = 1/28 (3%)

Query: 120 SNYDIRSDVWSLGISLIELAT-GRFPYD 146
           S +  +SDVW+ G+ + E+ + G+ PY+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYE 203


>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine
           Kinases, Tyrosine kinase expressed in hepatocellular
           carcinoma and Resting lymphocyte kinase.  Protein
           Tyrosine Kinase (PTK) family; Tyrosine kinase expressed
           in hepatocellular carcinoma (Tec) and Resting lymphocyte
           kinase (Rlk); catalytic (c) domain. The PTKc family is
           part of a larger superfamily, that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Tec and
           Rlk (also named Txk) are members of the Tec subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases with similarity to Src kinases in that they
           contain Src homology protein interaction domains (SH3,
           SH2) N-terminal to the catalytic tyr kinase domain.
           Unlike Src kinases, most Tec subfamily members (except
           Rlk) also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. Instead of PH, Rlk
           contains an N-terminal cysteine-rich region. In addition
           to PH, Tec also contains the Tec homology (TH) domain
           with proline-rich and zinc-binding regions. Tec kinases
           are expressed mainly by haematopoietic cells. Tec is
           more widely-expressed than other Tec subfamily kinases.
           It is found in endothelial cells, both B- and T-cells,
           and a variety of myeloid cells including mast cells,
           erythroid cells, platelets, macrophages and neutrophils.
           Rlk is expressed in T-cells and mast cell lines. Tec and
           Rlk are both key components of T-cell receptor (TCR)
           signaling. They are important in TCR-stimulated
           proliferation, IL-2 production and phopholipase C-gamma1
           activation.
          Length = 256

 Score = 29.0 bits (65), Expect = 1.3
 Identities = 13/30 (43%), Positives = 20/30 (66%), Gaps = 1/30 (3%)

Query: 118 NPSNYDIRSDVWSLGISLIELAT-GRFPYD 146
           N S Y  +SDVWS G+ + E+ T G+ P++
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203


>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine
           Kinase, Apoptosis-associated tyrosine kinase 2.  Protein
           Tyrosine Kinase (PTK) family; Apoptosis-associated
           tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Aatyk2 is
           a member of the Aatyk subfamily of proteins, which are
           receptor kinases containing a transmembrane segment and
           a long C-terminal cytoplasmic tail with a catalytic
           domain. Aatyk2 is also called lemur tyrosine kinase 2
           (Lmtk2) or brain-enriched kinase (Brek). It is expressed
           at high levels in early postnatal brain, and has been
           shown to play a role in nerve growth factor (NGF)
           signaling. Studies with knockout mice reveal that Aatyk2
           is essential for late stage spermatogenesis. Although it
           is classified as a tyr kinase based on sequence
           similarity and the phylogenetic tree, Aatyk2 has been
           characterized as a serine/threonine kinase.
          Length = 268

 Score = 29.1 bits (65), Expect = 1.4
 Identities = 16/43 (37%), Positives = 23/43 (53%), Gaps = 2/43 (4%)

Query: 126 SDVWSLGISLIEL-ATGRFPYDTWGSPFEQLKQVVQDDPPRLP 167
           S+VW+LG++L EL      PY    S  E L  V++D   +L 
Sbjct: 189 SNVWALGVTLWELFENAAQPYSHL-SDREVLNHVIKDQQVKLF 230


>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the
           Serine/Threonine Kinase, p38alpha Mitogen-Activated
           Protein Kinase.  Serine/Threonine Kinases (STKs),
           p38alpha subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           p38alpha subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. p38 kinases are mitogen-activated protein
           kinases (MAPKs), serving as important mediators of
           cellular responses to extracellular signals. They are
           activated by the MAPK kinases MKK3 and MKK6, which in
           turn are activated by upstream MAPK kinase kinases
           including TAK1, ASK1, and MLK3, in response to cellular
           stresses or inflammatory cytokines. Vertebrates contain
           four isoforms of p38, named alpha, beta, gamma, and
           delta. p38alpha, also called MAPK14, is expressed in
           most tissues and is the major isoform involved in the
           immune and inflammatory response. It is the central p38
           MAPK involved in myogenesis. It plays a role in
           regulating cell cycle check-point transition and
           promoting cell differentiation. p38alpha also regulates
           cell proliferation and death through crosstalk with the
           JNK pathway. Its substrates include MAPK activated
           protein kinase 2 (MK2), MK5, and the transcription
           factors ATF2 and Mitf.
          Length = 345

 Score = 28.9 bits (64), Expect = 1.4
 Identities = 15/51 (29%), Positives = 24/51 (47%), Gaps = 2/51 (3%)

Query: 118 NPSNYDIRSDVWSLGISLIELATGR--FPYDTWGSPFEQLKQVVQDDPPRL 166
           N  +Y+   D+WS+G  + EL TGR  FP        + + ++V      L
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241


>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 4.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 4 (FGFR4); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR4 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. Unlike other FGFRs,
           there is only one splice form of FGFR4. It binds FGF1,
           FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective
           ligand for FGFR4. Although disruption of FGFR4 in mice
           causes no obvious phenotype, in vivo inhibition of FGFR4
           in cultured skeletal muscle cells resulted in an arrest
           of muscle progenitor differentiation. FGF6 and FGFR4 are
           uniquely expressed in myofibers and satellite cells.
           FGF6/FGFR4 signaling appears to play a key role in the
           regulation of muscle regeneration. A polymorphism in
           FGFR4 is found in head and neck squamous cell carcinoma.
          Length = 314

 Score = 28.8 bits (64), Expect = 1.4
 Identities = 19/52 (36%), Positives = 27/52 (51%), Gaps = 8/52 (15%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQ-----DDPPRLP 167
           Y  +SDVWS GI + E+ T G  PY   G P E+L ++++     D P    
Sbjct: 213 YTHQSDVWSFGILMWEIFTLGGSPYP--GIPVEELFKLLREGHRMDKPSNCT 262


>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 3.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 3 (FGFR3); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR3 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. Many FGFR3 splice
           variants have been reported with the IIIb and IIIc
           isoforms being the predominant forms. FGFR3 IIIc is the
           isoform expressed in chondrocytes, the cells affected in
           dwarfism, while IIIb is expressed in epithelial cells.
           FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and
           FGF23. It is a negative regulator of long bone growth.
           In the cochlear duct and in the lens, FGFR3 is involved
           in differentiation while it appears to have a role in
           cell proliferation in epithelial cells. Germline
           mutations in FGFR3 are associated with skeletal
           disorders including several forms of dwarfism. Some
           missense mutations are associated with multiple myeloma
           and carcinomas of the bladder and cervix. Overexpression
           of FGFR3 is found in thyroid carcinoma.
          Length = 334

 Score = 28.8 bits (64), Expect = 1.5
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQD 161
           Y  +SDVWS G+ L E+ T G  PY   G P E+L +++++
Sbjct: 213 YTHQSDVWSFGVLLWEIFTLGGSPYP--GIPVEELFKLLKE 251


>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine
           Kinase, Receptor tyrosine kinase-like Orphan Receptor 1.
            Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
           kinase-like Orphan Receptor 1 (Ror1); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Ror
           proteins are orphan receptor tyr kinases (RTKs)
           containing an extracellular region with
           immunoglobulin-like, cysteine-rich, and kringle domains,
           a transmembrane segment, and an intracellular catalytic
           domain. Ror RTKs are unrelated to the nuclear receptor
           subfamily called retinoid-related orphan receptors
           (RORs). RTKs are usually activated through ligand
           binding, which causes dimerization and
           autophosphorylation of the intracellular tyr kinase
           catalytic domain. Ror kinases are expressed in many
           tissues during development. Avian Ror1 was found to be
           involved in late limb development. Studies in mice
           reveal that Ror1 is important in the regulation of
           neurite growth in central neurons, as well as in
           respiratory development. Loss of Ror1 also enhances the
           heart and skeletal abnormalities found in Ror2-deficient
           mice.
          Length = 283

 Score = 28.8 bits (64), Expect = 1.6
 Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 17/91 (18%)

Query: 91  DLLIIRGLYGAD---CDPNFIRPERIDPSGNP--SNYDIRSDVWSLGISLIELAT-GRFP 144
           DL + R +Y AD     P  + P R  P        +   SD+WS G+ L E+ + G  P
Sbjct: 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Query: 145 YDTWGSPFEQLKQVV---------QDDPPRL 166
           Y  +G   +++ ++V         +D PPR+
Sbjct: 227 Y--YGFSNQEVIEMVRKRQLLPCSEDCPPRM 255


>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional.
          Length = 496

 Score = 28.7 bits (64), Expect = 1.6
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 22/85 (25%)

Query: 105 PNFIRPE--RIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQD- 161
           P ++ PE  R  P      Y  ++D++SLG+ L EL T + P+D      E +++V+   
Sbjct: 209 PYYVAPEIWRRKP------YSKKADMFSLGVLLYELLTLKRPFDG-----ENMEEVMHKT 257

Query: 162 -----DPPRLPPGEFSSDFKDFITL 181
                DP  LPP   S + ++ +T 
Sbjct: 258 LAGRYDP--LPP-SISPEMQEIVTA 279


>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional.
          Length = 440

 Score = 28.8 bits (64), Expect = 1.7
 Identities = 14/41 (34%), Positives = 24/41 (58%), Gaps = 1/41 (2%)

Query: 120 SNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQ 160
           +NY    D+WSLG  + E+  G +P  +  S  +QL +++Q
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQ 285


>gnl|CDD|223714 COG0641, AslB, Arylsulfatase regulator (Fe-S oxidoreductase)
           [General function prediction only].
          Length = 378

 Score = 28.6 bits (64), Expect = 1.8
 Identities = 14/71 (19%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 13  IGVTVSSVKTTDDKKVVLVTGKGEAEKVQKELETLRCIYIQDYHLCVRSTRYFSVDTFHQ 72
           IG+++   +   DK  V  +GKG  ++V K LE      +Q + +   +    +      
Sbjct: 117 IGISIDGPEEIHDKYRVTKSGKGTFDRVMKGLE-----LLQAHGVDFNTLTVVNRQNVLH 171

Query: 73  RLQFLLHLFRF 83
             +    L   
Sbjct: 172 PEEIYHFLKSE 182


>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 2.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 2 (FGFR2); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR2 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. There are many splice
           variants of FGFR2 which show differential expression and
           binding to FGF ligands. Disruption of either FGFR2 or
           FGFR2b is lethal in mice, due to defects in the placenta
           or severe impairment of tissue development including
           lung, limb, and thyroid, respectively. Disruption of
           FGFR2c in mice results in defective bone and skull
           development. Genetic alterations of FGFR2 are associated
           with many human skeletal disorders including Apert
           syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and
           Pfeiffer syndrome.
          Length = 304

 Score = 28.4 bits (63), Expect = 1.9
 Identities = 16/41 (39%), Positives = 26/41 (63%), Gaps = 3/41 (7%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQD 161
           Y  +SDVWS G+ + E+ T G  PY   G P E+L +++++
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEELFKLLKE 254


>gnl|CDD|236908 PRK11423, PRK11423, methylmalonyl-CoA decarboxylase; Provisional.
          Length = 261

 Score = 28.5 bits (64), Expect = 1.9
 Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 2/39 (5%)

Query: 126 SDVWSLGISLIEL-ATGRFPYDTWGSPFEQLKQVVQDDP 163
           S VWS G  + EL + GR P  ++  P  Q+ +++Q  P
Sbjct: 59  SKVWSAGHDIHELPSGGRDPL-SYDDPLRQILRMIQKFP 96


>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mitogen-activated protein
           kinase kinase kinase kinase 5.  Serine/threonine kinases
           (STKs), mitogen-activated protein kinase (MAPK) kinase
           kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MAP4K5 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Members of this
           subfamily contain an N-terminal catalytic domain and a
           C-terminal citron homology (CNH) regulatory domain,
           similar to MAP4K4/6. MAP4Ks are involved in some MAPK
           signaling pathways that are important in mediating
           cellular responses to extracellular signals by
           activating a MAPK kinase kinase (MAPKKK or MAP3K or
           MKKK). Each MAPK cascade is activated either by a small
           GTP-binding protein or by an adaptor protein, which
           transmits the signal either directly to a MAP3K to start
           the triple kinase core cascade or indirectly through a
           mediator kinase, a MAP4K. MAP4K5, also called germinal
           center kinase-related enzyme (GCKR), has been shown to
           activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5
           also facilitates Wnt signaling in B cells, and may
           therefore be implicated in the control of cell fate,
           proliferation, and polarity.
          Length = 267

 Score = 28.5 bits (63), Expect = 1.9
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 7/81 (8%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFP-YDTWGSPFEQLKQVVQDD- 162
           P ++ PE      N   Y+   D+W++GI+ IELA  + P +D    P   L  + + + 
Sbjct: 170 PYWMAPEVAAVEKN-GGYNQLCDIWAVGITAIELAELQPPMFDL--HPMRALFLMSKSNF 226

Query: 163 -PPRLPPG-EFSSDFKDFITL 181
            PP+L    ++SS F +F+ +
Sbjct: 227 QPPKLKDKTKWSSTFHNFVKI 247


>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase,
           Kit.  Protein Tyrosine Kinase (PTK) family; Kit (or
           c-Kit); catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Kit is a member of the
           Platelet Derived Growth Factor Receptor (PDGFR)
           subfamily of proteins, which are receptor tyr kinases
           (RTKs) containing an extracellular ligand-binding region
           with five immunoglobulin-like domains, a transmembrane
           segment, and an intracellular catalytic domain. The
           binding of Kit to its ligand, the stem-cell factor
           (SCF), leads to receptor dimerization, trans
           phosphorylation and activation, and intracellular
           signaling. Kit is important in the development of
           melanocytes, germ cells, mast cells, hematopoietic stem
           cells, the interstitial cells of Cajal, and the
           pacemaker cells of the GI tract. Kit signaling is
           involved in major cellular functions including cell
           survival, proliferation, differentiation, adhesion, and
           chemotaxis. Mutations in Kit, which result in
           constitutive ligand-independent activation, are found in
           human cancers such as gastrointestinal stromal tumor
           (GIST) and testicular germ cell tumor (TGCT). The
           aberrant expression of Kit and/or SCF is associated with
           other tumor types such as systemic mastocytosis and
           cancers of the breast, neurons, lung, prostate, colon,
           and rectum.  Although the structure of the human Kit
           catalytic domain is known, it is excluded from this
           specific alignment model because it contains a deletion
           in its sequence.
          Length = 375

 Score = 28.7 bits (64), Expect = 1.9
 Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 8/55 (14%)

Query: 122 YDIRSDVWSLGISLIEL-ATGRFPYDTWGSP-----FEQLKQVVQDDPPRLPPGE 170
           Y   SDVWS GI L E+ + G  PY   G P     ++ +K+  +   P   P E
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYP--GMPVDSKFYKMIKEGYRMLSPECAPSE 345


>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase,
           REarranged during Transfection protein.  Protein
           Tyrosine Kinase (PTK) family; RET (REarranged during
           Transfection) protein; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. RET is a
           receptor tyr kinase (RTK) containing an extracellular
           region with four cadherin-like repeats, a
           calcium-binding site, and a cysteine-rich domain, a
           transmembrane segment, and an intracellular catalytic
           domain. It is part of a multisubunit complex that binds
           glial-derived neurotropic factor (GDNF) family ligands
           (GFLs) including GDNF, neurturin, artemin, and
           persephin. GFLs bind RET along with four GPI-anchored
           coreceptors, bringing two RET molecules together,
           leading to autophosphorylation, activation, and
           intracellular signaling. RET is essential for the
           development of the sympathetic, parasympathetic and
           enteric nervous systems, and the kidney. RET disruption
           by germline mutations causes diseases in humans
           including congenital aganglionosis of the
           gastrointestinal tract (Hirschsprung's disease) and
           three related inherited cancers: multiple endocrine
           neoplasia type 2A (MEN2A), MEN2B, and familial medullary
           thyroid carcinoma (FMTC).
          Length = 290

 Score = 28.4 bits (63), Expect = 1.9
 Identities = 13/25 (52%), Positives = 16/25 (64%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y  +SDVWS G+ L E+ T G  PY
Sbjct: 206 YTTQSDVWSFGVLLWEIVTLGGNPY 230


>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Protein Kinase B beta.
           Serine/Threonine Kinases (STKs), Protein Kinase B (PKB)
           or Akt subfamily, beta (or Akt2) isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PKB subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. There are three
           PKB isoforms from different genes, PKB-alpha (or Akt1),
           PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
           contains an N-terminal pleckstrin homology (PH) domain
           and a C-terminal catalytic domain. PKB-beta is the
           predominant PKB isoform expressed in insulin-responsive
           tissues. It plays a critical role in the regulation of
           glucose homeostasis. It is also implicated in muscle
           cell differentiation. Mice deficient in PKB-beta display
           normal growth weights but exhibit severe insulin
           resistance and diabetes, accompanied by lipoatrophy and
           B-cell failure.
          Length = 323

 Score = 28.4 bits (63), Expect = 1.9
 Identities = 16/63 (25%), Positives = 32/63 (50%), Gaps = 6/63 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P ++ PE ++ +    +Y    D W LG+ + E+  GR P+  +    E+L +++  +  
Sbjct: 159 PEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEI 212

Query: 165 RLP 167
           R P
Sbjct: 213 RFP 215


>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein
           Tyrosine Kinase, Janus kinase 1.  Protein Tyrosine
           Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic
           (c) domain (repeat 2). The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Jak1 is a member of the
           Janus kinase (Jak) subfamily of proteins, which are
           cytoplasmic (or nonreceptor) tyr kinases containing an
           N-terminal FERM domain, followed by a Src homology 2
           (SH2) domain, a pseudokinase domain, and a C-terminal
           tyr kinase domain. Jaks are crucial for cytokine
           receptor signaling. They are activated by
           autophosphorylation upon cytokine-induced receptor
           aggregation, and subsequently trigger downstream
           signaling events such as the phosphorylation of signal
           transducers and activators of transcription (STATs).
           Jak1 is widely expressed in many tissues. Many cytokines
           are dependent on Jak1 for signaling, including those
           that use the shared receptor subunits common gamma chain
           (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6,
           IL-11, oncostatin M, G-CSF, and IFNs, among others). The
           many varied interactions of Jak1 and its ubiquitous
           expression suggest many biological roles. Jak1 is
           important in neurological development, as well as in
           lymphoid development and function. It also plays a role
           in the pathophysiology of cardiac hypertrophy and heart
           failure. A mutation in the ATP-binding site of Jak1 was
           identified in a human uterine leiomyosarcoma cell line,
           resulting in defective cytokine induction and antigen
           presentation, thus allowing the tumor to evade the
           immune system.
          Length = 284

 Score = 28.4 bits (63), Expect = 2.1
 Identities = 12/21 (57%), Positives = 15/21 (71%)

Query: 120 SNYDIRSDVWSLGISLIELAT 140
           S + I SDVWS G++L EL T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207


>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the
           Protein Tyrosine Kinases, Janus kinases 2 and 3.
           Protein Tyrosine Kinase (PTK) family; Janus kinase 2
           (Jak2) and Jak3; catalytic (c) domain (repeat 2). The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Jak2 and
           Jak3 are members of the Janus kinase (Jak) subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal FERM domain, followed
           by a Src homology 2 (SH2) domain, a pseudokinase domain,
           and a C-terminal catalytic tyr kinase domain. Jaks are
           crucial for cytokine receptor signaling. They are
           activated by autophosphorylation upon cytokine-induced
           receptor aggregation, and subsequently trigger
           downstream signaling events such as the phosphorylation
           of signal transducers and activators of transcription
           (STATs). Jak2 is widely expressed in many tissues while
           Jak3 is expressed only in hematopoietic cells. Jak2 is
           essential for the signaling of hormone-like cytokines
           such as growth hormone, erythropoietin, thrombopoietin,
           and prolactin, as well as some IFNs and cytokines that
           signal through the IL-3 and gp130 receptors. Jak3 binds
           the shared receptor subunit common gamma chain and thus,
           is essential in the signaling of cytokines that use it
           such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.
           Disruption of Jak2 in mice results in an embryonic
           lethal phenotype with multiple defects including
           erythropoietic and cardiac abnormalities. It is the only
           Jak gene that results in a lethal phenotype when
           disrupted in mice. A mutation in the pseudokinase domain
           of Jak2, V617F, is present in many myeloproliferative
           diseases, including almost all patients with
           polycythemia vera, and 50% of patients with essential
           thrombocytosis and myelofibrosis. Jak3 is important in
           lymphoid development and myeloid cell differentiation.
           Inactivating mutations in Jak3 have been reported in
           humans with severe combined immunodeficiency (SCID).
          Length = 284

 Score = 28.2 bits (63), Expect = 2.2
 Identities = 12/25 (48%), Positives = 15/25 (60%)

Query: 116 SGNPSNYDIRSDVWSLGISLIELAT 140
           S   S + + SDVWS G+ L EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206


>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein
           Serine/Threonine Kinase, G protein-coupled Receptor
           Kinase 6.  Serine/Threonine Kinases (STKs), G
           protein-coupled Receptor Kinase (GRK) subfamily, GRK6
           isoform, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The GRK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. GRKs phosphorylate and regulate G
           protein-coupled receptors (GPCRs), the largest
           superfamily of cell surface receptors which regulate
           some part of nearly all physiological functions.
           Phosphorylated GPCRs bind to arrestins, which prevents
           further G protein signaling despite the presence of
           activating ligand. There are seven types of GRKs, named
           GRK1 to GRK7. GRK6 is widely expressed in many tissues.
           t is expressed as multiple splice variants with
           different domain architectures. It is
           post-translationally palmitoylated and localized in the
           membrane. GRK6 plays important roles in the regulation
           of dopamine, M3 muscarinic, opioid, and chemokine
           receptor signaling. It also plays maladaptive roles in
           addiction and Parkinson's disease. GRK6-deficient mice
           exhibit altered dopamine receptor regulation, decreased
           lymphocyte chemotaxis, and increased acute inflammation
           and neutrophil chemotaxis.
          Length = 285

 Score = 28.4 bits (63), Expect = 2.3
 Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 20/75 (26%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQ-DDP 163
           P  ++ ER         Y    D W+LG  L E+  G+       SPF+Q K+ ++ ++ 
Sbjct: 170 PEVVKNER---------YTFSPDWWALGCLLYEMIAGQ-------SPFQQRKKKIKREEV 213

Query: 164 PRL---PPGEFSSDF 175
            RL      E+S  F
Sbjct: 214 ERLVKEVQEEYSEKF 228


>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine
           Kinase, HER2.  Protein Tyrosine Kinase (PTK) family;
           HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. HER2 is a
           member of the EGFR (HER, ErbB) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular EGF-related ligand-binding region, a
           transmembrane helix, and a cytoplasmic region with a tyr
           kinase domain and a regulatory C-terminal tail. Unlike
           other tyr kinases, phosphorylation of the activation
           loop of EGFR proteins is not critical to their
           activation. Instead, they are activated by
           ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. HER2 does not bind to any known EGFR
           subfamily ligands, but contributes to the kinase
           activity of all possible heterodimers. It acts as the
           preferred partner with other ligand-bound EGFR proteins
           and functions as a signal amplifier, with the HER2-HER3
           heterodimer being the most potent pair in mitogenic
           signaling. HER2 plays an important role in cell
           development, proliferation, survival and motility.
           Overexpression of HER2 results in its activation and
           downstream signaling, even in the absence of ligand.
           HER2 overexpression, mainly due to gene amplification,
           has been shown in a variety of human cancers. Its role
           in breast cancer is especially well-documented. HER2 is
           up-regulated in about 25% of breast tumors and is
           associated with increases in tumor aggressiveness,
           recurrence and mortality. HER2 is a target for
           monoclonal antibodies and small molecule inhibitors,
           which are being developed as treatments for cancer. The
           first humanized antibody approved for clinical use is
           Trastuzumab (Herceptin), which is being used in
           combination with other therapies to improve the survival
           rates of patients with HER2-overexpressing breast
           cancer.
          Length = 279

 Score = 28.4 bits (63), Expect = 2.3
 Identities = 13/23 (56%), Positives = 17/23 (73%), Gaps = 1/23 (4%)

Query: 125 RSDVWSLGISLIELAT-GRFPYD 146
           +SDVWS G+++ EL T G  PYD
Sbjct: 191 QSDVWSYGVTVWELMTFGAKPYD 213


>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine
           Kinase, Muscle-specific kinase.  Protein Tyrosine Kinase
           (PTK) family; Muscle-specific kinase (Musk); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Musk is a receptor tyr kinase (RTK) containing an
           extracellular region with four immunoglobulin-like
           domains and a cysteine-rich cluster, a transmembrane
           segment, and an intracellular catalytic domain. Musk is
           expressed and concentrated in the postsynaptic membrane
           in skeletal muscle. It is essential for the
           establishment of the neuromuscular junction (NMJ), a
           peripheral synapse that conveys signals from motor
           neurons to muscle cells. Agrin, a large proteoglycan
           released from motor neurons, stimulates Musk
           autophosphorylation and activation, leading to the
           clustering of acetylcholine receptors (AChRs). To date,
           there is no evidence to suggest that agrin binds
           directly to Musk. Mutations in AChR, Musk and other
           partners are responsible for diseases of the NMJ, such
           as the autoimmune syndrome myasthenia gravis.
          Length = 288

 Score = 28.3 bits (63), Expect = 2.3
 Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 17/76 (22%)

Query: 87  GNQDDLLIIRGLYGADCDPNFIRPERIDPSGNPSNYDIRSDVWSLGISLIEL-ATGRFPY 145
            +++D + IR          ++ PE I      + Y   SDVW+ G+ L E+ + G  PY
Sbjct: 188 ASENDAIPIR----------WMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Query: 146 DTWGSPFEQLKQVVQD 161
             +G   E++   V+D
Sbjct: 234 --YGMAHEEVIYYVRD 247


>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine
           Kinases, Vascular Endothelial Growth Factor Receptors.
           Protein Tyrosine Kinase (PTK) family; Vascular
           Endothelial Growth Factor Receptor (VEGFR) subfamily;
           catalytic (c) domain. The VEGFR subfamily consists of
           VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar
           proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           VEGFR subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           seven immunoglobulin (Ig)-like domains, a transmembrane
           segment, and an intracellular catalytic domain. In
           VEGFR3, the fifth Ig-like domain is replaced by a
           disulfide bridge. The binding of VEGFRs to their
           ligands, the VEGFs, leads to receptor dimerization,
           activation, and intracellular signaling. There are five
           VEGF ligands in mammals, which bind, in an overlapping
           pattern to the three VEGFRs, which can form homo or
           heterodimers. VEGFRs regulate the cardiovascular system.
           They are critical for vascular development during
           embryogenesis and blood vessel formation in adults. They
           induce cellular functions common to other growth factor
           receptors such as cell migration, survival, and
           proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta
           growth factor (PLGF). It regulates monocyte and
           macrophage migration, vascular permeability,
           haematopoiesis, and the recruitment of haematopietic
           progenitor cells from the bone marrow.
          Length = 337

 Score = 28.3 bits (63), Expect = 2.3
 Identities = 12/25 (48%), Positives = 16/25 (64%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y  +SDVWS G+ L E+ + G  PY
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPY 276


>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein
           Kinase Like Serine/Threonine Kinases.  Serine/Threonine
           Kinases (STKs), Cyclin-dependent protein kinase like
           (CDKL) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           CDKL subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. CDKs belong to a large family of STKs that are
           regulated by their cognate cyclins. Together, they are
           involved in the control of cell-cycle progression,
           transcription, and neuronal function. This subfamily is
           composed of CDKL1-5 and similar proteins. Some CDKLs,
           like CDKL1 and CDKL3, may be implicated in
           transformation and others, like CDKL3 and CDKL5, are
           associated with mental retardation when impaired. CDKL2
           plays a role in learning and memory.
          Length = 288

 Score = 28.1 bits (63), Expect = 2.6
 Identities = 15/39 (38%), Positives = 20/39 (51%), Gaps = 5/39 (12%)

Query: 119 PSNYDIRSDVWSLGISLIELATGR--FPYDTWGSPFEQL 155
            +NY    DVW++G  + EL  G   FP D   S  +QL
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGD---SDIDQL 211


>gnl|CDD|205436 pfam13256, DUF4047, Domain of unknown function (DUF4047).  This
          presumed domain is functionally uncharacterized. This
          domain family is found in bacteria, and is
          approximately 130 amino acids in length. There are two
          conserved sequence motifs: TEA and FPKT.
          Length = 123

 Score = 27.1 bits (60), Expect = 2.7
 Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 5/44 (11%)

Query: 15 VTVSSVKTTDDKKVVLVTGKGEAEKVQKELETLRCIY--IQDYH 56
          V  +S++  + +   LV+ K + EKV  E E L+ IY  I+DY+
Sbjct: 54 VKATSIEVLEQR---LVSWKEQREKVAVEREALQKIYTEIEDYY 94


>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein
           Serine/Threonine Kinases, Novel Protein Kinase C theta
           and delta.  Serine/Threonine Kinases (STKs), Novel
           Protein Kinase C (nPKC), theta and delta-like isoforms,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The nPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           nPKCs are calcium-independent, but require DAG
           (1,2-diacylglycerol) and phosphatidylserine (PS) for
           activity. There are four nPKC isoforms, delta, epsilon,
           eta, and theta. PKC-theta is selectively expressed in
           T-cells and plays an important and non-redundant role in
           several aspects of T-cell biology. PKC-delta plays a
           role in cell cycle regulation and programmed cell death
           in many cell types.
          Length = 316

 Score = 27.8 bits (62), Expect = 2.9
 Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 6/63 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPP 164
           P++I PE +   G   N  +  D WS G+ L E+  G+ P+   G   ++L   + +D P
Sbjct: 160 PDYIAPEIL--KGQKYNESV--DWWSFGVLLYEMLIGQSPFH--GEDEDELFDSILNDRP 213

Query: 165 RLP 167
             P
Sbjct: 214 HFP 216


>gnl|CDD|238990 cd02033, BchX, Chlorophyllide reductase converts chlorophylls into
           bacteriochlorophylls by reducing the chlorin B-ring.
           This family contains the X subunit of this three-subunit
           enzyme. Sequence and structure similarity between bchX,
           protochlorophyllide reductase L subunit (bchL and chlL)
           and nitrogenase Fe protein (nifH gene) suggest their
           functional similarity. Members of the BchX family serve
           as the unique electron donors to their respective
           catalytic subunits (bchN-bchB, bchY-bchZ and nitrogenase
           component 1). Mechanistically, they hydrolyze ATP and
           transfer electrons through a Fe4-S4 cluster.
          Length = 329

 Score = 28.0 bits (62), Expect = 2.9
 Identities = 14/31 (45%), Positives = 16/31 (51%), Gaps = 1/31 (3%)

Query: 144 PYDTWGSPFEQLKQVVQDDPPRLPPGEFSSD 174
           P  TWG  FEQL   V + PP + P   S D
Sbjct: 257 PGTTWGPLFEQLATNVAEAPP-MRPKPLSQD 286


>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine
           Kinases, Tropomyosin Related Kinases.  Protein Tyrosine
           Kinase (PTK) family; Tropomyosin Related Kinase (Trk)
           subfamily; catalytic (c) domain. The Trk subfamily
           consists of TrkA, TrkB, TrkC, and similar proteins. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Trk
           subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular region with arrays of
           leucine-rich motifs flanked by two cysteine-rich
           clusters followed by two immunoglobulin-like domains, a
           transmembrane segment, and an intracellular catalytic
           domain. Binding to their ligands, the nerve growth
           factor (NGF) family of neutrotrophins, leads to Trk
           receptor oligomerization and activation of the catalytic
           domain. Trk receptors are mainly expressed in the
           peripheral and central nervous systems. They play
           important roles in cell fate determination, neuronal
           survival and differentiation, as well as in the
           regulation of synaptic plasticity. Altered expression of
           Trk receptors is associated with many human diseases.
          Length = 280

 Score = 27.8 bits (62), Expect = 2.9
 Identities = 11/25 (44%), Positives = 16/25 (64%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           +   SDVWS G+ L E+ T G+ P+
Sbjct: 201 FTTESDVWSFGVVLWEIFTYGKQPW 225


>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein
           kinase; Provisional.
          Length = 968

 Score = 28.3 bits (63), Expect = 3.2
 Identities = 11/22 (50%), Positives = 16/22 (72%)

Query: 125 RSDVWSLGISLIELATGRFPYD 146
           +SD++  G+ LIEL TG+ P D
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD 879


>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein
           Serine/Threonine Kinase, DMPK-related cell division
           control protein 42 binding kinase alpha.
           Serine/Threonine Kinases (STKs), DMPK-like subfamily,
           DMPK-related cell division control protein 42 (Cdc42)
           binding kinase (MRCK) alpha isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The DMPK-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MRCK is activated via interaction with the
           small GTPase Cdc42. MRCK/Cdc42 signaling mediates
           myosin-dependent cell motility. MRCKalpha is expressed
           ubiquitously in many tissues. It plays a role in the
           regulation of peripheral actin reorganization and
           neurite outgrowth. It may also play a role in the
           transferrin iron uptake pathway.
          Length = 332

 Score = 27.7 bits (61), Expect = 3.4
 Identities = 13/42 (30%), Positives = 20/42 (47%), Gaps = 1/42 (2%)

Query: 105 PNFIRPERIDP-SGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P++I PE +         Y    D WSLG+ + E+  G  P+
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208


>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of
           Phototropin-like Protein Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Phototropin-like
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           phototropin-like subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Included in this subfamily
           are plant phototropins and predominantly uncharacterized
           fungal STKs whose catalytic domains resemble the
           phototropin kinase domain. One protein from Neurospora
           crassa is called nrc-2. Phototropins are blue-light
           receptors that control responses such as phototropism,
           stromatal opening, and chloroplast movement in order to
           optimize the photosynthetic efficiency of plants. They
           are light-activated STKs that contain an N-terminal
           photosensory domain and a C-terminal catalytic domain.
           The N-terminal domain contains two LOV (Light, Oxygen or
           Voltage) domains that binds FMN. Photoexcitation of the
           LOV domains results in autophosphorylation at multiple
           sites and activation of the catalytic domain. Neurospora
           crassa nrc-2 plays a role in growth and development by
           controlling entry into the conidiation program.
          Length = 316

 Score = 27.6 bits (62), Expect = 3.4
 Identities = 22/75 (29%), Positives = 31/75 (41%), Gaps = 7/75 (9%)

Query: 107 FIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRL 166
           +I PE I   G+ S  D     W+LGI L E+  G  P+   GS  ++    +       
Sbjct: 198 YIAPEVISGDGHGSAVDW----WTLGILLYEMLYGTTPFK--GSNRDETFSNILKKEVTF 251

Query: 167 PP-GEFSSDFKDFIT 180
           P     SS  +D I 
Sbjct: 252 PGSPPVSSSARDLIR 266


>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine
           Kinase, Vascular Endothelial Growth Factor Receptor 2.
           Protein Tyrosine Kinase (PTK) family; Vascular
           Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           VEGFR2 (or Flk1) is a member of the VEGFR subfamily of
           proteins, which are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           seven immunoglobulin (Ig)-like domains, a transmembrane
           segment, and an intracellular catalytic domain. The
           binding of VEGFRs to their ligands, the VEGFs, leads to
           receptor dimerization, activation, and intracellular
           signaling. The carboxyl terminus of VEGFR2 plays an
           important role in its autophosphorylation and
           activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD
           and VEGFE. VEGFR2 signaling is implicated in all aspects
           of normal and pathological vascular endothelial cell
           biology. It induces a variety of cellular effects
           including migration, survival, and proliferation. It is
           critical in regulating embryonic vascular development
           and angiogenesis. VEGFR2 is the major signal transducer
           in pathological angiogenesis including cancer and
           diabetic retinopathy, and is a target for inhibition in
           cancer therapy.
          Length = 343

 Score = 27.7 bits (61), Expect = 3.5
 Identities = 13/25 (52%), Positives = 17/25 (68%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIEL-ATGRFPY 145
           Y I+SDVWS G+ L E+ + G  PY
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPY 282


>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent
           protein Kinase-like Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Cyclin-Dependent
           protein Kinase (CDK)-like subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The CDK-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. CDKs belong to a large family of STKs that are
           regulated by their cognate cyclins. Together, they are
           involved in the control of cell-cycle progression,
           transcription, and neuronal function. CDKs are partly
           regulated by their subcellular localization, which
           defines substrate phosphorylation and the resulting
           specific function. CDK1, CDK2, CDK4, and CDK6 have
           well-defined functions in the cell cycle, such as the
           regulation of the early G1 phase by CDK4 or CDK6, the
           G1/S phase transition by CDK2, or the entry of mitosis
           by CDK1. They also exhibit overlapping cyclin
           specificity and functions in certain conditions.
           Knockout mice with a single CDK deleted remain viable
           with specific phenotypes, showing that some CDKs can
           compensate for each other. For example, CDK4 can
           compensate for the loss of CDK6, however, double
           knockout mice with both CDK4 and CDK6 deleted die in
           utero. CDK8 and CDK9 are mainly involved in
           transcription while CDK5 is implicated in neuronal
           function. CDK7 plays essential roles in both the cell
           cycle as a CDK-Activating Kinase (CAK) and in
           transcription as a component of the general
           transcription factor TFIIH.
          Length = 282

 Score = 27.4 bits (62), Expect = 3.6
 Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 5/42 (11%)

Query: 121 NYDIRSDVWSLGISLIELATGR--FPYDTWGSPFEQLKQVVQ 160
           +Y    D+WS+G    E+ TG+  FP D   S  +QL ++ Q
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGD---SEIDQLFKIFQ 213


>gnl|CDD|151313 pfam10864, DUF2663, Protein of unknown function (DUF2663).  Some
          members in this family of proteins are annotated as
          YpbF however currently no function is known.
          Length = 131

 Score = 26.9 bits (60), Expect = 4.0
 Identities = 11/20 (55%), Positives = 13/20 (65%)

Query: 34 KGEAEKVQKELETLRCIYIQ 53
          K +AEK +KE   LRC  IQ
Sbjct: 79 KKKAEKAEKEFHALRCEIIQ 98


>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 1.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek1 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek1 is
           associated with centrosomes throughout the cell cycle.
           It is involved in the formation of primary cilium and in
           the maintenance of centrosomes. It cycles through the
           nucleus and may be capable of relaying signals between
           the cilium and the nucleus. Nek1 is implicated in the
           development of polycystic kidney disease, which is
           characterized by benign polycystic tumors formed by
           abnormal overgrowth of renal epithelial cells. It
           appears also to be involved in DNA damage response, and
           may be important for both correct DNA damage checkpoint
           activation and DNA repair.
          Length = 256

 Score = 27.5 bits (61), Expect = 4.0
 Identities = 15/59 (25%), Positives = 29/59 (49%), Gaps = 2/59 (3%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVVQDDPPRLPPGEFSSDFKDFIT 180
           Y+ +SD+W+LG  L E+ T +  ++        LK +    PP      +S D ++ ++
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP--VSSHYSYDLRNLVS 234


>gnl|CDD|173936 cd08177, MAR, Maleylacetate reductase is involved in many
          aromatic compounds degradation pathways of aerobic
          microbes.  Maleylacetate reductases (MAR) play an
          important role in the degradation of aromatic compounds
           in aerobic microbes. In fungi and yeasts, the enzymes
          are involved in the catabolism of compounds such as
          phenol, tyrosine, benzoate, 4-hydroxybenzoate and
          resorcinol. In bacteria, the enzymes contribute to the
          degradation of resorcinol, 2,4-dihydroxybenzoate
          ([beta]-resorcylate) and 2,6-dihydroxybenzoate
          ([gamma]-resorcylate) via hydroxyquinol and
          maleylacetate. Maleylacetate reductases catalyze NADH-
          or NADPH-dependent reduction, at the carbon-carbon
          double bond, of maleylacetate or 2-chloromaleylacetate
          to 3-oxoadipate. In the case of 2-chloromaleylacetate,
          Maleylacetate reductases initially catalyses the
          NAD(P)H-dependent dechlorination to maleylacetate,
          which is then reduced to 3-oxoadipate. This enzyme is a
          homodimer. It is inhibited by thiol-blocking reagents
          such as p-chloromercuribenzoate and Hg++, indicating
          that the cysteine residue is probably necessary for the
          catalytic activity of maleylacetate reductase.
          Length = 337

 Score = 27.5 bits (62), Expect = 4.0
 Identities = 6/43 (13%), Positives = 18/43 (41%)

Query: 5  RAVFNQDEIGVTVSSVKTTDDKKVVLVTGKGEAEKVQKELETL 47
          R VF    +    + ++     + +++T    A K+ + + + 
Sbjct: 3  RVVFGPGALAALAAELERLGASRALVLTTPSLATKLAERVASA 45


>gnl|CDD|224002 COG1076, DjlA, DnaJ-domain-containing proteins 1 [Posttranslational
           modification, protein turnover, chaperones].
          Length = 174

 Score = 26.9 bits (60), Expect = 4.3
 Identities = 5/34 (14%), Positives = 11/34 (32%)

Query: 72  QRLQFLLHLFRFALSGNQDDLLIIRGLYGADCDP 105
           + LQ   H  RF  +   +    ++     +   
Sbjct: 25  RELQRAYHPDRFGKASEAEQRKALQQSAEVNPAY 58


>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional.
          Length = 478

 Score = 27.7 bits (61), Expect = 4.6
 Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 122 YDIRSDVWSLGISLIELATGRFPYDTWGSPFEQLKQVV 159
           Y  ++D+WSLG+ L EL T   P+    S  E ++QV+
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVL 284


>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 9.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek9 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek9, also called
           Nercc1, is primarily a cytoplasmic protein but can also
           localize in the nucleus. It is involved in modulating
           chromosome alignment and splitting during mitosis. It
           interacts with the gamma-tubulin ring complex and the
           Ran GTPase, and is implicated in microtubule
           organization. Nek9 associates with FACT (FAcilitates
           Chromatin Transcription) and modulates interphase
           progression. It also interacts with Nek6, and Nek7,
           during mitosis, resulting in their activation.
          Length = 256

 Score = 27.0 bits (60), Expect = 4.9
 Identities = 10/19 (52%), Positives = 14/19 (73%)

Query: 122 YDIRSDVWSLGISLIELAT 140
           Y+ +SD+W+LG  L EL T
Sbjct: 178 YNFKSDIWALGCVLYELLT 196


>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine
           Kinases, Class EphB Ephrin Receptors.  Protein Tyrosine
           Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
           class EphB receptors; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). Class EphB receptors bind to transmembrane
           ephrin-B ligands. There are six vertebrate EhpB
           receptors (EphB1-6), which display promiscuous
           interactions with three ephrin-B ligands. One exception
           is EphB2, which also interacts with ephrin A5. EphRs
           contain an ephrin-binding domain and two fibronectin
           repeats extracellularly, a transmembrane segment, and a
           cytoplasmic tyr kinase domain. Binding of the ephrin
           ligand to EphR requires cell-cell contact since both are
           anchored to the plasma membrane. The resulting
           downstream signals occur bidirectionally in both
           EphR-expressing cells (forward signaling) and
           ephrin-expressing cells (reverse signaling). Ephrin/EphR
           interaction mainly results in cell-cell repulsion or
           adhesion. EphBRs play important roles in synapse
           formation and plasticity, spine morphogenesis, axon
           guidance, and angiogenesis. In the intestinal
           epithelium, EphBRs are Wnt signaling target genes that
           control cell compartmentalization. They function as
           suppressors of color cancer progression.
          Length = 269

 Score = 27.1 bits (60), Expect = 5.0
 Identities = 17/44 (38%), Positives = 24/44 (54%), Gaps = 4/44 (9%)

Query: 126 SDVWSLGISLIE-LATGRFPYDTWGSPFEQLKQVVQDDPPRLPP 168
           SDVWS GI + E ++ G  PY  W    + +   ++ D  RLPP
Sbjct: 192 SDVWSYGIVMWEVMSYGERPY--WDMSNQDVINAIEQD-YRLPP 232


>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein
           Serine/Threonine Kinase, Classical Protein Kinase C
           alpha.  Serine/Threonine Kinases (STKs), Classical
           Protein Kinase C (cPKC) subfamily, alpha isoform,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The cPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, cPKCs depend on calcium, DAG
           (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. There are four
           cPKC isoforms, named alpha, betaI, betaII, and gamma.
           PKC-alpha is expressed in many tissues and is associated
           with cell proliferation, apoptosis, and cell motility.
           It plays a role in the signaling of the growth factors
           PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha
           have been detected in many transformed cell lines and
           several human tumors. In addition, PKC-alpha is required
           for HER2 dependent breast cancer invasion.
          Length = 323

 Score = 27.3 bits (60), Expect = 5.4
 Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYD 146
           P++I PE I  +  P  Y    D W+ G+ L E+  G+ P+D
Sbjct: 165 PDYIAPEII--AYQP--YGKSVDWWAYGVLLYEMLAGQPPFD 202


>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy
           protein kinase-like Protein Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Myotonic Dystrophy
           protein kinase (DMPK)-like subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The DMPK-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The DMPK-like subfamily is composed of DMPK
           and DMPK-related cell division control protein 42
           (Cdc42) binding kinase (MRCK). Three isoforms of MRCK
           are known, named alpha, beta and gamma. The DMPK gene is
           implicated in myotonic dystrophy 1 (DM1), an inherited
           multisystemic disorder with symptoms that include muscle
           hyperexcitability, progressive muscle weakness and
           wasting, cataract development, testicular atrophy, and
           cardiac conduction defects. The genetic basis for DM1 is
           the mutational expansion of a CTG repeat in the 3'-UTR
           of DMPK. DMPK is expressed in skeletal and cardiac
           muscles, and in central nervous tissues. The functional
           role of DMPK is not fully understood. It may play a role
           in the signal transduction and homeostasis of calcium.
           MRCK is activated via interaction with the small GTPase
           Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent
           cell motility. MRCKgamma is expressed in heart and
           skeletal muscles, unlike MRCKalpha and MRCKbeta, which
           are expressed ubiquitously.
          Length = 331

 Score = 27.1 bits (60), Expect = 5.5
 Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 15/84 (17%)

Query: 105 PNFIRPERIDP-SGNPSNYDIRSDVWSLGISLIELATGRFPY------DTWGSPFEQLKQ 157
           P++I PE +         Y    D WSLG+ + E+  G  P+      +T+G      K 
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KI 220

Query: 158 VVQDDPPRLPPGE--FSSDFKDFI 179
           +   +  + PP     S + KD I
Sbjct: 221 MNHKEHFQFPPDVTDVSEEAKDLI 244


>gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23.  All proteins
           in this family for which functions are known are
           components of a multiprotein complex used for targeting
           nucleotide excision repair to specific parts of the
           genome. In humans, Rad23 complexes with the XPC protein.
           This family is based on the phylogenomic analysis of JA
           Eisen (1999, Ph.D. Thesis, Stanford University) [DNA
           metabolism, DNA replication, recombination, and repair].
          Length = 378

 Score = 27.2 bits (60), Expect = 5.6
 Identities = 11/17 (64%), Positives = 14/17 (82%)

Query: 152 FEQLKQVVQDDPPRLPP 168
           F+QL+QVVQ +P  LPP
Sbjct: 257 FQQLRQVVQQNPQLLPP 273


>gnl|CDD|214764 smart00653, eIF2B_5, domain present in translation initiation
          factor eIF2B and eIF5. 
          Length = 110

 Score = 26.1 bits (58), Expect = 5.7
 Identities = 12/35 (34%), Positives = 19/35 (54%), Gaps = 4/35 (11%)

Query: 24 DDKKVVLVTGKGEAEKVQKELETLRCIYIQDYHLC 58
          D K  ++V G+   +K+Q  L      YI++Y LC
Sbjct: 53 DGKGRLIVNGRFTPKKLQDLLR----RYIKEYVLC 83


>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine
           Kinase, Tie2.  Protein Tyrosine Kinase (PTK) family;
           Tie2; catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tie2 is a receptor tyr
           kinase (RTK) containing an extracellular region, a
           transmembrane segment, and an intracellular catalytic
           domain. The extracellular region contains an
           immunoglobulin (Ig)-like domain, three epidermal growth
           factor (EGF)-like domains, a second Ig-like domain, and
           three fibronectin type III repeats. Tie2 is expressed
           mainly in endothelial cells and hematopoietic stem
           cells. It is also found in a subset of tumor-associated
           monocytes and eosinophils. The angiopoietins (Ang-1 to
           Ang-4) serve as ligands for Tie2. The binding of Ang-1
           to Tie2 leads to receptor autophosphorylation and
           activation, promoting cell migration and survival. In
           contrast, Ang-2 binding to Tie2 does not result in the
           same response, suggesting that Ang-2 may function as an
           antagonist. Tie2 signaling plays key regulatory roles in
           vascular integrity and quiescence, and in inflammation.
          Length = 303

 Score = 26.9 bits (59), Expect = 6.4
 Identities = 20/52 (38%), Positives = 27/52 (51%), Gaps = 3/52 (5%)

Query: 116 SGNPSNYDIRSDVWSLGISLIELAT-GRFPY--DTWGSPFEQLKQVVQDDPP 164
           S N S Y   SDVWS G+ L E+ + G  PY   T    +E+L Q  + + P
Sbjct: 194 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245


>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein
           Tyrosine Kinases, Janus kinases.  Protein Tyrosine
           Kinase (PTK) family; Janus kinase (Jak) subfamily;
           catalytic (c) domain (repeat 2). The Jak subfamily is
           composed of Jak1, Jak2, Jak3, TYK2, and similar
           proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Jak subfamily proteins are cytoplasmic (or nonreceptor)
           tyr kinases containing an N-terminal FERM domain,
           followed by a Src homology 2 (SH2) domain, a
           pseudokinase domain, and a C-terminal tyr kinase
           catalytic domain. Most Jaks are expressed in a wide
           variety of tissues, except for Jak3, which is expressed
           only in hematopoietic cells. Jaks are crucial for
           cytokine receptor signaling. They are activated by
           autophosphorylation upon cytokine-induced receptor
           aggregation, and subsequently trigger downstream
           signaling events such as the phosphorylation of signal
           transducers and activators of transcription (STATs).
           Jaks are also involved in regulating the surface
           expression of some cytokine receptors. The Jak-STAT
           pathway is involved in many biological processes
           including hematopoiesis, immunoregulation, host defense,
           fertility, lactation, growth, and embryogenesis.
          Length = 284

 Score = 27.0 bits (60), Expect = 6.4
 Identities = 11/21 (52%), Positives = 14/21 (66%)

Query: 120 SNYDIRSDVWSLGISLIELAT 140
           S +   SDVWS G++L EL T
Sbjct: 187 SKFSSASDVWSFGVTLYELFT 207


>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine
           Kinase, HER3.  Protein Tyrosine Kinase (PTK) family;
           HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic
           domain) family to which this subfamily belongs, is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. HER3 is a
           member of the EGFR (HER, ErbB) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular EGF-related ligand-binding region, a
           transmembrane helix, and a cytoplasmic region with a tyr
           kinase domain and a regulatory C-terminal tail. Unlike
           other tyr kinases, phosphorylation of the activation
           loop of EGFR proteins is not critical to their
           activation. Instead, they are activated by
           ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. HER3 binds the neuregulin ligands, NRG1 and
           NRG2. HER3 contains an impaired tyr kinase domain and
           relies on its heterodimerization partners for activity
           following ligand binding. The HER2-HER3 heterodimer
           constitutes a high affinity co-receptor capable of
           potent mitogenic signaling. HER3 participates in a
           signaling pathway involved in the proliferation,
           survival, adhesion, and motility of tumor cells.
          Length = 279

 Score = 26.8 bits (59), Expect = 6.5
 Identities = 11/25 (44%), Positives = 17/25 (68%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y  +SDVWS G+++ E+ + G  PY
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEPY 212


>gnl|CDD|173941 cd08182, HEPD, Hydroxyethylphosphoate dehydrogenase (HEPD)
          catalyzes the reduction of phosphonoacetaldehyde (PnAA)
          to hydroxyethylphosphoate (HEP).
          Hydroxyethylphosphoate dehydrogenase (HEPD) catalyzes
          the reduction of phosphonoacetaldehyde (PnAA) to
          hydroxyethylphosphoate (HEP) with either NADH or NADPH
          as a cofactor. NADH is the preferred cofactor. PnAA is
          a biosynthetic intermediate for several phosphonates
          such as the antibiotic fosfomycin, phosphinothricin
          tripeptide (PTT), and 2-aminoethylphosphonate (AEP).
          This enzyme is named PhpC in PTT biosynthesis pathway
          in Streptomyces hygroscopicus and S. viridochromogenes.
          Members of this family are only found in bacteria.
          Length = 367

 Score = 26.9 bits (60), Expect = 6.5
 Identities = 14/47 (29%), Positives = 21/47 (44%), Gaps = 2/47 (4%)

Query: 5  RAVFNQDEIGVTVSSVKTTDDKKVVLVTGKGEAEK--VQKELETLRC 49
          R +F +  I    S +K    K+V+LVTG   A    +   L+ L  
Sbjct: 3  RIIFGRGAIAKLPSLLKGLGGKRVLLVTGPRSAIASGLTDILKPLGT 49


>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family
           Serine/Threonine Kinases.  Serine/Threonine Kinases
           (STKs), CMGC family, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           CMGC family is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The CMGC family consists of Cyclin-Dependent
           protein Kinases (CDKs), Mitogen-activated protein
           kinases (MAPKs) such as Extracellular signal-regulated
           kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38,
           and similar proteins. CDKs belong to a large subfamily
           of STKs that are regulated by their cognate cyclins.
           Together, they are involved in the control of cell-cycle
           progression, transcription, and neuronal function. MAPKs
           serve as important mediators of cellular responses to
           extracellular signals. They control critical cellular
           functions including differentiation, proliferation,
           migration, and apoptosis. They are also implicated in
           the pathogenesis of many diseases including multiple
           types of cancer, stroke, diabetes, and chronic
           inflammation.
          Length = 283

 Score = 26.9 bits (60), Expect = 6.8
 Identities = 14/63 (22%), Positives = 23/63 (36%), Gaps = 17/63 (26%)

Query: 122 YDIRSDVWSLGISLIELATGR--FP-----------YDTWGSPFEQ----LKQVVQDDPP 164
           Y    D+WS+G    EL + R  FP           + T G+P  +       + ++   
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 165 RLP 167
             P
Sbjct: 236 SFP 238


>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein
           Serine/Threonine Kinase, DMPK-related cell division
           control protein 42 binding kinase beta.
           Serine/Threonine Kinases (STKs), DMPK-like subfamily,
           DMPK-related cell division control protein 42 (Cdc42)
           binding kinase (MRCK) beta isoform, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The DMPK-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MRCK is activated via interaction with the
           small GTPase Cdc42. MRCK/Cdc42 signaling mediates
           myosin-dependent cell motility. MRCKbeta is expressed
           ubiquitously in many tissues.
          Length = 331

 Score = 26.9 bits (59), Expect = 6.8
 Identities = 13/42 (30%), Positives = 20/42 (47%), Gaps = 1/42 (2%)

Query: 105 PNFIRPERIDP-SGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P++I PE +         Y    D WSLG+ + E+  G  P+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208


>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine
           Kinase, Platelet Derived Growth Factor Receptor beta.
           Protein Tyrosine Kinase (PTK) family; Platelet Derived
           Growth Factor Receptor (PDGFR) beta; catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. PDGFR
           beta is a receptor tyr kinase (RTK) containing an
           extracellular ligand-binding region with five
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding to
           its ligands, the PDGFs, leads to receptor dimerization,
           trans phosphorylation and activation, and intracellular
           signaling. PDGFR beta forms homodimers or heterodimers
           with PDGFR alpha, depending on the nature of the PDGF
           ligand. PDGF-BB and PDGF-DD induce PDGFR beta
           homodimerization. PDGFR signaling plays many roles in
           normal embryonic development and adult physiology. PDGFR
           beta signaling leads to a variety of cellular effects
           including the stimulation of cell growth and chemotaxis,
           as well as the inhibition of apoptosis and GAP
           junctional communication. It is critical in normal
           angiogenesis as it is involved in the recruitment of
           pericytes and smooth muscle cells essential for vessel
           stability. Aberrant PDGFR beta expression is associated
           with some human cancers. The continuously-active fusion
           proteins of PDGFR beta with COL1A1 and TEL are
           associated with dermatofibrosarcoma protuberans (DFSP)
           and a subset of chronic myelomonocytic leukemia (CMML),
           respectively.
          Length = 401

 Score = 26.9 bits (59), Expect = 7.1
 Identities = 14/25 (56%), Positives = 15/25 (60%), Gaps = 1/25 (4%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPY 145
           Y   SDVWS GI L E+ T G  PY
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTPY 342


>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine
           Kinase, Protein Kinase B.  Serine/Threonine Kinases
           (STKs), Protein Kinase B (PKB) or Akt subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PKB subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase (PI3K). There are
           three PKB isoforms from different genes, PKB-alpha (or
           Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
           contains an N-terminal pleckstrin homology (PH) domain
           and a C-terminal catalytic domain. It is activated
           downstream of PI3K and plays important roles in diverse
           cellular functions including cell survival, growth,
           proliferation, angiogenesis, motility, and migration.
           PKB also has a central role in a variety of human
           cancers, having been implicated in tumor initiation,
           progression, and metastasis.
          Length = 323

 Score = 26.7 bits (59), Expect = 7.1
 Identities = 12/41 (29%), Positives = 22/41 (53%), Gaps = 4/41 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
           P ++ PE ++ +    +Y    D W LG+ + E+  GR P+
Sbjct: 159 PEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPF 195


>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional.
          Length = 391

 Score = 26.9 bits (59), Expect = 7.2
 Identities = 9/16 (56%), Positives = 11/16 (68%)

Query: 127 DVWSLGISLIELATGR 142
           D+WS GI L E+AT  
Sbjct: 265 DIWSAGIVLFEMATCH 280


>gnl|CDD|132837 cd07198, Patatin, Patatin-like phospholipase.  Patatin is a storage
           protein of the potato tuber that shows Phospholipase A2
           activity (PLA2; EC 3.1.1.4). Patatin catalyzes the
           nonspecific hydrolysis of phospholipids, glycolipids,
           sulfolipids, and mono- and diacylglycerols, thereby
           showing lipid acyl hydrolase activity. The active site
           includes an oxyanion hole with a conserved GGxR motif;
           it is found in almost all the members of this family.
           The catalytic dyad is formed by a serine and an
           aspartate. Patatin belongs to the alpha-beta hydrolase
           family which is identified by a characteristic
           nucleophile elbow with a consensus sequence of
           Sm-X-Nu-Sm (Sm = small residue, X = any residue and Nu =
           nucleophile). Members of this family have been found
           also in vertebrates. This family includes PNPLA (1-9),
           TGL (3-5), ExoU-like, and SDP1-like subfamilies. There
           are some additional hypothetical proteins included in
           this family.
          Length = 172

 Score = 26.5 bits (59), Expect = 7.4
 Identities = 6/36 (16%), Positives = 12/36 (33%)

Query: 110 PERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPY 145
                P+G       +  + +L     E A+G+   
Sbjct: 68  DGAFPPTGRLLGILRQPLLSALPDDAHEDASGKLFI 103


>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine
           Kinases, Discoidin Domain Receptors.  Protein Tyrosine
           Kinase (PTK) family; Discoidin Domain Receptor (DDR)
           subfamily; catalytic (c) domain. The DDR subfamily
           consists of homologs of mammalian DDR1, DDR2, and
           similar proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           DDR subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular discoidin homology domain, a
           transmembrane segment, an extended juxtamembrane region,
           and an intracellular catalytic domain. The binding of
           the ligand, collagen, to DDRs results in a slow but
           sustained receptor activation. DDRs regulate cell
           adhesion, proliferation, and extracellular matrix
           remodeling. They have been linked to a variety of human
           cancers including breast, colon, ovarian, brain, and
           lung. There is no evidence showing that DDRs act as
           transforming oncogenes. They are more likely to play a
           role in the regulation of tumor growth and metastasis.
          Length = 296

 Score = 26.5 bits (59), Expect = 7.7
 Identities = 14/43 (32%), Positives = 25/43 (58%), Gaps = 9/43 (20%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQL--KQVVQD 161
           +  +SDVW+ G++L E+ T  R        P+E L  +QV+++
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQ------PYEHLTDQQVIEN 245


>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine
           Kinases, Cyclin-Dependent protein Kinase 2 and 3.
           Serine/Threonine Kinases (STKs), Cyclin-dependent
           protein kinase 2 (CDK2) and CDK3 subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The CDK2/3 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. CDKs belong to a
           large family of STKs that are regulated by their cognate
           cyclins. Together, they are involved in the control of
           cell-cycle progression, transcription, and neuronal
           function. CDK2 is regulated by cyclin E or cyclin A.
           Upon activation by cyclin E, it phosphorylates the
           retinoblastoma (pRb) protein which activates E2F
           mediated transcription and allows cells to move into S
           phase. The CDK2/cyclin A complex plays a role in
           regulating DNA replication. CDK2, together with CDK4,
           also regulates embryonic cell proliferation. Despite
           these important roles, mice deleted for the cdk2 gene
           are viable and normal except for being sterile. This may
           be due to compensation provided by CDK1 (also called
           Cdc2), which can also bind cyclin E and drive the G1 to
           S phase transition. CDK3 is regulated by cyclin C and it
           phosphorylates pRB specifically during the G0/G1
           transition. This phosphorylation is required for cells
           to exit G0 efficiently and enter the G1 phase.
          Length = 284

 Score = 26.7 bits (59), Expect = 8.4
 Identities = 21/70 (30%), Positives = 27/70 (38%), Gaps = 19/70 (27%)

Query: 122 YDIRSDVWSLGISLIELATGR--FPYD-----------TWGSPFEQLKQVVQDDP----- 163
           Y    D+WSLG    E+ T R  FP D           T G+P E +   V   P     
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 164 -PRLPPGEFS 172
            P+    +FS
Sbjct: 238 FPKWARQDFS 247


>gnl|CDD|235851 PRK06676, rpsA, 30S ribosomal protein S1; Reviewed.
          Length = 390

 Score = 26.8 bits (60), Expect = 8.6
 Identities = 13/36 (36%), Positives = 21/36 (58%), Gaps = 3/36 (8%)

Query: 11  DEIGVTVSSVKTTDDKKVVLVTGK-GEAEKVQKELE 45
           DE+ V V  +K  D +  +L++ +  EAEK   +LE
Sbjct: 67  DELEVYV--LKVEDGEGNLLLSKRRLEAEKAWDKLE 100


>gnl|CDD|224371 COG1454, EutG, Alcohol dehydrogenase, class IV [Energy production
          and conversion].
          Length = 377

 Score = 26.4 bits (59), Expect = 8.7
 Identities = 10/46 (21%), Positives = 19/46 (41%), Gaps = 5/46 (10%)

Query: 5  RAVFNQDEIGVTVSSVKTTDDKKVVLVTGKGE-----AEKVQKELE 45
            +F +  +      VK    K+ ++VT +G       +KV   L+
Sbjct: 9  EILFGRGSLKELGEEVKRLGAKRALIVTDRGLAKLGLLDKVLDSLD 54


>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine
           Kinase, Mitogen-Activated Protein Kinase.
           Serine/Threonine Kinases (STKs), Mitogen-Activated
           Protein Kinase (MAPK) subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The MAPK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. MAPKs serve as important
           mediators of cellular responses to extracellular
           signals. They control critical cellular functions
           including differentiation, proliferation, migration, and
           apoptosis. They are also implicated in the pathogenesis
           of many diseases including multiple types of cancer,
           stroke, diabetes, and chronic inflammation. Typical MAPK
           pathways involve a triple kinase core cascade comprising
           of the MAPK, which is phosphorylated and activated by a
           MAPK kinase (MAP2K or MKK), which itself is
           phosphorylated and activated by a MAPK kinase kinase
           (MAP3K or MKKK). Each cascade is activated either by a
           small GTP-binding protein or by an adaptor protein,
           which transmits the signal either directly to a MAP3K to
           start the triple kinase core cascade or indirectly
           through a mediator kinase, a MAP4K. There are three main
           typical MAPK subfamilies: Extracellular signal-Regulated
           Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38.
           Some MAPKs are atypical in that they are not regulated
           by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7.
          Length = 330

 Score = 26.3 bits (59), Expect = 9.0
 Identities = 15/45 (33%), Positives = 21/45 (46%), Gaps = 7/45 (15%)

Query: 118 NPSNYDIRSDVWSLGISLIELATGR--FPYDTWG-SPFEQLKQVV 159
           + S Y    D+WS+G    EL T +  FP    G    +QL  +V
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFP----GRDYIDQLNLIV 220


>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine
           Kinase, Tropomyosin Related Kinase C.  Protein Tyrosine
           Kinase (PTK) family; Tropomyosin Related Kinase C
           (TrkC); catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. TrkC is a member of the
           Trk subfamily of proteins, which are receptor tyr
           kinases (RTKs) containing an extracellular region with
           arrays of leucine-rich motifs flanked by two
           cysteine-rich clusters followed by two
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. Binding of TrkC
           to its ligand, neurotrophin 3 (NT3), results in receptor
           oligomerization and activation of the catalytic domain.
           TrkC is broadly expressed in the nervous system and in
           some non-neural tissues including the developing heart.
           NT3/TrkC signaling plays an important role in the
           innervation of the cardiac conducting system and the
           development of smooth muscle cells. Mice deficient with
           NT3 and TrkC have multiple heart defects. NT3/TrkC
           signaling is also critical for the development and
           maintenance of enteric neurons that are important for
           the control of gut peristalsis.
          Length = 291

 Score = 26.5 bits (58), Expect = 9.0
 Identities = 17/53 (32%), Positives = 27/53 (50%), Gaps = 5/53 (9%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQD---DPPRLPPGE 170
           +   SDVWS G+ L E+ T G+ P+       E ++ + Q    + PR+ P E
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIECITQGRVLERPRVCPKE 253


>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine
           Kinase, Ephrin Receptor A2.  Protein Tyrosine Kinase
           (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2
           receptor; catalytic (c) domain. The PTKc family is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). In general, class EphA receptors bind
           GPI-anchored ephrin-A ligands. There are ten vertebrate
           EphA receptors (EphA1-10), which display promiscuous
           interactions with six ephrin-A ligands. EphRs contain an
           ephrin binding domain and two fibronectin repeats
           extracellularly, a transmembrane segment, and a
           cytoplasmic tyr kinase domain. Binding of the ephrin
           ligand to EphR requires cell-cell contact since both are
           anchored to the plasma membrane. The resulting
           downstream signals occur bidirectionally in both
           EphR-expressing cells (forward signaling) and
           ephrin-expressing cells (reverse signaling). Ephrin/EphR
           interaction mainly results in cell-cell repulsion or
           adhesion, making it important in neural development and
           plasticity, cell morphogenesis, cell-fate determination,
           embryonic development, tissue patterning, and
           angiogenesis. The EphA2 receptor is overexpressed in
           tumor cells and tumor blood vessels in a variety of
           cancers including breast, prostate, lung, and colon. As
           a result, it is an attractive target for drug design
           since its inhibition could affect several aspects of
           tumor progression.
          Length = 268

 Score = 26.5 bits (58), Expect = 9.4
 Identities = 19/44 (43%), Positives = 25/44 (56%), Gaps = 6/44 (13%)

Query: 126 SDVWSLGISLIELAT-GRFPYDTWG-SPFEQLKQVVQDDPPRLP 167
           SDVWS GI + E+ + G  PY  W  S  E +K +  +D  RLP
Sbjct: 191 SDVWSFGIVMWEVMSFGERPY--WDMSNHEVMKAI--NDGFRLP 230


>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Classical Protein Kinase C
           beta.  Serine/Threonine Kinases (STKs), Classical
           Protein Kinase C (cPKC) subfamily, beta isoforms,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The cPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, cPKCs depend on calcium, DAG
           (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. There are four
           cPKC isoforms, named alpha, betaI, betaII, and gamma.
           The PKC beta isoforms (I and II), generated by
           alternative splicing of a single gene, are
           preferentially activated by hyperglycemia-induced DAG in
           retinal tissues. This is implicated in diabetic
           microangiopathy such as ischemia, neovascularization,
           and abnormal vasodilator function. PKC-beta also plays
           an important role in VEGF signaling. In addition,
           glucose regulates proliferation in retinal endothelial
           cells via PKC-betaI. PKC-beta is also being explored as
           a therapeutic target in cancer. It contributes to tumor
           formation and is involved in the tumor host mechanisms
           of inflammation and angiogenesis.
          Length = 323

 Score = 26.5 bits (58), Expect = 9.5
 Identities = 14/42 (33%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 105 PNFIRPERIDPSGNPSNYDIRSDVWSLGISLIELATGRFPYD 146
           P++I PE I  +  P  Y    D W+ G+ L E+  G+ P++
Sbjct: 165 PDYIAPEII--AYQP--YGKSVDWWAFGVLLYEMLAGQAPFE 202


>gnl|CDD|216854 pfam02033, RBFA, Ribosome-binding factor A. 
          Length = 104

 Score = 25.5 bits (57), Expect = 9.5
 Identities = 11/36 (30%), Positives = 17/36 (47%), Gaps = 5/36 (13%)

Query: 15 VTVSSVKTTDDKKV--VLVT---GKGEAEKVQKELE 45
          VTV+ V+ + D     V V+    + E E+  K L 
Sbjct: 29 VTVTEVEVSPDLSHAKVYVSVLGDEEEKEETLKALN 64


>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine
           Kinases, Anaplastic Lymphoma Kinase and Leukocyte
           Tyrosine Kinase.  Protein Tyrosine Kinase (PTK) family;
           Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine
           (tyr) Kinase (LTK); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to tyr
           residues in protein substrates. ALK and LTK are orphan
           receptor tyr kinases (RTKs) whose ligands are not yet
           well-defined. RTKs contain an extracellular
           ligand-binding domain, a transmembrane region, and an
           intracellular tyr kinase domain. They are usually
           activated through ligand binding, which causes
           dimerization and autophosphorylation of the
           intracellular tyr kinase catalytic domain. ALK appears
           to play an important role in mammalian neural
           development as well as visceral muscle differentiation
           in Drosophila. ALK is aberrantly expressed as fusion
           proteins, due to chromosomal translocations, in about
           60% of anaplastic large cell lymphomas (ALCLs). ALK
           fusion proteins are also found in rare cases of diffuse
           large B cell lymphomas (DLBCLs). LTK is mainly expressed
           in B lymphocytes and neuronal tissues. It is important
           in cell proliferation and survival. Transgenic mice
           expressing TLK display retarded growth and high
           mortality rate. In addition, a polymorphism in mouse and
           human LTK is implicated in the pathogenesis of systemic
           lupus erythematosus.
          Length = 277

 Score = 26.2 bits (58), Expect = 9.7
 Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 7/50 (14%)

Query: 125 RSDVWSLGISLIEL-ATGRFPYDTWGSPFEQLKQVVQD----DPPRLPPG 169
           ++DVWS G+ L E+ + G  PY   G   +++ + V      DPP+  PG
Sbjct: 201 KTDVWSFGVLLWEIFSLGYMPYP--GRTNQEVMEFVTGGGRLDPPKGCPG 248


>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine
           Kinase, Insulin-like Growth Factor-1 Receptor.  Protein
           Tyrosine Kinase (PTK) family; Insulin-like Growth
           Factor-1 Receptor (IGF-1R); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. IGF-1R is
           a receptor tyr kinases (RTK) that is composed of two
           alphabeta heterodimers. Binding of the ligand (IGF-1 or
           IGF-2) to the extracellular alpha subunit activates the
           intracellular tyr kinase domain of the transmembrane
           beta subunit. Receptor activation leads to
           autophosphorylation, which stimulates downstream kinase
           activities and biological function. IGF-1R signaling is
           important in the differentiation, growth, and survival
           of normal cells. In cancer cells, where it is frequently
           overexpressed, IGF-1R is implicated in proliferation,
           the suppression of apoptosis, invasion, and metastasis.
           IGF-1R is being developed as a therapeutic target in
           cancer treatment.
          Length = 277

 Score = 26.1 bits (57), Expect = 10.0
 Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 3/41 (7%)

Query: 122 YDIRSDVWSLGISLIELAT-GRFPYDTWGSPFEQLKQVVQD 161
           +   SDVWS G+ L E+AT    PY   G   EQ+ + V +
Sbjct: 198 FTTYSDVWSFGVVLWEIATLAEQPYQ--GMSNEQVLRFVME 236


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.322    0.141    0.434 

Gapped
Lambda     K      H
   0.267   0.0685    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 9,605,708
Number of extensions: 893943
Number of successful extensions: 1177
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1147
Number of HSP's successfully gapped: 261
Length of query: 182
Length of database: 10,937,602
Length adjustment: 91
Effective length of query: 91
Effective length of database: 6,901,388
Effective search space: 628026308
Effective search space used: 628026308
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 56 (25.4 bits)